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Abstract 
 
Oesophageal hypomotility is prevalent in 30-50% of the patients with GORD and/or dysphagia. Despite 
advances in diagnosing oesophageal hypomotility, there is no established therapy for this group of 
patients.  
I studied the effect of Azithromycin in patients with Ineffective oesophageal motility (IOM). I assessed 
the value of stimulation tests during oesophageal manometry (multiple rapid swallows, bread swallows 
and swallows with abdominal compression), in identifying the patients who might benefit from 
prokinetic treatment with Azithromycin. 
Effect of stimulation tests in healthy subjects was investigated and normal ranges for oesophageal 
response to these tests was established. Characteristics of normal proximal oesophageal motility were 
defined and the role of proximal oesophageal hypomotility in symptomatology of the patients with IOM 
investigated. Effect of azithromycin on IOM and on the symptoms of these patients were studied in a 
double blind placebo controlled parallel design study. The predictive value of the stimulation tests in 
identifying the responders to azithromycin therapy was evaluated. 
Stimulation tests proved to be effective on inducing stronger motility response in oesophageal body and 
this effect was reproducible. Weak proximal oesophageal motility in patients with IOM is associated 
with reflux symptoms presentation. Azithromycin can convert IOM to normal motility in a subgroup of 
patients. Multiple rapid swallowing as well as swallows with abdominal compression can moderately 
predict the response to prokinetic therapy with Azithromycin. 
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CHAPTER 1: INTRODUCTION 
 
Ineffective oesophageal motility (IOM) is defined as a swallow response associated with poor 
bolus transit in the distal oesophagus on conventional line tracing. Ineffective oesophageal 
motility is believed to be an important pathologic feature of both gastroesophageal reflux disease 
(GORD) (3) and dysphagia symptoms making it an important diagnosis in classification schemes 
for oesophageal manometry (4). In spite of the significant prevalence and role of IOM in the 
pathophysiology of GORD and dysphagia the mechanisms of IOM are not clear and the 
treatment options have very variable and disappointing results. In the present chapter I aim to 
review normal oesophageal motility and current knowledge about the mechanisms of IOM and 
oesophageal hypomotility (OH) as well as the treatment options available.  
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1. NORMAL HUMAN OESOPHAGUS 
 
The oesophagus is a 25-cm long 
muscular tube that connects the pharynx 
to the stomach. The length of the 
oesophagus  at birth varies between 8 and 
10 cm and measures about 19 cm at age 
15 years (5). The oesophagus extends 
from the lower border of the cricoid 
cartilage (at the level of the sixth cervical 
vertebra) to the cardiac orifice of the 
stomach at the side of the body of the 
11th thoracic vertebra. The upper limit in 
the newborn infant is found at the level 
of the fourth or fifth cervical vertebra, and it ends higher, at the level of the ninth thoracic 
vertebra (5).  
 
 
Food, once chewed, tasted and lubricated in the mouth is transported into the stomach via the 
oesophagus. The lower oesophageal sphincter allows gastric content to remain in place and not 
easily regurgitated even during vigorous physical activities. This prevents corrosive digestive 
juices from contaminating the oesophagus itself as well as the mouth, teeth, and vocal cords. 
Swallowing of solids could even take place when one is upside down or in outer space, with 
Figure 1 - Oesophageal landmarks and length (image from About 
Cancer.com) 
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peristalsis alone without the help of gravitational force. Gastric content can also be expelled 
retrogradely in the case of vomiting and reflux. The muscular composition and innervation of the 
oesophagus can sense a multitude of stimuli, propel food bolus inwards and outwards, and form 
areas of high tone (sphincters) which contract and relax appropriately. All these functions are 
only possible due to the extensive nerve supply, receptors, and musculature arrangements within 
this complex organ. Many of these physiological characteristics of the oesophagus can be altered 
in pathological conditions. In order to understand alteration in disease states, understanding of 
normal anatomy and physiology is necessary. 
2. ANATOMICAL AND PHYSIOLOGICAL CONSIDERATIONS 
 
The oesophagus can be divided into upper, middle and lower parts. This distinction is not just 
physical, but has a different embryological basis which determines the anatomy of the organ 
including; muscular composition, innervation, vascular supply and drainage. The embryological 
origin of the upper oesophagus is from branchial arches 4, 5 (6) and, they mainly form the 
striated muscular components of the upper oesophagus; the lower oesophagus by contrast 
originates from mesenchyme of the somites (6) which forms the smooth muscle layers of the 
middle and lower oesophagus. 
 
2.1. Muscle structure of the oesophagus 
 
The oesophagus is a muscular organ composed of two different types of muscles (6). The 
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muscular composition is mainly striated in the upper oesophagus, and as it progresses to the 
lower oesophagus, it becomes mixed with smooth muscle and by the lower third of the 
oesophagus, it is mainly smooth muscle. The oesophageal wall is composed of the outer 
longitudinal muscle and inner circular layer (7). The longitudinal muscle is arranged in fasciculi. 
These fasciculi are more distinct in the upper oesophagus, and merge into a single sheet towards 
the distal oesophagus (6). The circular muscle is arranged as concentric circles and provides the 
peristaltic contractions. Accessory bands of muscles connect the oesophagus to adjacent 
structures (Figure 1). 
 
Page 25 of 281 
 
 
 
Figure 2 - Musculature of the oesophagus - From the following article: Oesophagus - anatomy and development, Braden Kuo 
and Daniela Urma, GI Motility online (2006). (Source of image: Netter medical illustration with permission from Elsevier. All 
rights reserved.) 
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Adaptation within the muscular tube forms the 2 oesophageal sphincters; the upper oesophageal 
sphincter (UOS) and lower oesophageal sphincter (LOS). Upper oesophageal sphincter separates 
the oropharynx from the oesophagus and the lower oesophageal sphincter separates the 
oesophagus from the  stomach. The UOS is mainly a functional sphincter (without any specific 
sphincteric muscle within oesophageal structure), an area with highly sensitive nerves and 
reflexes triggered by swallowing. The LOS on the other hand, is both a functional as well as 
anatomical sphincter.   
 
The lower oesophageal sphincter (LOS) is the incrassate muscle bundle located at the 
oesophagogastric junction, and includes the sling fibers from the greater curvature and clasp 
fibers from the lesser curvature of the stomach (8). In 1979, Liebermann-Meffert et al. 
characterized the clasp and sling muscle fibers in cadavers. They described the sling muscle 
fibers on the greater curvature of the stomach and the clasp muscle fibers on the lesser curvature, 
both found within the gastric cardia (9). The clasp and sling muscle fibers have been 
characterized as having an asymmetric distribution and being the major anatomic component 
within the HPZ (Figure 2). Three distinct anatomic structures, the clasp and sling muscle fibers, 
crural diaphragm, and lower oesophageal circular muscle combine to form the antireflux barrier 
of the proximal stomach and distal oesophagus. The clasp and sling muscle fibers combine with 
the crural diaphragm to form a distal pressure profile. 
 
The LOS tone is maintained by a constant smooth muscle contraction controlled by the nervous 
plexi and neuro-hormonal factors. In addition, the anatomy of LOS represents an area of 
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thickened musculature, corresponding to the diaphragmatic ring, and enters the abdomen at an 
angle. These mechanisms form the LOS and contribute to the prevention of reflux of gastric 
contents as well as allowing the entry of food bolus into the stomach when necessary.  
 
 
 
 
Figure 3 - Micro-computed tomography (Micro-CT) images showing clasp and sling muscle fibers from two different stomach 
and oesophagus specimens procured from organ donors. The image on the left is a view from the inside of the stomach after 
virtually dissecting the mucosa. The sling fibers can be observed encircling more than 75% of the oesophageal lumen and 
then running along the lesser curvature. The image on the right is a view from the outside of the stomach and oesophagus 
after virtually dissecting the longitudinal muscle fibers along the lesser curvature. The sling fibers can be seen running 
longitudinally and being bridged by the clasp fibers (10). 
 
1.1 Layers of the oesophageal wall 
Oesophageal wall is organised into distinct layers (Figure 3 and 4). This layout allows 
movements between the layers that are optimum for a dynamic tube. Within the layers, blood 
vessels, nerves complexes, receptors and connective tissues exist. Histologically, the oesophagus 
has the following 4 concentric layers (11):  
• Mucosal layer 
• Submucosal layer 
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• Muscular layer 
• Adventitial layer 
 
 
A) The mucosal layer consists of three sub-layers (12): 
1- The luminal surface of the oesophagus is lined by "mucous" or non-keratinized stratified 
squamous epithelium(7). The squamous epithelium is adapted to withstand abrasions. 
The epithelium is rich in receptors and sensitive nerves endings(13) that respond to a 
range of stimuli and therefore, intact epithelium is important in normal oesophageal 
sensation.  
2- Below the epithelium are the lamina propria and  
3- muscularis mucosae (12).  
B) The submucosa is mainly connective tissue and it loosely connects the mucous membrane 
and the muscular coat. This layer contains the larger blood vessels, the submucosal 
(Meissner) nerve plexus, and oesophageal glands. 
C) The third layer is the muscular coat, consisting of inner circular and outer longitudinal 
muscles (6). The longitudinal layer is generally thicker than the circular layer:  
a. Inner circular muscle fibers - These fibers are continuous superiorly with the 
fibers of the cricopharyngeal part of the inferior constrictor and inferiorly with 
oblique fibers of the stomach (5).  
b. Outer longitudinal muscle fibers - The longitudinal muscle fibers form a 
continuous coat around the whole of the oesophagus  except posterosuperiorly, 3-
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4 cm below the cricoid cartilage; here, they diverge as 2 fascicles that ascend 
obliquely to the anterior aspect of the oesophagus  (5).  
 
D) The fourth and the outermost fibrous layer is formed by external adventitia of irregular, 
dense connective tissue containing many elastic fibers. The thoracic oesophagus has no 
serosa, which makes it unique to the rest of the gastrointestinal tract (14).  
 
 
Figure 4 - Different layers of the oesophagus including retroperitoneal and intraperitoneal aspects of the oesophagus. 
(Anaesthesia UK: training site of Royal College of Anaesthetics, UK) 
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Figure 5 - A, Normal anatomy of the oesophageal wall; B, endoscopic ultrasonography (EUS) image (Source of the image 
Johns Hopkins Medicine). 
 
1.2 Innervation 
1.2.1 Intrinsic nerve supply 
There are 2 separate plexi within the wall of the oesophagus (Figure 5).  
3. Associated within the submucosal layer is Meissner’s plexus which innervates the muscularis 
mucosae and secretory glands.  
4. Within the deeper muscular layer, between the longitudinal and circular muscle layers is the 
myenteric Auerbach’s plexus. Myenteric plexus controls the contractions of the circular and 
longitudinal layers. The Myenteric plexus also exist in the striated muscle of the upper 
oesophagus, although its function there is less clear.  
5. A network of fibres is believed to connect the two plexi (6).  
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Together the submucous (Meissner’s) and myenteric (Auerbach’s) plexi form the intrinsic 
innervation of the oesophagus. The coordination of spontaneous peristalsis by the smooth muscle 
is controlled by the intrinsic system which is independent from extrinsic control.  
 
 
 
Figure 6 – Intrinsic innervation of oesophagus. (Source of image: Netter medical illustration with permission from Elsevier. 
All rights reserved.) 
 
1.2.2 Extrinsic nerve supply 
A) Motor innervation 
The main motor supply of the oesophagus is the vagus nerve which supplies the upper and lower 
oesophagus.  
1- Branches supplying the upper oesophageal muscles and upper oesophageal sphincter come 
from the nucleus ambiguous. 
2- The vagal efferents for the distal oesophagus and lower oesophageal sphincter originate 
from the dorsal motor neuron of the vagus nerve(6).   
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Although the vagus controls most of the motor function of the oesophagus, it is mainly a sensory 
nerve with up to 85% of vagus nerve fibres being sensory(15). This is discussed further below. 
 
B) Sensory innervation 
The sensory nerves of the oesophagus are less well studied to date compared to motor nerves. 
Sensation in the viscera is also much less discrete compared to somatic sensation. However, 
sensory modalities that exist within the oesophagus are quite wide ranging including; thermo, 
chemo, and mechano-sensations. The sensory innervation can be divided into 2 systems: 
1- vagal afferents are mainly parasympathetic and  
2- spinal afferents which are predominantly sympathetic (16).  
These 2 systems  share some similar activation pathways(17) and interaction between them 
occurs(16). For example, the vagus system, is shown to reduce hyperalgesia by reducing release 
of epinephrine from adrenals(18) as well as reducing sympathetically controlled neurogenic 
inflammation(19). (Figure 6) 
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1.2.3 Vagus afferents 
The vagal fibres are mainly un-myelinated C-fibres and have their cell bodies in the nodose 
ganglia before projecting into the nucleus solitary tract (NST). From the NST, these fibres form 
synapses with second order neurons and project to the brainstem, hypothalamus, amygdale and 
cerebral cortex(15, 20). Vagal afferents are traditionally thought to mediate physiological 
sensations such as satiety and nausea(21). However, related to its physiological motor function, 
the vagus nerve is also believed to be sensitive to mechanosensation (21). Vagal afferents have 
receptors in the mucosa which respond to mucosal fine stroking as well as tension receptors in 
the oesophageal wall responsive to distension(22). Vagal afferents are also enriched with 
Figure 7 - Schematic diagram of vagal and spinal nerve supply to the oesophagus (source of the 
image is GI Motility online (2006)(1). 
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receptors responsive to polymodal intra-luminal stimuli(18) including; osmo(23)-, chemo(24)- 
and thermo(25)-sensations.  
 
1.2.4 Spinal afferents 
The current understanding is that there are mucosal nerve endings that sense intra-luminal 
stimuli(13). They are located in the lamina propria of the mucosa. These nerve endings are 
mainly spinal afferents and have cell bodies in dorsal root ganglia. From the spinal cord, they 
travel into the thalamus and primary sensory cortical areas. The distribution of nerve endings is 
thought to vary according to stimuli. Acid sensing nerve endings are believed to be superficial in 
the epithelium whereas nerve endings deeper in the muscle and serosa are believed to be 
important for mechanosensation..  
1.2.5 Efferent nerves: Autonomic Nervous System 
1- As discussed above in motor supply, the vagus which is predominantly 
parasympathetic(23) provides motor innervation to the muscular layers as well as 
secretory function to the mucosal glands. The origins of the vagus nerve are the nucleus 
ambiguous and dorsal motor nucleus. 
2- Sympathetic innervation of the oesophagus originates mainly from the thoracic 
sympathetic chain (T1-10) with the first thoracic ganglion frequently joint to the cervical 
ganglion to form the stellate ganglion(7). The sympathetic system regulates vascular 
smooth muscle tone, and to a lesser extent than the parasympathetic system, oesophageal 
contractile and secretory functions.  Sympathetic activation had been traditionally 
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believed to increase LOS tone and causes contraction(26) via adrenergic system(27). 
However, a study performed in cats did not show sympathetic modulation of LOS 
function(28). 
 
1.2.6 Efferent nerves: Central nervous system  
Oesophageal body - Within the brain the two main areas for oesophageal sensation, including 
pain processing, are the thalamus and cerebral cortex. The thalamus located in the diencephalon, 
at the dorsal end of the brainstem forms the central core of the brain. It is an important centre for 
relaying and integrating important sensory and motor messages from the periphery to cortical 
areas. It also integrates factors such as consciousness, attention, memory and emotions. The 
cortical areas for oesophageal sensation are; cingulate, insular, sensory, parietal occipital, and 
prefrontal regions based on human studies(29-31).  
 
Since the motor function of the oesophagus is mainly involuntary, much of the known 
information of the role that the central nervous system plays in its function pertains to sensation.  
 
Swallowing - There is limited evidence of motor representation of oesophagus in the cortex in 
swallowing studies. A sophisticated human study using transcranial magnetic stimulation and 
magnetic resonance imaging by Hamdy et al showed that swallowing musculature is discreetly 
and somato-topically represented in the motor and pre-motor cortex of both hemispheres 
asymmetrically and not influenced by the dominant handedness. The loci for mylohyoid, 
pharynx and oesophagus were discreet with the oesophageal locus predominantly in the pre-
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motor cortex (32). Cortical swallowing motor pathways from each hemisphere interact and their 
excitability is modulated by sensory input(33). For example, stimulation of afferent branches of 
cranial nerves Trigeminal and Vagus had been shown to facilitate cortical swallowing pathways 
in the brainstem(34) which will be further discussed below. 
   
Role of the nervous system in regulation of oesophageal motility    
The sequence of peristaltic events has limited contribution of  extrinsic autonomic innervation 
but rather involves the activation of intrinsic sensory neurons, which are coupled via modulatory 
interneurons to excitatory and inhibitory motor neurons projecting into the smooth muscle layer 
(35). 
In contrast to other parts of the gastrointestinal tracts, the external muscle layer of the 
mammalian oesophagus  contains striated muscle fibers, which extend from the 
pharyngoesophageal junction to the thoracic or even abdominal portion, depending on the 
species (36, 37). 
In humans, horses, cats and pigs, the upper and lower portions of the oesophagus  are composed 
of striated and smooth muscles, respectively, with a mixed portion between them  On the other 
hand, the tunica muscularis of the LOS  consists of smooth muscles (37). Proximal oesophageal 
motility is controlled centrally by an extrinsic neuronal mechanism whereas mid and distal 
oesophageal motility is controlled  peripherally by an intrinsic neuronal mechanism (37, 38).  
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2.1 Neural mechanisms of the Oesophageal body    
The mechanisms of peristalsis control are different between striated muscle and smooth muscle 
in the oesophageal body. However, in both portions, oesophageal peristalsis is influenced by a 
swallowing pattern generator (SPG) located in the brainstem (39) 
2.1.1 Neural control of peristalsis in the oesophageal striated muscle portion    
According to the conventional view, the SPG both initiates and organizes peristalsis in the  
striated oesophageal muscle, i.e., both primary and secondary peristaltic contractions are 
centrally mediated in the striated muscle portion(38, 39). Striated muscle fibers are innervated 
exclusively by excitatory vagal efferents that arise from motor neurons localized in the nucleus 
ambiguus and terminate on motor endplates(40). It is possible to confirm this view additionally 
by demonstrating that vagal nerve stimulation evokes twitch contractile responses of the striated 
muscle in an isolated segment of mammalian oesophagus , which are abolished by d-
tubocurarine, an antagonist of nicotinic acetylcholine receptors on the striated muscle, but not by 
atropine, an antagonist of muscarinic acetylcholine receptors on the smooth muscle, or 
hexamethonium, a blocker of ganglionic acetylcholine receptors (41). Peristalsis in the striated 
oesophageal muscle is executed according to a sequence pre-programmed in the compact 
formation of the nucleus ambiguus. The compact formation of the nucleus ambiguus receives 
projections from the central subnucleus of the nucleus of the solitary tract (42), which in turn 
receives vagal afferents from the oesophagus , thus closing a reflex loop for oesophageal motor 
control (42). 
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2.1.2 Neural control of peristalsis in the oesophageal smooth muscle portion    
Motor innervation of the smooth muscle oesophagus  is more complex. Here, the SPG initiates 
peristalsis via preganglionic neurons in the dorsal motor nucleus of the vagus that project to the 
myenteric ganglia in the oesophagus , i.e., the primary peristalsis involves both central and 
peripheral mechanisms (43). The smooth muscle is innervated by myenteric motor neurons that 
can release acetylcholine, tachykinins or nitric oxide (NO) (43). However, the progressing front 
of contraction is organized by virtue of their local reflex circuits that are composed of sensory 
neurons, interneurons and motor neurons as elsewhere in the gut, i.e., the secondary peristalsis is 
entirely due to peripheral mechanisms in the smooth muscle oesophagus  (38, 43). In fact, the 
smooth muscle oesophagus  can exhibit propulsive peristaltic contractions in response to an 
intraluminal bolus of food even in a vagotomised model. Moreover, peristaltic reflexes can be 
elicited by distension in an isolated segment of the smooth muscle oesophagus from the 
opossum. 
 
2.2 Involvement of intrinsic neurons in motility of the oesophageal striated muscle    
The striated muscle fibers in the oesophagus  were hitherto considered as ‘classical’ skeletal 
muscle fibers, innervated exclusively by excitatory vagal motor neurons, which terminate on 
motor endplates (40).  It is believed that peristalsis in the striated muscle is executed according to 
a sequence pre-programmed in a medullary swallowing network and modulated via vago-vagal 
reflexes as described above (43). On the other hand, the presence of a distinct ganglionated 
myenteric plexus in the striated muscle portion of the mammalian oesophagus , comparable to 
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other gastrointestinal tracts, has been well known for a long time. However, functional roles of 
the intrinsic nervous system in peristalsis of the striated muscle in the oesophagus  have 
remained enigmatic and have been neglected in concepts of peristaltic control (37, 43).     
Investigation of the regulatory role of intrinsic neurons in the oesophagus  was advanced by the 
discovery of ‘enteric co-innervation’ of oesophageal motor endplates. The enteric co-innervation 
challenged the conventional view of peristalsis control in the striated oesophageal muscle. 
Originally described in the rat, oesophageal striated muscle receives dual innervation from both 
vagal motor fibers originating in the brainstem and varicose intrinsic nerve fibers originating in 
the myenteric plexus. This new paradigm of striated muscle innervation has been confirmed in a 
variety of species including humans, underlining its significance (37, 44). It has been 
demonstrated that neuronal nitric oxide synthase (nNOS) was highly colocalized with vasoactive 
intestinal peptide (VIP), neuropeptide Y (NPY), galanin and Met-enkephalin in enteric nerve 
terminals on oesophageal motor endplates. These markers are suggestive of inhibitory 
modulation of vagally-induced striated muscle contraction (37). Since morphological studies 
revealed further that spinal afferent nerve fibers closely innervate myenteric neurons in the 
oesophagus  (37), the presence of ‘a peripheral mechanism’ regulating the motility of 
oesophageal striated muscle including afferent and enteric neurons in the oesophagus  was 
suggested (37).  
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2.3 Factors affecting strength of peristaltic contractions 
Several factors influence the amplitude, duration, and propagation velocity of the contraction 
wave in the oesophagus: oesophageal site; posture of the patient; consistency, size, and 
temperature of the food bolus; and resistance to the movement of the bolus. 
The contraction amplitude is highest in the lower oesophagus [69.5 12.1 mmHg, mean 
standard error (SE)] and lowest in the mid-esophagus (35.0 6.4 mmHg). The area of lower 
pressure wave corresponds to the region of mixed striated and smooth muscles. The mean 
contraction in the proximal oesophagus measures 53.4 9.0 mmHg. The duration of the 
contraction waves increases progressively in the distal parts of the oesophagus. The propagation 
of the wave is fastest in the upper oesophagus, and decreases in the middle and lower 
oesophagus. 
The strength of contraction is less when the patient is upright compared to supine, and a liquid 
food bolus is associated with longer duration, stronger contraction, and slower propagation 
compared to a dry bolus of swallowed air. A larger bolus of food leads to stronger contractions. 
Warm boluses of food increase, whereas cold boluses decrease, the strength of contraction. The 
osmolality does not appear to affect the contraction wave. Increased abdominal pressure, as in 
the Valsalva maneuver, or strictures leading to outflow obstruction in the oesophagus will slow 
the propagation of the contraction. 
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2.4 Factors affecting latency of peristaltic contractions 
Deglutitive Inhibition - The swallow-evoked peristaltic contraction consists of a wave of 
inhibition followed by that of contraction. The wave of inhibition that precedes peristaltic 
contraction is called deglutitive inhibition. The phenomenon of deglutitive inhibition is essential 
for drinking of fluids at a rate faster than one swallow every 10 seconds. During the usual 
drinking of water, swallows may be accomplished every 1 to 2 seconds. This is made possible by 
the phenomenon of deglutitive inhibition in which a swallow abruptly inhibits any on-going 
contraction in the oesophagus. When multiple swallows are taken in rapid succession, the 
oesophageal body remains inhibited until the last of the series of swallow, after which there is a 
fully conducted peristaltic contraction wave. 
 
Role of latency in generating peristaltic contraction (45) - The peristalsis in the smooth 
muscle is based on the fact that the duration of the deglutitive inhibition associated with 
swallowing increases distally along the length of the oesophagus. This gradient of inhibition is 
manifested only as the gradient of increasing latency of contraction in the non-contracted 
oesophageal body smooth muscle. This gradient is due to both central and peripheral 
mechanisms. The central mechanism involves near-instantaneous activation of the inhibitory 
short-latency vagal fibers, which arise from neurons located in the caudal part of DMN. This is 
transmitted to all levels of the oesophagus by the SPG so that the oesophagus in its entire length 
is inhibited promptly on swallowing. The distally increasing inhibitory nerve influence is 
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responsible for the distally increasing duration of inhibition along the oesophagus. The myenteric 
inhibitory neurons were thought to act by releasing a Non-noradrenergic, non-cholinergic 
(NANC) inhibitory neurotransmitter that is now shown to be nitric oxide. In addition, regional 
properties of the oesophageal smooth muscle may also contribute to the distally increasing 
gradient of the duration of the deglutitive inhibition. 
Primary peristalsis in the thoracic oesophagus is also orchestrated by the swallowing program 
generator (SPG) in the brainstem. However, the mechanism of peristalsis in the smooth muscle 
segment is complex and involves coordinated activities of the vagal inhibitory and excitatory 
pathway, regional gradients of the myenteric inhibitory and cholinergic excitatory nerves, and 
the regional characteristics of the oesophageal smooth muscle. 
 
 
Figure 8 - Central control of peristalsis in the smooth muscle 
portion of the oesophagus. - Upon swallowing (stimulus), the 
inhibitory pathway neurons in the caudal DMN (cDMN) are 
activated first, which causes simultaneous inhibition of all 
parts of the oesophagus. This inhibition lasts longer in the 
lower than in the upper parts. As the inhibition ends, 
sequential activation of excitatory (including cholinergic) 
neurons in the rostral DMN (rDMN) elicits a contraction wave 
that is peristaltic in nature (45). 
. 
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The deglutitive inhibition is immediately followed by deglutitive excitation that is manifested by 
the oesophageal contraction. Deglutitive excitation involves noncholinergic rebound excitation 
as well as cholinergic excitation. 
 
Experimental studies have shown that stimulation of the NANC inhibitory nerves causes 
inhibition of the oesophageal smooth muscle that is followed by a rebound contraction. The 
mechanism of rebound contraction is not known. It is clearly not cholinergically mediated. It is 
not clear whether the inhibitory transmitter itself somehow causes rebound contraction or an 
unknown NANC excitatory neurotransmitter is released after the release of the inhibitory 
neurotransmitter. The contribution of the noncholinergic rebound contraction to the force of 
oesophageal peristaltic contraction increases distally along the length of the oesophagus. 
 
The deglutitive cholinergic excitation also follows the deglutitive inhibition and overlaps the 
rebound contraction. The cholinergic excitation involves activation of the excitatory vagal (long 
latency fibers) pathway consisting of preganglionic neurons in the rostral part of the DMN and 
postganglionic cholinergic neurons in the myenteric plexus. The sequential activation of the 
excitatory vagal pathway supplying the oesophagus in a craniocaudal orientation leads to a 
sequential wave of excitation that is timed to cause a peristaltic contraction in the oesophagus. 
There is a distally decreasing gradient of cholinergic innervation along the oesophagus. As a 
consequence, cholinergic excitation provides a greater contribution to the force of peristaltic 
contraction in the upper than the lower parts of the smooth muscle oesophagus. 
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The swallow-evoked sequential cholinergic excitation is timed to occur when the deglutitive 
inhibition at different oesophageal levels is terminated. However, there is overlap between the 
deglutitive inhibition and the deglutitive excitation. This overlap is most prominent in the 
proximal and least prominent in the distal parts of the oesophagus. As a consequence, cholinergic 
deglutitive excitation causes greater shortening of latency of swallow-associated contraction in 
the proximal than in the distal parts of the oesophagus. (Figure 8). 
 
Figure 9 - Gradient of cholinergic excitatory and noncholinergic inhibitory nerves in the smooth muscle portion of the 
oesophagus (45). The cholinergic excitatory innervation (open circles) is most marked in the proximal part and decreases 
gradually in the distal part. On the other hand, the inhibitory innervation (close circles) increases distally along the 
oesophagus. As a result, upon stimulation the latency of contraction increases gradually distally along the oesophagus, 
resulting in peristaltic sequence of contraction that is entirely located locally in wall of oesophagus. (Source: Crist J, Gidda JS, 
Goyal RK. Intramural mechanism of oesophageal peristalsis: roles of cholinergic and noncholinergic nerves. Proc Natl Acad 
Sci USA 1984; 81(11):3595–3599 with permission). 
 
In conclusion, peristalsis in the oesophageal smooth muscle is due to distally increasing duration 
of deglutitive inhibition followed by deglutitive excitation. The pattern of activation of the 
inhibitory and excitatory vagal pathways, the regional gradients of inhibitory and excitatory 
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myenteric nerves, and the intrinsic properties of the smooth muscle all determine velocity of 
peristalsis. The oesophageal peristaltic contractions themselves are a blend of noncholinergic and 
cholinergic components. As a consequence, cholinergic antagonists such as atropine increase the 
latency and decrease the amplitude of contraction in the proximal but not the distal parts of the 
oesophagus. In contrast, antagonists of NOS reduce the latency mainly in the distal segments of 
the oesophagus and lead to simultaneous contractions. 
 
Nitric oxide (NO) produced from nNOS in the nerve terminals is the major inhibitory 
neurotransmitter in the oesophagus. Nitric oxide causes inhibition by a cyclic guanosine 
monophosphate (cGMP)-dependent mechanism. Vasoactive intestinal peptide serves as an 
intermediate in enhancing electrical spike–induced augmentation of calcium influx and NO 
synthesis from nNOS. Adenosine triphosphate (ATP) is not involved as an inhibitory 
neurotransmitter in the oesophagus. 
 
2.5 LOS 
The LOS  is a specialized region of the oesophageal circular smooth muscle that allows the 
passage of a swallowed bolus to the stomach and prevents reflux of gastric contents into the 
oesophagus  (38, 43, 46). Appropriate opening and closure of the LOS is controlled by neuronal 
mechanisms that normally maintain tonic contraction of the musculature to prevent reflux and 
cause relaxation during swallowing. The LOS is innervated by both excitatory and inhibitory 
motor neurons that are located in the myenteric plexus of the LOS  and the oesophageal body. 
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Acetylcholine and NO are the main excitatory and inhibitory neurotransmitters involved in LOS  
contraction and relaxation, respectively (46). In addition, VIP, ATP, carbon monoxide (CO), and 
calcitonin gene-related peptide (CGRP) also have been proposed as putative neurotransmitters in 
the LOS  (46). A subclass of intrinsic neurons is innervated by vagal preganglionic fibers as 
postganglionic neurons (38).     
 
Hormonal Influences on the Oesophagus - Swallowing is not under direct hormonal control but 
oesophageal motility, particularly LOS, may be influenced by a number of hormonal factors. 
This has significance with regard to gastroesophageal reflux. Gastrin tends to increase LOS  
tone. Motilin also increases LOS tone, which could explain the rise in LOS pressure during the 
migrating motor complex. Secretin, CCK, and GIP all tend to inhibit the LOS tone. VIP, like 
secretin, inhibits LOS tone. Progesterone also inhibits LOS tone and may account for an 
increased incidence of gastroesophageal reflux during pregnancy. Any factor that inhibits LOS 
tone may enhance the occurance of gastroesophageal reflux and the adverse effects of acidic 
stomach contents in the oesophagus. 
 
Transient lower oesophageal sphincter relaxations (TLOSRs) - LOS contracts and relaxes 
appropriately to allow the inward passage of food into the stomach for digestion and prevents the 
reflux of gastric content. Even in the presence of normal anatomy, inappropriate and 
uncoordinated relaxation of the LOS can cause reflux. This phenomenon is called transient lower 
oesophageal sphincter relaxations (TLOSRs). In a study in human volunteers, gastro-
oesophageal reflux was shown to be not related to low steady-state basal LOS pressure, but 
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rather occurred during inappropriate transient relaxations(47). TLOSRs mostly tend to occur 
after eating due to distension of the proximal stomach(48, 49) although they can occur 
spontaneously too. It is thought to be a vagally mediated reflex from gastric mechano-
distension(48, 50). A study in humans after fundoplication showed that TLOSRs were reduced, 
although gastric accommodation was not altered indicating that the receptive field for TLORs 
was located within a wider sensory field, perhaps in a region affected by fundoplication; 
proximal stomach (49) close to the oesophagus.  
 
1.3 Oesophageal role on prevention of reflux 
 
Related to the main function of swallowing and entry of food into the stomach, the lower 
oesophageal sphincter (LOS) also functions to prevent reflux of gastric contents into the 
oesophagus. The LOS as described above, is a muscular sphincter as well as functional sphincter 
dependent on maintenance of muscular tone and its angle. Inability of LOS to relax and contract 
appropriately would result in diseased states. Dysphagia (eg. in achalasia) occur when 
oesophagus and LOS fails to relax in a coordinated way to allow entry of food. Gastro-
oesophageal reflux disease (GORD) is associated with spillage of gastric contents into the 
oesophagus. Many factors normally contribute to the prevention of this backflow from 
happening and in GORD, one or more of these mechanisms may fail (discussed below in: 
Pathogenesis of GORD). 
 
One old concept recently being in the centre of attention in the pathophysiology of GORD is the 
“acid pocket”. Acid reflux and its associated symptoms occur most frequently following the 
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ingestion of a meal. This observation presented a dilemma as intragastric pH is at its least acidic 
following eating due to the buffering effect of the food. However, the observation by Fletcher et 
al that the proximal cardia region of the stomach escapes the buffering effect of the meal 
provided a rational explanation for the acidic nature of the postprandial refluxate (51, 52). The 
zone of high acidity detected in the proximal stomach after a meal has been termed as the acid 
pocket. The relation of acid pocket with effect of prokinetic therapy is under debate but in the 
section 7.1.3.2 is discussed in more details. 
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2 OESOPHAGEAL HYPOMOTILITY 
 
The oesophagus functions solely to deliver food from the mouth to the stomach where the 
process of digestion can begin. Efficient transport by the oesophagus requires a coordinated, 
sequential motility pattern that propels food from above and clears acid and bile reflux from 
below. Disordered pharyngeal and oesophageal motor function is a common cause of symptoms, 
particularly dysphagia, chest pain, and gastroesophageal reflux symptoms (heartburn and 
regurgitation). Motor function can be assessed by a variety of recording techniques including 
radiology, scintigraphy manometry, and most recently intraluminal electrical impedance 
monitoring. Some of these are complementary. The gold standard, however, for the assessment 
of motor disorders remains manometry. Manometric measurement of oesophageal pressure is the 
most direct method for assessment of motor function. Only manometry can give information on 
the strength of contractions. Hypo-contraction abnormalities of oesophagus that result from weak 
(low amplitude) muscle contractions can cause ineffective oesophageal motility (IOM) that 
delays oesophageal clearance, and LOS hypotension.  In this section the terms of OH and 
ineffective oesophageal motility will be discussed in more details. 
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3 Definitions (definition of IOM used in this thesis) 
 
OH is a term used to define low amplitude contractions in the body of the oesophagus 
(oesophageal hypotensive peristalsis) and hypotensive LOS.  
 
Until 1997, the term ‘nonspecific oesophageal motor abnormalities’ was generally used by 
physiologists to denote any dysmotility pattern that was not achalasia, spasm, nutcracker or LOS 
dysfunction. Then, Leite et. al published their finding that ‘ineffective oesophageal motility’ 
(IEM or IOM) was the primary finding in patients with nonspecific oesophageal motility 
disorder(53, 54). 
In 2001, this was incorporated into Spechler and Castell’s(55) classification of oesophageal 
motor disorders, based on conventional manometry. In their classification, OH was defined as 
distal-oesophageal hypocontractility in at least 30% of wet swallows, characterized either as low-
amplitude peristaltic waves (<30 mmHg), low-amplitude simultaneous waves (<30 mmHg), 
peristaltic waves that are not propagated to the distal-oesophagus, or absent peristalsis. The 30-
mmHg criterion was derived from the observation that amplitudes <30 mmHg were frequently 
associated with bolus escape and incomplete bolus clearance(56) measured either 
radiologically(56) or scintigraphically(58). More recently, High-resolution manometry (HRM), 
with or without concurrent intraluminal impedance monitoring, allows a more complete 
definition of peristalsis (Figure 9).  
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In the recently developed Chicago classification(59) frequent failed peristalsis (>30% of wet 
swallows) is separated from weak peristalsis (defined as breaks in the 20-mmHg isobaric 
contour). Weak peristalsis with large defects is judged to be present when breaks >5 cm are 
present in >20% of swallows (Fig. 2). Weak peristalsis with small defects is present when breaks 
of 2–5 cm in length are present in >30% of swallows(60). This classification of manometric 
abnormalities is also based on the likelihood that such defects are associated with oesophageal 
dysfunction (i.e. bolus escape). However, the clinical relevance of such observations remains 
uncertain. Indeed, it is likely that several abnormal swallows in a series are required before 
symptoms are experienced(61) (Figure 10). In the latest study to define IOM using high 
resolution manometry, Xiao et al 238 suggested that IOM should be identified in two ways: 1) 
50% or more swallows with any combination of failed peristalsis, weak contraction with small 
break or weak peristalsis with large break in the middle/distal oesophagus or 2) 50% or more 
swallows associated with a DCI < 450 mmHg-s-cm (DCI or distal contractile integral will be 
Figure 10 - Comparison of conventional verus high resolution manometry. (Image from internal source) 
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described in the following sections in more detail). In 2014, Chicago group defined IOM as: 
≥50% ineffective swallows (Ineffective swallows can be failed or weak with DCI<450 
mmHg•s•cm) and generated a new class of diagnosis as “Fragmented peristalsis” (≥50% 
fragmented contractions with peristaltic gap >5cm and DCI > 450 mmHg•s•cm). Therefore, 
weak peristalsis with small breaks disappeared form the Chicago classification (62).  
In this thesis, I adopted Xiao’s definition of the IOM however weak peristalsis with small breaks 
are exclude as Chicago group suggested and in I believe this minute motility finding will not be 
affecting clinical circumstances of the patients. Hence, the definition of IOM in this thesis is: 1) 
having fragmented peristalsis [50% or more swallows with any combination of failed peristalsis 
and weak peristalsis with large break (>5cm) in the middle/distal oesophagus], or 2) 50% or 
more swallows associated with a DCI < 450 mmHg-s-cm.  
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Figure 11 - Examples of high-resolution manometry showing weak peristalsis with small (2–5 cm) (A) and large (>5 cm) (B) 
breaks in the 20-mmHg isobaric contour. Reproduced with permission from Roman et al. Am J Gastroenterol 2011;106:349–
356. 
 
 
4 Prevalence of OH 
Normal values for conventional manometry are based on observations in 95 healthy subjects 
with a mean age of 43 years (range 22–79 years)(53), whereas the two HRM studies upon which 
the cutoff values for peristaltic breaks were based on volunteers under the age of 50(60, 64). 
Data gathered with conventional manometry suggest that the amplitude of oesophageal 
contractions is higher in men than women, rises with increasing age and is higher in Afro-
Caribbean than Hispanic and Caucasian populations(53, 65). This variation between 
demographic and racial groups may be due to specific effects of age, gender and race, or 
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common factors such as increased outflow resistance caused by central obesity. OH (weak, 
absent or failed peristalsis) is the most prevalent finding in clinical series. Smout et al reported 
that  OH  with or without hypotensive LOS was found in 58% of 2610 patients referred for 
(conventional) manometry(66). Other observers reported OH in 27–32% of patients presenting 
with non-obstructive dysphagia without GORD(67-70). Oesophageal hypocontractility is also the 
most prevalent oesophageal motor disorder in GORD, found in 21–38% of patients in large 
series(69, 71-73). In patients with GORD, OH is linked to the degree of mucosal damage 
expressed as oesophagitis. In a review by Kahrilas et al, peristaltic dysfunction was increasingly 
prevalent with increasing severity of peptic oesophagitis, occurring in 25% of patients with mild 
oesophagitis and 48% of patients with severe oesophagitis(74). Hence, patients with long 
segment Barrett’s had a significantly lower distal oesophageal peristaltic amplitude as compared 
with normals (75). Other researchers reported that the majority of GORD patients diagnosed with  
OH  have between 30% and 70% of their swallows followed by ‘ineffective contractions’, 
whereas a more severe form, with more than 80% of abnormal contractions, is less frequent and 
may represent 20–40% of all GORD patients with  OH (4, 76).  
Similarly a high prevalence of OH is found in patients with respiratory disorders and GORD 
(chronic cough, IPF, cystic fibrosis).  OH  was found in 53% of asthmatics, 41% of chronic 
coughers and 31% of those with laryngitis(3). 
In eosinophilic oesophagitis, HRM shows frequently  weak peristalsis and frequent failed 
peristalsis (77-83).  
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Most connective tissue disorders may affect oesophageal motility, either with impairment of  
the smooth muscle (scleroderma) or the striated muscle (dermato-polymyositis). Severe 
oesophageal dysmotility is most frequently observed in scleroderma. (84, 85). Scleroderma 
frequently involves the oesophagus, with severe gastroesophageal reflux (GER) and dysphagia as 
clinical consequences of oesophageal dysmotility. Castell et al studied 36 patients with 
scleroderma and reported that distal oesophageal aperistalsis was noted in 70% of patients. 
However, normal proximal oesophageal contraction pressures were documented in all cases(86). 
In a larger study, in 148 patients, decreased amplitude of the post-deglutition contraction-wave 
was seen in 79.8% patients(87). 
 
4.1 Prevalence of OH in the Upper GI Physiology Unit (RLH) 
In the upper GI Physiology at the Royal London Hospital (RLH) I receive more than 800 patients 
referred for oesophageal function assessment including different type of manometry and reflux 
monitoring. 32.5% of all referrals are OH patients out of which almost half have dysphagia 
(44%), and other symptoms included 57% reflux symptoms (i.e. heartburn and/or regurgitation), 
23% cough. 1 in 3 of patients referred to this upper GI Physiology department has OH. 
 
 
5 Pathogenesis of OH   
The pathogenesis of  OH  is not completely understood.  OH  can be secondary to other diseases 
or as a primary entity.  
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5.1 Mechanism of   OH  
 
Data from experimental models of oesophagitis ((by inducing cycles of oesophagitis and 
healing),(88) in-vitro human tissue (studying effect of endogenous cytokines on oesophageal 
motor function)(89) and a positive response to prokinetic drugs suggest impaired cholinergic 
stimulation as the main defect underlying  OH  (90). Few myopathic pathologies can produce 
OH(91).   OH can be observed in patients without GORD or connective tissue disorder. The 
pathogenesis of this idiopathic disorder ( OH ) is unknown, although Kim and coworkers(91) 
have provided initial evidence that an imbalance between the excitatory and inhibitory 
innervation of the oesophagus, reflected in the ratio between choline acetyltransferase (ChAT) 
and nitric oxide synthase (nNOS) expressed in the oesophageal muscle wall, may be present in 
patients with OH. This group recruited gastric cancer patients and reported that oesophageal 
tissues of patients with  OH  revealed histopathological changes of myopathy with a 
morphologically normal-appearing myenteric plexus, suggesting that the myopathic process may 
contribute to   OH  (91).  
 
 
 
5.2 Causes of  OH  
 
The diseases that might lead to  OH  are listed in table 1-1.  
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Table  1-1 - Secondary causes of OH 
Diabetes mellitus 
• Autoimmune diseases 
                        – PSS - progressive systemic sclerosis 
                       – CREST syndrome 
                       – Sjogren’s syndrome 
                       – Polymyositis-dematomyositis 
                       – MCTD – mixed connective tissue disease 
• Neuro-muscular diseases 
                       – cerebrovascular (stroke), Parkinson’s syndrome, 
                       – motoneuron-, demyelinisation diseases (MS) 
                       – muscular dystrophies, myasthenia gravis 
• Chagas’ disease - (Trypanosoma cruzi) 
• Amyloidosis 
• Presbyoesophagus 
• Pharmacological agents ie anticholinergic medications 
 
 
Scleroderma – There are three stages in the development of oesophageal involvement in 
scleroderma: neuropathy, myopathy, and fibrosis(92). The hallmark of the first stage is neural 
dysfunction due to arteriolar changes in the vasa nervorum. At this point, the smooth muscle may 
contract with methacholine, which acts directly on the muscle, but not with edrophonium, which 
enhances the effect of available acetylcholine by inhibiting its breakdown. The consequent 
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muscle ischemia characterises the second stage, leading to atrophy of the muscle layers. Finally, 
the muscle tissue is replaced by fibrosis(93) which then eliminates the response to methacholine. 
In patients with systemic sclerosis, oesophageal wall thickness has been reported to be no more 
than 3 mm(94). Ultrasound images show hyperechoic areas within the normal hypo-echoic 
muscularis propria corresponding to fibrosis found on histological sections of the autopsy 
specimens(95). The smooth muscle in the oesophagus is most commonly affected, provoking 
feeble contractions in the mid and distal oesophageal body and low LOS pressure. The striated 
muscle in the oesophagus is less frequently affected. 
 
Severe hypomotility in the oesophageal body and low LOS pressure promote increased gastro-
oesophageal reflux and impaired oesophageal clearance, particularly in the supine position(96-
98). Consequently, oesophagitis and its complications (ulcer, stenosis and Barrett’s oesophagus) 
are frequently observed in scleroderma. This may trigger a vicious circle which exacerbates OH. 
Both OH and reflux may contribute to pulmonary disease by micro-aspiration of acid and by 
vagal stimulation from oesophageal acid causing bronchoconstriction. Oesophageal manometric 
abnormalities were found to be more prevalent in patients with poor lung function and the most 
interstitial lung disease. Nevertheless, the causative role of oesophageal  involvement in 
scleroderma related interstitial lung disease remains an area of debate(99). In general, OH in 
scleroderma is characterized histopathologically by atrophy and fibrosis of the muscular tissue 
and a normal-appearing myenteric plexus (100). 
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OH in GORD - Knowledge about the mechanisms underlying OH associated with GORD is 
accumulating. Acute (experimental) oesophagitis significantly reduces the frequency and 
amplitude of peristaltic contractions in the oesophagus (88, 101-103). In vitro studies suggested 
that acute oesophagitis dysmotility is mainly due to abnormal neural modulation (104, 105). 
Inflammatory mediators, such as interleukin-6 and platelet-activating factor, produced during 
acute oesophagitis, can diffuse through the oesophageal wall and reduce acetylcholine release 
from excitatory myenteric neurons to circular smooth muscle(89, 106, 107). 
Experimental studies have shown that acute oesophagitis-associated with OH can disappear after 
spontaneous healing(88, 101, 103). In patients with chronic erosive GORD, however, healing of 
oesophagitis with medical or surgical treatment is not associated with complete recovery of 
oesophageal dysmotility(108-111), suggesting a secondary, irreversible motor abnormality or a 
primary phenomenon leading to OH. Nevertheless, it is uncertain whether OH associated with 
GORD is always the consequence of inflammation. It is also possible that it is a primary motor 
disorder leading to GORD(112). 
The oesophageal body is a major component of the antireflux mechanism. Once reflux has 
occurred the reflux contents can be cleared by peristaltic sequences (113). An intact peristaltic 
mechanism is essential for effective acid clearance. Thus, disruption of oesophageal peristalsis 
affects clearance of the refluxates, resulting in excessive acid reflux and then onset of  GORD 
(114).  
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It has been suggested that imbalance of excitatory and inhibitory mechanisms can be important 
in the pathogenesis of GORD related  OH  (91, 115). In GORD patients, ineffective oesophageal 
motility (IOM), is the most common motor abnormality (76).   OH   patients have more than the 
normal number of NOS-positive neurons in the circular muscle in the oesophagus , which might 
result in enhancement of inhibitory neural components (76).  
 
5.3  Excessive activation of the local inhibitory neural reflex in onset of GORD   
 
Application of capsaicin can attenuate the mechanical activity of the oesophageal striated muscle 
via activation of the local neural reflex including primary afferents and intrinsic neurons in vitro 
(41). In the mouse oesophagus, capsaicin inhibits the vagally mediated striated muscle 
contractions mainly through its action on mucosal primary afferents, which in turn activate the 
presumed inhibitory local reflex arc thus being involved in dysmotility of the oesophagus and 
then the pathogenesis of GORD. Acid exposure not only induces inflammation in the 
oesophageal mucosa (117) but also might influence afferent neurons expressing TRPV1, which 
can be stimulated by protons (118). If acid excessively activates local neural reflex expressing 
TRPV1 in the oesophageal body, oesophageal motility might be attenuated, resulting in decrease 
of clearance activity. In addition, functional changes of TRPV1 by pro-inflammatory mediators 
such as prostaglandin E2 (119) might facilitate activation of the inhibitory local neural reflex, 
resulting in low clearance activity. Therefore, it is presumed that excessive activation of the local 
inhibitory neural reflex might be involved in the pathophysiology of GORD.   
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Of course, dysmotility of the striated muscle portion of the oesophagus as described here might 
not directly be involved in gastroesophageal reflux in humans because the external muscle layer 
in the distal portion of human oesophagus  is composed with smooth muscle fibers (37). 
Nevertheless, the above phenomenon might affect coordination of motility between striated 
muscle segment and the distal oesophageal motility contributing to  OH . The inhibitory neural 
pathway activated by acid reflux has not been demonstrated in smooth muscle of the human 
oesophagus . In fact, spastic contractions are induced by acid reflux in the distal oesophagus  
(diffuse oesophageal spasm), which frequently are responsible for chest pain in GORD 
patients(120).  
 
5.4 Abnormal relaxation of the LOS  and GORD (2) 
 
Abnormal LOS function is important in GORD. This includes LOS hypotension and TLOSRs. 
LOS  hypotension may be due to a number of potential disturbances, including abnormality of 
the muscle function itself, lack of normal cholinergic activation, decreased reflex excitation, 
decreased responsiveness to circulating substances such as gastrin, and activation of inhibitory 
system (121). The LOS is innervated by inhibitory and excitatory intrinsic neurons that are 
located in the myenteric plexus not only of the LOS  but also of the oesophageal body. Abnormal 
activation of vagal afferents and/or efferents might activate inhibitory intrinsic neurons and cause 
LOS relaxation. It is reported that a subpopulation of myenteric nitrergic neurons is 
immunoreactive for a tachykinin receptor in the oesophageal body of a rat (122). Considering 
that myenteric neurons are closely innervated by spinal afferents in which TRPV1 and 
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tachykinins might be expressed in the oesophagus  (37) as well as vagal afferent neurons, it is 
possible that acid can induce the release of tachykinins from afferent neurons and subsequently 
tachykinins would act on intrinsic nitrergic neurons innervated to the LOS.  This suggests that 
excessive acid reflux to the oesophageal body might evoke abnormal relaxation of the LOS  by 
NO, resulting in severe GORD.   
 
5.5 A putative vicious circle in onset and exacerbation of GORD (2) 
 
Chronic oesophagitis may damage not only the mucosa but also intrinsic neurons (117). In fact, 
it has been reported that pro-inflammatory cytokines reduce oesophageal contraction by 
inhibiting release of acetylcholine from myenteric neurons (106). Oesophageal dysmotility might 
expose the mucosa to further acid exposure, which would cause more severe inflammation by 
directly influencing the mucosa or neurogenic mechanism via TRPV1-positive neurons and 
peptidergic neurotransmitters (123). Considering that the severity of myenteric plexus damage is 
positively correlated with the duration of history of oesophageal diseases (124), there might be a 
vicious circle in GORD (Figure 12).       
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In general, inflammation affects nerves and muscle to alter LOS and oesophageal body motility. 
Both a decrease in cholinergic excitatory and an increase in nitrergic and other inhibitory 
mechanisms appear to be involved. This combination would result in OH.  
The decrease in cholinergic excitation may have a vagal component (125). Animal experiments 
and studies of human LOS tissue demonstrate a decrease in local cholinergic excitation (105, 
126, 127), and major changes in calcium stores (128) can mediate oesophageal body 
contractility. In particular, prostanoids are involved. Inflammatory mediators such as interleukin-
1B (IL-1B) and increases of reactive oxygen species (e.g. H2O2) are associated with increases in 
prostaglandin E2 (PGE2) and an isoform of PGE2. Prostaglandin E2 relaxes the LOS, whereas the 
Figure 12 - A predicted vicious circle model of GORD. The circle might exacerbate GORD. GORD; 
gastroesophageal reflux disease. NERD; nonerosive reflux disease. LOS; lower oesophageal 
sphincter. TRPV1; transient receptor potential vanilloid 1. (Image source Shiina (2)) 
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isoform of PGE2 blocks prostaglandin F2a (PGF2a)-mediated contraction (129). Prostaglandin E2a 
along with thromboxane A2/B2 are important in maintenance of LOS tone, and blockade of 
PGE2a activity further reduces LOS tone (130). Recent studies also indicate that inflammation 
induces the production of IL-6 in the mucosa and that IL-6, but not (IL-1B), leads to an increase 
of H2O2 in the muscle (131).  H2O2 appears to be the main culprit that causes increases in 
platelet-activating factor (PAF) and PGE2, both of which can act to reduce both ACh release 
(132) and LOS muscle tone (133). Earlier studies indicated that inhibition of prostaglandin 
synthesis with indomethacin prevented or corrected oesophagitis-associated LOS hypotension, 
presumably through a reduction of PGE2 (134). oesophageal IL-8 is also increased in reflux 
oesophagitis, and presumably enhances neutrophil trafficking (135). 
In addition to prostanoid effects, inflammation is associated with increased NO in oesophageal 
tissues (127) (136) and evidence of increased activity of the nitrergic inhibitory innervation (105, 
127) These changes also result in low LOS pressure and decreased oesophageal body motility. 
Of interest, acid infusion causes shortening of the oesophagus (137)in response in part to 
inflammatory mediators (138), and NO contracts longitudinal oesophageal smooth muscle (139). 
These responses to acid and acid-induced inflammation have been proposed as potential factors 
contributing to the development of hiatus hernia. 
 
5.6 Relationship between OH  and GORD 
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In spite of the high prevalence of both OH and GORD, the relation between the two remains 
controversial. OH has been blamed as the cause of abnormal oesophageal clearance and 
increased acid exposure, extra-oesophageal symptoms and dysphagia both before and after 
antireflux surgery. In recent studies, Fornari et al analysed the association between different 
degrees of OH  and prolongation of acid clearance and increased oesophageal acid 
exposure(140). The results showed that only severe  OH  is associated with longer oesophageal 
clearance and the highest acid exposure, mainly in supine periods. 
A recent study compared oesophageal motility in patients with NERD (non-erosive reflux 
disease) and patients with ERD (erosive reflux disease).  70% of the patients with ERD failed to 
respond to the physiologic challenge of solid bolus and MWS (multiple water swallows).  This 
failure might result in impaired clearance following reflux events and increase exposure to 
gastric refluxate(141). A recent study showed that there is a higher prevalence of partial failure 
of peristalsis (segmental failure) compared to total failure of peristalsis (failed sequences) in 
subjects with reflux and Barrett’s oesophagus (142). In this study fragmented smooth muscle 
contraction segments are considered to be a marker of  OH .  
In a different approach to study the OH in GORD, Kim et al(143),found a statistically significant 
increase in oesophageal-wall thickness, by using HFIUS, in patients with non–GORD-related 
ineffective oesophageal motility, when compared with controls, and with the patients who had 
both GORD and ineffective oesophageal motility. The investigators postulated that the 
pathophysiologic mechanisms that underlie ineffective oesophageal motility are different in 
patients with GORD, in whom the manometric abnormality may be induced by chronic acid-
reflux exposure. In those patients without GORD, there may be a primary oesophageal muscular 
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disorder measured by HFIUS. This seems to correlate with a study by Mittal(144) of increased 
oesophageal wall thickness by HFIUS in patients with a number of oesophageal motor 
disorders(145).  
 
 
6 Clinical Presentation of OH   
Oesophageal symptoms in impaired oesophageal peristalsis include dysphagia, odynophagia, 
heartburn and regurgitation. Also, extra-oesophageal symptoms such as cough(146), globus and 
hoarseness are attributed to OH. However, the correlation between the severity of the 
manometric findings and symptoms is extremely poor. Even in patients with complete absence of 
peristalsis, as is often the case in scleroderma, symptoms may be absent. On the other end of the 
spectrum, one can find patients who complain of severe dysphagia but who have completely 
normal oesophageal peristalsis, LOS function, and bolus transit on barium studies. 
Dysphagia is a common symptom in patients with oesophageal hypotensive peristalsis (147) and 
studies have shown that oesophageal clearance is compromised significantly when the amplitude 
of peristaltic contractions in the distal oesophagus falls to values below 25-30 mm Hg(58, 56).  
 
Hypomotility in the oesophageal body impairs the refluxate clearance leading to prolonged 
oesophageal exposure to aggressive refluxate and GORD symptoms(56, 54). However, only 
severe  OH  is associated with prolonged clearance and acid exposure, particularly in supine 
periods(151).  
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The association of cough with OH is not clear at this moment and in fact this association might 
be independent from GORD in this group of patients.  OH  is more common in patients with 
chronic cough although many of them have a normal pH profile(146). The mechanism of cough 
in these patients is probably due to disordered peristalsis that may lead to impaired oesophageal 
clearance, as has been reported in a proportion of patients with chronic cough(152). This could 
result in prolonged stimulation of oesophageal cough receptors or micro-aspiration of 
oesophageal contents(153) causing direct stimulation of laryngeal and tracheal cough receptors.  
 
7 Investigations 
Symptom based diagnosis is not reliable in patients with swallowing problems, heartburn and 
other dyspeptic complaints (154, 155). The aim of investigation is to provide clinically relevant 
measurements of gastrointestinal (GI) structure and function that explain the cause of symptoms, 
identify pathology, and guide effective management(61, 157).  
Endoscopic examination of the oesophagus is not a valuable tool to diagnose oesophageal 
motility although endoscopy should always be carried out to exclude ulceration, stenosis, and 
neoplastic lesions before the patient is referred for evaluation of oesophageal function. In OH 
oesophagoscopy is either normal or shows evidence of reflux oesophagitis.   
Barium oesophagogram is a useful technique in the work-up of patients with a suspected 
oesophageal motility disorder. It will detect obstructive lesions, oesophageal dilation, and hiatus 
hernia as a complementary tool to endoscopy. In addition, and most importantly, the barium 
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oesophagogram provides information about oesophageal transit. For this purpose, not only 
barium suspension should be used, but also swallowing a solid bolus, such as a marshmallow or 
a piece of bread, should be part of the examination.  
Scintigraphy does not provide structural information but is one of the best techniques (besides 
timed Barium swallow) that quantify oesophageal transit. Oesophageal scintigraphy can detect 
oesophageal involvement in patients with asymptomatic scleroderma, showing a typical pattern 
of retention of radioactivity in the lower oesophagus, with clearing after the patient is upright or 
drinks a glass of water. As an indicator of dysmotility in both early and advanced disease, 
oesophageal scintigraphy has a higher sensitivity than manometry and barium swallows(158).  
Manometry is often considered to be the gold standard, being able to detect subtle impairment of 
oesophageal peristalsis. The most characteristic finding, low-amplitude simultaneous waves, can 
be observed in connective tissue diseases, diabetes, amyloidosis, myxedema, multiple sclerosis, 
chronic idiopathic intestinal pseudo-obstruction, and in severe end-stage GORD without 
scleroderma. 
Major evolution in manometric methodology has been the introduction of high-resolution 
manometry (HRM); the basic concept being that by vastly increasing the number of recording 
sites and decreasing the spacing between them, one can more completely define the intraluminal 
pressure environment, minimizing the impact of spatial gaps between recording sites.(64) In 
recent years, HRM is believed to be an essential tool for mechanistic studies of oesophageal 
function in research and in clinical practice. HRM has been even used to study the effects of 
pharmacological agents on different oesophageal segments(159, 160). In clinical practice, HRM 
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has largely replaced conventional manometry. First of all HRM is easy to perform. Secondly, 
HRM predicts abnormal bolus transport more accurately than conventional manometry(157). 
Lastly, not only is the diagnostic agreement between conventional and HRM high(161) but 
regardless of clinical value and availability of the conventional method, some publications also 
emphasize that clinically important pathologies (impaired OGJ relaxation, achalasia, distal 
oesophageal spasm, localized abnormality of peristalsis) can be detected by HRM more 
accurately(157, 161)A classification of oesophageal motility disorders based on pressure 
topography characteristics has been proposed by the Chicago group(162, 163). 
Whether conventional or high-resolution manometry is used, care must be taken to avoid 
circumstances that can lead to a spurious diagnosis of OH. Examples of these are drugs that 
inhibit oesophageal contractions (anticholinergic agents and calcium channel blockers), failure to 
have an appropriate time interval between swallows, and inclusion of dry swallows. 
Additionally, the appropriate normal values must be applied depending on the examination 
position because contractile vigor decreases on moving from the supine to the upright 
position(164). 
The combination of oesophageal manometry and intraluminal impedance measurement allows 
assessment of the functional impact of ineffective oesophageal contractions. In a study of 350 
patients, it was found that one-third of patients with a manometric diagnosis of OH had 
‘effective’ transit for both liquid and viscous swallows(165). Similar findings were reported by 
others, suggesting that the definition of weak peristalsis should include functional correlates(60, 
166). HRM, only when combined with fluoroscopy or impedance, clarifies the relationship 
between dysmotility and bolus retention(60, 166). A key insight from studies that combine 
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oesophageal manometry with impedance is that oesophageal symptoms are rarely caused by 
dysmotility unless this is accompanied by bolus retention or reflux(165, 167). 
 
7.1 Complementary investigations in studying   OH   
Despite the technical advances set out above, standard methodologies using HRM still fail to 
establish a definitive diagnosis that explains the cause of symptoms in many patients with 
swallowing problems or reflux(157, 160). None of the standard methods are able to distinguish 
the underlying cause of the OH i.e. structural versus neurological defects. Consequently, these 
methods of oesophageal assessment have not been able to predict the outcome of medical 
treatments in these patients. Preoperative oesophageal manometry has not been able to 
distinguish the patients who may develop dysphagia after antireflux surgery (168) and so far 
there is no preoperative test to predict postoperative dysphagia in this group of patients (169).  
These shortcomings might be due to the fact that HRM does not provide a direct assessment of 
oesophageal shortening, sensitivity, motor reserved capacity, or other biomechanical properties. 
Alternatively it may be because tests based on small volume water swallows in the supine 
position are not representative of normal behavior and/or do not ‘challenge’ oesophageal 
function. 
7.1.1 Additional analysis 
 In recent years, attempts have been made to improve the sensitivity and the usefulness of 
oesophageal HRM testing by adding different parameters in the analysis of the  oesophageal 
motility tracings. Pandolfino et al. defined the flow permissive time as the time when the bolus 
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domain pressure exceeds the OGJ obstruction pressure(170). A flow permissive time less than or 
equal to 2.5seconds had high sensitivity and specificity (86 and 92% respectively) for predicting 
incomplete oesophageal clearance. Incomplete bolus transit (IBT) is defined when bolus exit on 
impedance recording is not identified at any one of the three distal impedance-measuring sites. 
Normal transit is defined when 80% liquid and 70% viscous swallows demonstrates complete 
transit. IBT seems a reasonable surrogate end point for gauging the adequacy of peristalsis. IBT 
occurs more frequently with weak peristalsis. Kahrilas et al. (56) reported that IBT invariably 
occurred in the distal oesophagus when peristaltic amplitude was < 20 mm Hg, whereas it rarely 
occurred when the peristaltic amplitude was 31–45 mm Hg. Moreover, IBT is associated with 
dysphagia. Consistent with previous investigations (157, 171, 172), Roman et al(60) reported 
that failed peristaltic contractions and oesophageal pressure topography  plots with breaks in the 
20 mm Hg isobaric contour were associated with IBT. HRM   plots with breaks > 5 cm (large) 
were consistently associated with IBT; 2–5 cm (small) breaks were variably associated with IBT.  
Topography plots without breaks or with breaks in the 20 mm Hg isobaric contour < 2 cm in 
length uniformly achieved complete bolus transit. Large (> 5 cm) and small (2–5 cm) pressure 
troughs in the 20 mm Hg isobaric contour of peristalsis, but not failed peristalsis (failed 
peristalsis = when the peristalsis is <3cm in length or <100mmHg.cm.s DCI), occurred more 
frequently in patients with unexplained non-obstructive dysphagia than in control subjects. The 
individuals with absent peristalsis (100 % failed peristalsis) were excluded from the latter study. 
 
7.1.2 Additional methods 
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 The use of provocative testing with solid or high volume water swallow challenge in correlation 
with symptom assessment have been shown to improve the diagnostic yield of HRM   
studies(173). Solid bolus swallows, multiple rapid swallows, and abdominal compression test are 
the provocative tests of choice applied in this study. The details of these tests are described in the 
following chapters in more detail. 
In 2007, Lever et al.(174) introduced the possibility that an effortful swallow (i.e., volitional 
manipulation of the oropharyngeal phase of swallowing) may affect oesophageal peristalsis. The 
effortful swallow, which requires the patient to ‘swallow hard’, is often used as a treatment for 
oropharyngeal dysphagia.  The authors reported increased amplitudes in the distal oesophagus 
during the effortful swallow compared with non-effortful swallowing. In 2012, Nekl et al 
reported that the effortful swallow condition yielded significantly higher oesophageal amplitudes 
across all sensor locations (P < 0.05). They also found that the effortful swallowing decreased 
the risk of incomplete bolus clearance when compared with non-effortful swallowing (OR: 0.51; 
95% CI: 0.30–0.86)(175). However, there has not been much subsequent interest shown in the 
study of effortful swallowing in the literature and confirming the findings of the aforementioned 
authors requires further studies. 
 
Most oesophageal motility studies focusing on oesophageal motility triggered by mechanical 
stimuli ie bolus volume rather than sensory factors such as chemothermal triggers of oesophageal 
motility. The use of carbonated water and different bolus temperatures on swallows have been 
studied in oropharyngeal  motility with more significant results than on oesophageal body 
motility(176-178). Nevertheles, a recent study reported that chemothermal stimulation with 
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carbonation and cold boluses are most effective at modulating oesophageal body 
contractility(179). There are not many recent studies done on this matter however older studies 
confirm a similar effect of bolus temperature on oesophageal motility. Segall et al(180) reported 
that the mean amplitude of oesophageal contractions in response to cold (22°C) tap water 
swallows was 188 mm Hg (95% confidence interval, 165-211); In response to hot (60°C) 
swallows, the mean amplitude decreased to 125 mm Hg (95% confidence interval 106-144; p < 
0.001). Other papers performed with standard oesophageal manometry reported that in healthy 
subjects oesophageal cooling decreased amplitude and velocity and increased duration of the 
peristaltic wave (338, 339). Overall, due to controversial findings regarding the effect of bolus 
temperature on oesophageal motility, some not showing effect on oesophageal body and some do 
and also regarding stimulating effect of hot or cold water, it requires further studies to decide 
whether this type of swallows can be uses as clinical tool in oesophageal motility 
assessments(181). 
 
 
7.2 Critical review of high resolution manometry (HRM) 
HRM is a reproducible method for studying oesophageal motor disorders and is being accepted 
internationally as the physiological test of choice. However, considerable day-to-day variability 
may occur that should be taken into account when borderline findings are made during HRM 
(182). Furthermore, the ability of HRM to assess the OGJ pressure morphology such as radial 
and axial pressure effects is still limited (183). This will affect quantifying the indications for, 
and objectives of, antireflux surgery as well as OGJ bolus transit assessments.  
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Other limitations of HRM to consider: 
- LOS pressure,  TLOSRs, oesophageal body hypomotility and their relation to GORD has 
not been considered in the classification of oesophageal disorders using HRM 
- There are no data on UOS and upper oesophageal motility disorders 
- Rumination/postprandial belching cannot be identified, or is poorly defined in the current 
diagnostic criteria of HRM 
- Normal values are only derived from 1 manufacturer of the HRM machines. Therefore, 
the data derived in one study with one brand of software and hardware cannot be 
generalized to other brands until more data are available (184). 
- Effect of respiration on measuring amplitude of peristalsis has not been considered 
- There is no established method in HRM to distinguish neurological versus muscular 
abnormalities in oesophagus. For example one cannot decide whether the hypomotility 
seen in a patient is due to muscular fibrosis or damage to excitatory neurons. Hence, 
reserved oesophageal motor capacity is not assessed. 
- HRM provides minimal information about longitudinal muscle function 
- There is no information regarding the luminal diameter of the oesophagus 
- HRM alone cannot determine successful bolus transit hence recently combined HRM-
impedance monitoring has been introduced 
- HRM cannot provide any information regarding distensibility of the oesophagus and 
specifically OGJ. Lack of distensibility might explain the mechanism of having high 
intrabolus pressure in spite of complete relaxation of LOS. 
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7.3 EndoFLIP System 
 
The endoluminal functional lumen imaging probe (EndoFLIP) system) (Crospon, Galway, 
Ireland)  uses impedance planimetry for the real time measurement of the diameter of the 
oesophago-gastric junction. This system is the first  to permit GOJ diameter to be directly 
measured without providing information about oesophageal body motility. Nevertheless, its 
clinical value is still under investigation and it is mostly used under general anaesthesia due to 
the amount of discomfort involved, especially during insertion. 
 
8 Reversibility of OH 
 
In the process of developing management strategies in OH, testing the potential reversibility of 
OH in patients could be useful to predict the response of these patients to new treatments and 
prokinetic drugs (reversible conditions may respond to prokinetic therapy). The reversibility of 
OH probably depends on the depth of injury within the oesophageal wall, the involvement of 
peripheral neural control of motility and/or oesophageal muscle layers, the inflammatory 
mechanism that is triggered ie due to oesophagitis, and the type of healing or restitution process. 
For example, patients with scleroderma have a severe defect in peristalsis due to replacement of 
oesophageal muscle with fibrous connective tissue which is not expected to be reversible(95), 
whereas patients with moderate oesophagitis may have OH that reverses after appropriate 
cholinergic stimulation with edrophonium (185).  
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Data from experimental acute oesophagitis (88, 186) and indirect evidence from acute positive 
response to prokinetic drugs in humans suggested an impaired cholinergic stimulation as the 
main defect (90).  
 
Animal studies by Sifrim et al showed that repeated episodes of acute experimental oesophagitis 
lead to a progressive irreversible impairment of oesophageal motor function similar to that 
observed in patients with severe GORD (88). Another study on patients with GORD did not find 
any oesophageal motility improvement with meticulous antireflux therapy (111). In this study, it 
was concluded that impaired motility in reflux oesophagitis is either an irreversible consequence 
of oesophageal inflammation, or a (pre-existent) factor in its pathogenesis. 
 
All standard methods of assessing oesophageal motility including high resolution manometry 
failed to provide information regarding potential reversibility of oesophageal motility. None of 
the standard methods have been able to accurately measure viability of oesophageal neuro-
muscular structure in patients with OH (non-standard methods which are not suitable for daily 
practice such as edrophonium test can be useful in non-clinical settings). 
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9 Treatment of OH 
Specific treatment is clearly desirable for patients with evidence of symptoms related to OH. 
Effective control of acid reflux, if present, is the mainstay of clinical management at present. 
 
9.1.1 Dietary and lifestyle management 
A ‘common sense’ approach can reduce the risk of symptomatic bolus retention. Patients should 
favor liquid and semi-solid nutrition over solids, consume meals in the upright position, chew 
well and take plenty of fluids as these measures all promote oesophageal clearance (187). Indeed, 
it appears that the ‘pharyngeal pump’ together with gravity and hydrostatic forces can move not 
only liquids but also most solid food through the oesophagus without the need for active 
oesophageal contraction (140, 187). Many experts also recommend liberal use of carbonated 
beverages, because this may prevent as well as resolve bolus retention (188). 
9.1.2 Treatment of gastroesophageal reflux disease associated with 
hypotensive dysmotility 
OH patients with weak lower oesophageal sphincter function often experience severe symptoms 
and complications of GORD because poor clearance leads to prolonged acid exposure, 
particularly at night (92). These problems are marked in patients with systemic sclerosis in 
whom the combination of poor motility and poor salivation impacts on both volume and 
chemical (i.e. acid) clearance (93) although the relation of OH and GORD is still controvertial 
and a place of debate. Dietary and lifestyle measures may be helpful in GORD and GORD 
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related OH, although these are rarely sufficient in severe GORD. A systematic review identified 
several such interventions that reduce oesophageal acid exposure(189), some of which may be of 
particular benefit in patients with hypotensive dysmotility (190, 191). These include (i) weight 
loss, (ii) keeping the upper body in an elevated position after a meal, (iii) lying down in the right 
lateral position, (iv) not smoking, (v) not consuming alcohol, (vi) reduction of meal size, and 
(vii) reduction in calorie load. Reduction in fat intake may be of additional value as this has high 
caloric density and also appears to sensitize the oesophagus to acid reflux events (192). In 
addition, chewing gum for half an hour after meals may be helpful(193), as this stimulates 
salivation and swallowing, improving both volume and chemical clearance. 
High-dose acid suppression taken twice a day is often required to suppress gastric acid, heal 
oesophagitis and provide effective symptom relief in patients with severe hypotensive 
disease(194). Some patients benefit also from alginate preparations taken after a meal to suppress 
both acid and non-acid reflux events by forming a viscous layer over the gastric contents(194). 
The addition of ranitidine to suppress basal nocturnal acid secretion appears to be helpful in 
some patients but was not effective in a randomized controlled trial in 14 patients with systemic 
sclerosis (195). 
9.1.3 Prokinetics 
Cholinergic agents Medications that increase the concentration of acetylcholine in the synaptic 
cleft or directly stimulate muscarinic receptors promote smooth-muscle contractility. 
Bethanechol, a direct-acting muscarinic receptor agonist, has been shown in healthy volunteers 
and patients with hypotensive oesophageal dysmotility to increase peristaltic amplitude in the 
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distal-oesophagus(196). Using combined multichannel intraluminal impedance- manometry in 
seven patients with severe OH, Agrawal and coworkers(196) demonstrated that a single oral dose 
of 50 mg bethanechol increased both contractile pressure and bolus clearance. Similar effects on 
contractile pressure were reported by Blonski and coworkers(197) for a range of oral cholinergic 
agents, including bethanechol (25 mg), pyridostygmine (60 mg), and buspirone (20 mg), with 
pyridostigmine also promoting bolus transport. No trials demonstrating clinical efficacy have 
been published. Nevertheless, some experts report benefit of these medications in individual 
patients, although side-effects such as excessive salivation and diarrhea may limit their use. 
9.1.3.1 Dopamine antagonists  
 
Domperidone is a D2 receptor (dopaminergic receptor type 2) antagonist that promotes 
gastrointestinal motility by antagonizing the inhibitory effects of dopamine on postsynaptic 
cholinergic neurons in the myenteric plexus(198). Metoclopramide augments this peripheral 
effect with procholinergic properties and also has central anti-emetic actions at the 
chemoreceptor trigger zone(199). These medications increase LOS pressure, accelerate gastric 
emptying and improve symptoms in patients with GORD and also diabetic gastroparesis(200, 
201). Effects on oesophageal peristalsis and clearance are well established. No effect of 20 mg 
domperidone on oesophageal emptying is found on scintigraphy in 12 patients with diabetic 
autonomic neuropathy and oesophageal dysfunction(202). In contrast, a significant improvement 
in clearance was reported after administration of 10 mg intravenous metoclopramide in 14 
patients with systemic sclerosis(203). MHRA guidelines suggest that Domperidone should not be 
used when stimulation of gastric motility could be harmful: gastro-intestinal haemorrhage, 
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mechanical obstruction or perforation (MHRA publication on “DOMPERIDONE 10MG 
TABLETS”, PL 21880/0110, UKPAR). 
 
9.1.3.2 Motilin agonists and Azithromycin 
 
Erythromycin and other macrolide antibiotics have pronounced prokinetic effects that are 
utilized by physicians treating patients with severe gastrointestinal dysmotility such as 
gastroparesis and pseudo-obstruction(204). This effect is mediated by motilin receptors that play 
a key role in the initiation of phase III migrating motor complex (MMC), inter-digestive 
‘housekeeping’ contractions that sweep the stomach, and bowel clear of undigested material and 
bacterial overgrowth(204). Chrysos and co-workers (205), (206)showed that intravenous 
erythromycin (200 mg i.v. bolus) increased contractile vigor and LOS pressure in 15 GORD 
patients. Erythromycin (200/500 mg) also given intravenously reduced post-prandial 
gastroesophageal reflux in GORD patients by 50% (207, 208). In a 2-week clinical study Chang 
and co-workers(209) reported that erythromycin (250 mg tid) significantly shortened 
oesophageal and gastric transit and improved glycaemic control in diabetic patients. Similarly, 
other researchers reported that erythromycin improved oesophageal transit in patients with 
diabetes and autonomic dysfunction (67, 210). Although these findings are significant, the 
clinical use of erythromycin is limited by tachyphylaxis and side-effects including dyspepsia and 
diarrhoea. Erythromycin used in adults and paediatric patients with  OH  (211) showed variable 
and somewhat disappointing results. New motilin agonists that may be better tolerated are in 
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development. However, one recent example, ABT-229, had no effect on LOS function, 
oesophageal motility and reflux in GORD patients(212).   
 
Recently, Mertens et al reported that the macrolide azithromycin (AZI), a macrolide similar in 
structure and function to erythromycin (213), reduced the rate of reflux episodes in patients with 
a lung transplant (214, 215). Boeckxtaens et al showed that during treatment with AZI, the 
proximal extent of refluxate was significantly reduced compared with placebo. In patients with 
small HH, treatment with AZI led to a significantly smaller mean hiatal hernia size before reflux 
episodes. In line with this, the hiatal hernia was more often in the reduced state during AZI 
treatment than during placebo. Boeckxtaens concluded that the effect of azithromycin on reflux 
was mainly caused by a more distal position of the acid pocket, probably resulting from a 
reduction of the hiatal hernia size. An alternative hypotheses is that azithromycin accelerates 
gastric emptying and improves mixing of stomach contents, potentially affecting acid pocket 
properties(216, 217). Further reduction in acid secretion by AZI might have contributed to the 
reduced number of acidic reflux events. Yet another hypothesis is that azithromycin improves 
oesophageal motility which in turn reduces the clearance time seen in those patients. Other 
studies on the effect of azithromycin on gastrointestinal motility showed effect of this drug on 
the gastric antrum and duodenum to be stronger than that of erythromycin with longer duration 
of effect (218, 219).  
 
9.1.3.3 5 HT agonists  
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Cisapride and mosapride are prokinetic agents with mixed 5-HT4 agonist/5-HT3 antagonist 
action. Tegaserod, prucalopride, and other selective 5HT4 agonists have similar actions(199). 
Serotonin is released from enterochromaffin cells on mechanical stimulation and 5-HT4 receptors 
facilitate acetylcholine release in the myenteric plexus that triggers peristaltic contraction and 
clearance(220). Thus, in contrast to muscarinic antagonists and motilin agonists, 5-HT4 agonists 
promote normal gastrointestinal transit rather than inducing powerful but un-physiological 
contractions. These agents have prokinetic effects throughout the gastrointestinal tract and 
proven clinical efficacy in various conditions characterized by slow-transit, including GORD, 
diabetic gastroparesis and constipation(221). Studies have demonstrated that cisapride and 
mosapride increase LOS pressure, promote oesophageal clearance, and reduce acid exposure in 
health and GORD patients(222, 223). However, the mechanism of this action was not evident on 
conventional motility studies(222-224). Soon after the introduction of high-resolution 
manometry with oesophageal pressure topography Staiano and Clouse(225) observed that 
cisapride enhanced contraction in the proximal smooth-muscle segment of the oesophageal body. 
The functional significance of this effect was confirmed by combined HRM-videofluoroscopy 
that showed tegaserod improved co-ordination between contractile segments, leading to more 
effective solid-bolus transport (Figure 12)(159). Cisapride and tegaserod have been withdrawn 
due to rare, but occasionally life-threatening, side-effects; however, new 5-HT4 agonists are in 
the pipeline or are in the market approved for other indications(221). Clinical trials in GORD are 
in progress and, hopefully, studies in symptomatic, hypotensive oesophageal motility will 
follow. 
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Figure 13 - Concurrent fluoroscopy and high-resolution manometry (HRM) reveals the functional importance of co-ordination 
between the proximal and mid-distal oesophageal contractions for solid-bolus transport and the prokinetic effects of the 5-
HT4 agonist tegaserod. (A) Patient no. 6: placebo treatment. HRM shows a break in the contractile front (>3 cm) at the 
proximal transition zone, the peristaltic contraction is otherwise preserved. Concurrent fluoroscopy reveals solid-bolus 
escape at the level of the proximal transition zone (note the corresponding pressure rise at the level of bolus impaction). In 
contrast, the liquid barium ingested with the marshmallow was propelled into the distal-esophagus and most was 
transported into the stomach. (B) Patient no. 6: tegaserod treatment. The pressure trough at the proximal transition zone is 
less pronounced on the HRM plot, the peristaltic contraction in the proximal oesophagus is well co-ordinated with the mid- 
and distal-esophagus. Concurrent fluoroscopy reveals effective solid and liquid bolus transport (note the pressure rise as the 
bolus passes through the gastro-esophageal junction into the stomach). Adapted with permission from Fox et al. Aliment 
Pharmacol Ther 2006; 24: 1017–1027. 
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9.1.4 Surgery 
In patients with severe GORD, impaired peristalsis, impaired oesophageal clearance, and 
dysphagia are common. The dysphagia may not only be due to the hypotensive dysmotility(56), 
but also to mechanical outflow obstruction at the oesophagogastric junction in the presence of 
hiatus hernia(226). In some cases anti-reflux surgery may not only improve reflux symptoms but 
also reduce dysphagia(108, 227-231). This may be due to improvement of oesophageal motility 
and visceral hypersensitivity with normalization of acid exposure or due to reduction of the 
hiatus hernia. However, the literature on the effect of fundoplication on oesophageal motility and 
the relationship between preoperative motility and outcome of surgery should be interpreted with 
caution. Flaws in the design of these studies and manometric techniques employed should be 
taken into account. Although some of these studies concluded that hypotensive dysmotility is not 
a contra-indication to surgical management of GORD, many experts in the field hold the opinion 
that fundoplication should not be carried out in patients with severe OH. 
 
9.2 Summary 
 
OH is a term used to define low amplitude contractions in the body of oesophagus and 
hypotensive LOS and is frequently found in patients with non-obstructive dysphagia and in 
gastroesophageal reflux disease. Oesophageal manometry is considered the "gold standard" test 
for the evaluation of oesophageal motility. Compared to conventional manometry, High-
resolution manometry (HRM); vastly increasing the number of recording sites and decreasing the 
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spacing between them, can more completely define the intraluminal pressure environment, by 
minimizing the impact of spatial gaps between recording sites.(2) 
  OH   can be a secondary phenomenon associated with severe inflammation or systemic 
disorders such as scleroderma, but often occurs in patients without significant reflux disease or 
evident systemic disease. Clinically OH  may present with symptoms of GORD (heartburn 
and/or regurgitation), dysphagia, extra-oesophageal symptoms such as cough and hoarseness and 
it may also develop after antireflux surgery (fundoplication). 
In the assessment of   OH, to exclude mechanical/pathological causes of dysphagia, upper 
endoscopy and barium swallow should be performed. Motility testing is performed by 
oesophageal HRM or preferably by combined HRM-impedance monitoring which can define 
both a detailed motor pattern and its impact on bolus transit and oesophageal emptying.  
The presence of OH  in experimental manometric studies with single liquid swallows might not 
reflect the status of oesophageal contractility during meals or after reflux in “real life”, 
Therefore, complementary stimulation tests could potentially add further information regarding 
the neuromuscular capacity of oesophageal wall. 
To date, prokinetics have shown disappointing results in treatment of OH in which might be due 
to a failure to phenotype patients before treatment according to the reserved oesophageal 
neuromuscular capacity. It thus has the potential to be a new medication for the treatment of 
gastroparesis and gastrointestinal dysmotility.  
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9.3 Remaining questions and aim of this thesis  
OH is a common clinical condition in patients with dysphagia (69). OH can be due to a 
functional neuromuscular disorder or to a structural change of the oesophageal anatomy (i.e. 
fibrosis, connective tissue disorder or infiltration). The former can theoretically improve with 
adequate stimulation whereas structural disorders can be irreversible. It could be, therefore, very 
important to assess the degree of reversibility of this condition for management purposes. 
Several pharmaceutical agents known as prokinetic drugs can stimulate GI motility. Objective 
assessment of the severity of oesophago-gastric hypomotility and viability (as non-viable muscle 
will not react to therapies) of oesophageal neuromuscular function, prior to prokinetic therapy, 
would improve the clinical impact of these agents in patients with the appropriate phenotype.  
Moreover, a diagnostic tool for patients with OH, able to predict response to prokinetic therapy 
is an unmet need. Oesophageal manometry provides the diagnosis of hypomotility but does not 
reveal the potential reversibility or severity of this condition.  
 
9.4 Aims 
 
1) To assess IOM in patients with non-obstructive dysphagia and GORD, using HRM; 
2) To develop and standardize a set of “stimulation tests” to assess degree of IOM 
reversibility  
3) To treat IOM with a prokinetic agent and assess the outcome on oesophageal  
motility, dysphagia and GORD; 
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4) To evaluate the role of stimulation tests in predicting manometric and clinical to 
prokinetic therapy in patients with  IOM  
9.5 How these aims are achieved in this PhD project 
1.  Studied healthy asymptomatic subjects to obtain normal values for oesophageal motility 
and “oesophageal stimulation tests”  
2.  Assessed reproducibility of “stimulation tests” in normal subjects 
3.  Assessed the relationship between the response to stimulation test and symptom 
characteristics in patients with  IOM  
4.  Performed a randomized placebo controlled clinical trial to assess the effect of the 
prokinetic Azithromycin (AZI) on severe IOM in patients with dysphagia and/or GORD 
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CHAPTER 2: 
SUBJECTS AND METHODS 
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CHAPTER 2: SUBJECTS AND METHODS  
 
The methods and materials used in the studies presented in this PhD thesis will be described 
here, and specific methods will be presented in greater details in the relevant chapters. 
10 Subjects 
 
Healthy volunteers within the age range of 18-70 years old with no reflux symptoms, dysphagia, 
history of GI surgery or major medical conditions are studied to establish the normal values for 
the HRM device and stimulation tests used in this study. 
 
Patients with non-obstructive dysphagia and GORD with diagnosis of IOM are studied at the 
upper GI physiology unit at the Royal London Hospital. These patients presented with 
dysphagia, gastro-oesophageal reflux symptoms, cough or a combination of all the three 
symptoms.  
 
Recruitment Procedure 
 
Healthy volunteers are recruited from the general public by advertisement and direct contacts. 
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The volunteers who met the inclusion criteria were contacted via letter or telephone and invited 
to participate.  
 
All the patients undergoing oesophageal motility testing at the Upper GI Unit at the Royal 
London Hospital as well as at the same unit at Guy’s Hospital with a diagnosis of severe OH 
were considered as potential participants in the relevant studies of this PhD project.  
 
11 METHODS 
 
11.1 Questionnaires 
 
Standardized questionnaires were used to quantify symptoms and assess the effect of the 
interventions i.e. prokinetic/placebo treatment: 
 
To evaluate the effect of AZI on symptoms I used  the following questionnaires: 
Dysphagia Odynophagia Questionnaire – This is a validated 10-item questionnaire that assesses 
the frequency of dysphagia, food impaction and odynophagia. Items are scored from 0-5, using a 
Likert scale where higher scores represent worse symptoms. A total score out of 50 is calculated 
– higher scores represent more severe dysphagia. A score of >5 has 86% sensitivity and 97% 
specificity for identifying the presence of objective dysphagia to avoid inaccurate description of 
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other symptoms such as feeling of fullness in epigastr in place of dysphagia (Escobar, Pandolfino 
et al. 2011). 
 
Reflux symptoms were assessed using the Reflux Disease Questionnaire (RDQ)  (232) – This is 
a 12-item self-administered questionnaire, designed to assess the frequency and severity of 
heartburn, regurgitation, and dyspeptic complaints and to facilitate the diagnosis of GORD in 
primary care (232). It scores 12 individual items relating to the frequency and severity of reflux, 
using a Likert scale, where 0 represents the most negative option and 5 the most positive one. A 
raw score is calculated for domains of heartburn (score: 0-20), regurgitation (score: 0-20) and 
dyspepsia (score: 0-20), the scores of heartburn and regurgitation can be combined to give a total 
GORD score (0-40) (Since dyspepsia is not considered a typical GORD symptom it is eliminated 
to establish a specific GORD scoring when indicated). 
 
Psychological assessment was performed using Hospital Anxiety and Depression Scale (HADS) 
(233). This rating scale has been established as a much applied and convenient self-rating 
instrument for anxiety and depression in patients with both somatic and mental problems, and 
with equally good sensitivity and specificity as other commonly used self-rating screening 
instruments. The HADS is a fourteen item scale that generates ordinal data. Seven of the items 
relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-
3 and this means that a person can score between 0 and 21 for either anxiety or depression. The 
licence to use this questionnaire has been obtained for the Neurogastroenterology team at the site 
of conducting this project. 
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Dysphagia questionnaire 
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11.2 Oesophageal physiology tests 
 
11.2.1 High resolution manometry – Technique 
 
Manometry is often considered to be the gold standard, being able to detect subtle impairment of 
oesophageal peristalsis. A major evolution in manometric methodology has been the introduction 
of high-resolution manometry (HRM); the basic concept being that by vastly increasing the 
number of recording sites and decreasing the spacing between them, one can more completely 
define the intraluminal pressure environment, minimizing the impact of spatial gaps between 
recording sites (64). In recent years, HRM has become an essential tool for mechanistic studies 
of oesophageal function in research and in clinical practice (Figure 13). HRM has been even 
used to study the effects of pharmacological agents on different oesophageal segments(159, 160). 
In clinical practice, HRM should replace conventional manometry. First of all HRM is easy to 
perform and probably more reproducible. Secondly, HRM predicts abnormal bolus transport 
more accurately than conventional manometry(157). Lastly, not only is the diagnostic agreement 
between conventional and HRM high(161) but some publications also emphasize that clinically 
important pathologies (impaired OGJ relaxation, achalasia, distal oesophageal spasm, localized 
abnormality of peristalsis) can only be detected by HRM(157, 161)A classification of 
oesophageal motility disorders based on pressure topography characteristics has been proposed 
by the Chicago group (162, 163). 
Whether conventional or high-resolution manometry is used, care must be taken to avoid 
circumstances that can lead to a spurious diagnosis of OH. Examples of these are the use of 
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drugs that inhibit oesophageal contractions (anticholinergic agents and calcium channel 
blockers), failure to have an appropriate time interval between swallows, and inclusion of dry 
swallows. Additionally, depending on the examination position, the appropriate normal values 
must be applied because contractile vigor decreases on moving from the supine to the upright 
position(164). 
 
 
 
Figure 14 - Left: Station pull-through manometry curtsey of J. R. Siewert, H. Feussner (Munich); Right: high resolution 
manometry for a single swallow. (Image from internal source) 
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11.2.2 HRM Protocol 
After overnight fasting, pressure calibration and applying local anaesthetic to nasal and 
pharyngeal cavities, a 32-channel solid state circumferential combined manometric and 
impedance monitoring catheter (Unisensor, AG) was inserted transnasally to 60 cm from the 
nares. The participant lay down on their right side and rested for 5 minutes before any 
measurements were taken. The gastric baseline was recorded and the catheter positioned in order 
that both upper and lower oesophageal sphincters were visible on the screen. Basal oesophageal 
body and LOS measurement were recorded. Using a syringe to inject water orally, a total of 10 
single swallows of 5ml water was performed. There was at least a 20 second interval between 
each swallow.  
Lying down position was preferred in this study as it increases the workload of the oesophagus 
making it more accurate (both sensitive and specific) to detect peristaltic dysfunctions(234).  
After recording basal oesophageal motility with 10 water swallows, stimulation tests follow 
without any change to the HRM settings or the participant’s position.  
Stimulation tests 
The first stimulation test consisted of three series of multiple rapid swallows (MRS). The 
participant swallowed in total 10mls of water in 5 swallows with 1-2 second intervals (each 
swallow contained 2mls  of water).  
The next stimulation test was an abdominal compression test. A specially designed inflatable 
cuff (21 x 55 cm) (VBM Medizintechnik, Sulz, Germany) was wrapped around the abdomen to 
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induce external abdominal compression which in turn will increase gastric pressure and 
oesophageal outlet resistance to bolus transit. The cuff is equipped with external manometers. 
The participant was given 10 swallows of 5mls of water with sufficient time intervals to allow 
oesophageal motility to settle back to baseline. 
The last step, after 10-15 minutes rest, was solid bolus swallows. The participant swallowed 10 
pieces (1-2 cm3)(164) of white bread without crust in 10 single swallows. Between each swallow 
the participant was given enough time to recover from each swallow.  
 
11.3 Detailed description of  oesophageal stimulation tests  
 
11.3.1 Multiple rapid swallowing (MRS):  
Multiple rapid swallowing (MRS), by overloading the oesophagus with water, provokes an 
intense central and peripheral oesophageal neural inhibition resulting in the absence of 
contractions in the smooth muscle portion of the oesophagus and prolonged, complete relaxation 
of the LOS. The last swallow of the MRS series is followed by a powerful peristaltic sequence in 
the oesophageal body together with a post relaxation contraction in the LOS (24). A normal 
response to multiple rapid swallowing requires integrity of inhibitory and excitatory mechanisms 
(regulating oesophageal body and LOS motility) as well as oesophageal muscle integrity. 
Multiple rapid swallowing could be an intense stimulation exercise to test the integrity of 
inhibitory and excitatory mechanisms that regulate oesophageal motility. I use MRS to test 
oesophageal and LOS neuromuscular viability in patients with hypomotility.  
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Figure 15 - Normal (left) and abnormal (right) response to MRS. (Image from internal source) 
 
11.3.2 Solid food swallows: 
Studies have shown that swallowing bread boluses can produce peristalsis with higher amplitude, 
longer duration and slower velocity than single water swallows(25-26). Peristaltic velocity 
becomes progressively slower and contractile pressure more powerful as the work required for 
bolus transport increases from dry (i.e.; no bolus) to fluid swallows and from fluid to solid bolus 
swallows (27).  The contractile integral, a variable that summarizes the vigour of oesophageal 
contractility (2), is higher in the smooth muscle oesophagus during solid rather than liquid bolus 
transport and the pressure gradient across the gastro-oesophageal junction is greater. (28). 
Therefore, it is considered that resistance to solid bolus transit would provide a greater challenge 
to oesophageal function (28). I use solid bolus swallows as part of testing oesophageal and LOS 
neuromuscular viability in patients with hypomotility. 
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Figure 16 - Example of bread swallows compared with water swallow in the same patient: UP< swallows of water Down: 
bread swallows. (Image from internal source) 
 
11.3.3 Oesophageal outlet obstruction with abdominal compression:   
This test is used on both patients with IOM and/or GORD. Abdominal compression increases 
intragastric pressure provoking outlet obstruction to oesophageal bolus transport.  In response, 
the normal oesophagus produces contractions of increased amplitude and duration in order to 
overcome the increased distal pressure and keep a normal bolus transit.  Compared with the 
Page 102 of 281 
 
baseline, the amplitude of oesophageal contractions increases with outlet obstruction in healthy 
subjects (29-30). However this does not occur in patients with irreversible hypomotility. These 
patients may not be able to compensate for outlet obstruction.   
 
 
Figure 17 - Example of swallow with abdominal compression compared with water swallows in the same patient: UP< water 
swallow, Down: swallow of water with abdominal compression. (Image from internal source) 
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11.4 Physiology studies to investigate gastro-oesophageal reflux  
 
11.4.1 24hour impedance-pH (reflux monitoring) - Technique 
Even though many clinicians and investigators consider oesophageal pH monitoring the "gold 
standard" for measuring gastroesophageal reflux, this method has some inherent limitations. 
Impedance monitoring is the only recording method that can achieve high sensitivity for the 
detection of all types of reflux(235). The combination of both techniques is better than pH-metry 
or impedance monitoring alone (235). Impedance monitoring is based on measuring the 
resistance to alternating current (i.e., impedance) of the content of the oesophageal lumen. When 
a pair of electrodes, separated by an isolator (i.e., catheter) is placed inside the oesophagus, the 
electrical circuit is closed by electrical charges (i.e., ions) present in the oesophageal mucosa that 
surround the catheter. The 2.1-mm diameter combined MII-pH catheter is passed transnasally 
into the oesophagus and stomach and positioned so that the oesophageal pH electrode is located 
5 cm above the proximal border of the LOS.  
 
11.4.1.1 Reflux monitoring - Protocol 
 
All patients underwent 24 h MII-pH monitoring. Patients had to be fasting from the night before 
and had to be off medication (any kind of PPI, prokinetics, opiod derived drugs, Erythormycin) 
for at least 5 days. A dedicated MII-pH catheter (with intraluminal impedance segments 
positioned at 3, 5, 7, 9, 15 and 17 cm above the LOS) (Sandhill Scientific Inc., Highlands Ranch, 
CO, USA) was placed transnasally, with the oesophageal pH sensor positioned 5 cm above the 
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manometrically determined LOS. Patients were requested to mark any symptoms that occurred 
along the recording time as well as every meal and change of position (to upright or recumbent) 
on the device. The catheter transmitted information into the software that was included in the 
device (Sleuth System – Sandhill Scientific Inc., Highlands Ranch, CO, USA). MII-pH data were 
collected and analyzed with the Bioview Analysis Software (Sandhill Scientific Inc., Highlands 
Ranch, Colorado, USA). By means of MII-pH it was determined whether the patient had 
pathological GOR or not (Figure 17). The cut off value of distal oesophageal acid exposure as 
percentage (%) of time with pH < 4 was considered abnormal if total time with pH < 4 was 
greater than 4.2%, and/or upright time with pH < 4 was greater than 6.3%, and/or recumbent 
time with pH < 4 was greater than 1.2%).  
 
 
 
 
 
 
 
 
 
 
Figure 18 - Gastroesophageal reflux detected by combined multichannel intraluminal impedance and pH (MII-pH) monitoring.
Impedance-detected reflux episodes during which the intraoesophageal pH drops from above to below 4.0 are considered 
acid (a), whereas impedance-detected reflux episodes during which the intraoesophageal pH remains above 4.0 are 
considered non-acid (b). From the following article: Gastroesophageal reflux monitoring: pH and impedance, Radu Tutuian 
and Donald O. Castell, GI Motility online (2006) 
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11.5 Physiology studies to investigate gastric emptying 
 
11.5.1 Gastric emptying test: Technique 
Breath tests have recently been developed and validated to allow the non-invasive and non-
radioactive (hence sued in this study to recude the risks imposed on participants) measurement of 
gastric emptying which has shown significant correlation with the gold standard scitygraphic 
method (Hauser et al 2006). 13C breath tests involve the measurement of the 13C:12C ratio present 
in breath carbon dioxide after ingestion of a nutrient meal, or other substrate containing 13C. 13C 
is a non-radioactive stable isotope that occurs naturally at an abundance of 1.1%. When a 
substrate that is relatively 13C rich is ingested, the 13C contained within it, after digestion and 
absorption, enters oxidative metabolic pathways. The end product of oxidative metabolism is 
13CO2, which is expired in the breath. This is separated from other components of expired air and 
its 13C enrichment can be measured by infrared isotope ratio spectrometry. Breath samples are 
obtained before and at 30min intervals (15min interval for first 2hrs) after administration of the 
substrate for 4 hours. (Figures 18 and 19). 
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Figure 19 – Gastric emptying breath test with C13-octanoic acid test meal. 
(Image source Wagner Analysen Technik) 
Figure 20 – Gastric emptying breath test analysis (a normal study curve). 
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11.5.2 Gastric emptying test: Protocol 
 
Overnight fasted patients ingested a test meal of egg sandwich within 10 min. The meal 
comprised a scrambled egg with the yolk mixed with 100 mg of [13C]octanoic acid and yolk and 
egg white cooked separately and two slices of white bread followed by 75 mL of still water. 
During the following 4-h test period the subjects stayed in a sitting position. Breath samples for 
13CO2 measurement were collected in breath bags every 15 min during the first 2 hours and 
thereafter in 30-min intervals. Control (baseline) sample was collected before the test meal.  
Measurement of 13CO2 in exhaled air was carried out by IRIS with the infrared spectrometer at 
our disposal (from Wagner Analysentechnik, Worpswede, Germany).  
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11.6 Statistics 
 
11.6.1 General statistical considerations 
 
Statistical analysis for descriptive data such as means, prevalence, 5% and 95% were performed 
using column statistics by Prism software version 5 (Graph Pad, La Jolla, CA, USA). 2×2 
contingency table, Student's t-test or chi-squared analysis as appropriate were applied to 
determine the significance level, considering P < 0.05 as statistically significant. 
 
In chapter 3-2 we show the reproducibility of the Distal Contractile Integral (DCI). In statistical 
analysis of reproducibility, percentage coefficient of variation (100 · SD/mean: %COV) was 
derived as a measure of inter and intraindividual variation. Moreover, intra-class correlation 
coefficient (ICC) and concordance correlation coefficient (CCC) were measured as other means 
of assessment of reproducibility. Bland–Altman plots were used to express the concordance of 
variables graphically. 
 
In chapter 6, studying the effect of azithromycin on ineffective oesophageal motility, the 
following statistical considerations were applied. The primary outcome measure used in the 
analysis of the data to decide the effect of azithromycin or placebo is the distal contractile 
integral (DCI). The cut off level of DCI to diagnose IOM (236) is 447 ± 279.4 mmHg.cm.s. I 
expected that the increase of DCI post azithromycin therapy to be at least 50% above the 
baseline. For the calculation of sample size I took the level of significance of the test to be 0.05 
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and the power of the test to be 80%. The required number of participants in each arm 
(azithromycin and placebo) was calculated to be 13 subjects. 
 
Comparisons between the Azithromycin and placebo group were made using contingency tables, 
and t test. P-values <0.05 were accepted as statistically significant. The data were presented as 
mean (±s.d.) or median (±interquartile range) as appropriate. 
 
Finally, in studies of predictive values to identify responders to AZI the sensitivity, specificity 
and likelihood ratios were calculated based on the ROC curve to validate the most accurate 
predictive parameters.  
 
11.6.2 Clinical trial of AZI vs Placebo on IOM - Primary Endpoint Efficacy Analysis  
 
Increase of distal contractile integral (DCI) in the oesophageal body induced by AZIor 
placebo. 
 
11.6.3 Secondary Endpoint Efficacy Analysis  
 
1. Evaluation of changes in symptoms pre and post AZI therapy 
2. Evaluation of manometric oesophageal body response to stimulation tests ie. solid 
bolus swallows, MRS and outlet obstruction in healthy subjects and patients with 
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IOM. 
3. Effect of AZI on gastric emptying and gastroesophageal reflux 
 
11.7 Research ethics committee approval 
 
Studies on both healthy volunteer group and patient participants were approved by the NRES 
Committee: South East Coast – Kent and Sussex. Ethics committee reference number: 
12/LO/0835 Queen Mary, University of London reference number: ReDA008188 
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CHAPTER 3-1: HIGH RESOLUTION MANOMETRY: 
NORMAL VALUES FOR HRM USED IN THIS PHD 
COURSE 
 
12  INTRODUCTION 
 
Oesophageal motility studies are indicated for patients with dysphagia and non-cardiac chest 
pain, and may be useful in evaluating patients with gastro oesophageal  reflux disease (GORD). 
Oesophageal motility was traditionally assessed by manometry employing a low compliance 
water-perfused catheter system. High resolution manometry with oesophageal pressure 
topography (HRM), overcomes several limitations of the conventional manometry by utilizing 
enhanced spatial pressure resolution and data visualisation.  As a consequence, HRM widened 
the horizons for the understanding  of oesophageal physiology and improvement in the clinical 
evaluation of  oesophageal  motor disorders (237). In addition , HRM is easy to perform and 
easily learned by the clinician(238). A major advantage gained in the adoption of HRM over 
conventional manometry has been the establishment of objective quantitative measurements of 
both  oesophageal  body motor response and GOJ relaxation (239-61).  
Specific criteria for the interpretation of HRM and a new classification of oesophageal  motility 
disorders (Chicago classification) were developed and have been improved (242), (59). 
Published normal values  of HRM-specific metrics have been obtained from the Given Imaging 
HRM system, and it is not certain that these normative values necessarily apply to data derived 
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from other manufacturers’ devices (244). This is a particularly important issue for Integrated 
Relaxation Pressure (IRP), a key measurement in the HRM criteria for achalasia diagnosis 
(239),(59). Although conceptually sound as a metric of GOJ  relaxation, IRP is a technology-
sensitive measurement, so that normal values  presumably are specific for specific sensor types 
and arrays and the normative values  of the metric must be linked to the assembly with which 
they were derived (239). Other oesophageal  metrics are essential for the purpose of our research 
i.e. peristaltic break (PB) and distal contractile integral (DCI).  
 
In the present PhD project an HRM assembly from Unisensor AG was used. To date, although 
more than 100 GI physiology research or clinical centres worldwide are using this system, 
normative values for HRM  metrics were not established. Previous studies either used a different 
version of the HRM assembly (245) (a 36-channel solid-state unidirectional manometric catheter 
- Unisensor AG) or were performed on a particular population group (246). I established  
normative ranges and cut-off values  for the HRM  metrics derived from the Unisensor AG’s 
32channel solid state circumferential combined manometric catheter. 
 
13 MATERIALS AND METHODS 
 
13.1 Participants 
 
Sixty-nine healthy volunteers (31 male, 38 female, mean age 30.33, age range 19-67) were 
included in this study. In this study, 35 volunteers were recruited in the UK and 34 volunteers 
recruited in Brazil. These healthy volunteers were clinically asymptomatic from both 
gastrointestinal symptoms as well as other significant medical conditions. None of the 
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participants were on regular medication except for oral contraceptive pills for some of the female 
participants. Ethics approval for running this study was obtained from the South East Coast – 
Kent. Ethics committee as well as the local ethics authorities in Brazil for the Brazilian 
participants and all the participants voluntarily signed informed consent before any assessment 
were performed for this study.  
 
13.2 Oesophageal HRM 
 
After overnight fasting, a 32channel solid state circumferential manometric monitoring catheter 
(Unisensor AG) was inserted transnasally at 60 cm from the nares. The participant lay down on 
their right lateral side and rested for 5 minutes before any measurements taken. The gastric 
baseline was recorded and the catheter was then repositioned in a way that both  the upper and 
lower oesophageal   sphincters could be identified simultaneously on the screen. The catheter 
was securely fastened to the face of the patient using adhesive tape. Basal oesophageal body and 
LOS measurements were recorded.  
Using a syringe to inject water orally, a total of 10 single swallows of 5mls of water were  
performed with. at least 20 seconds interval between each swallow.  
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Figure 21 - Normal HRM tracing. High resolution manometry tracing and placement of catheter 
 
 
13.3 Data analysis 
 
Data was analysed using Bioview Analysis software version 5.6.3.0 (Sandhill Scientific Ltd.). 
The Chicago classification parameters (59) which are widely accepted and applied in the 
assessment of oesophageal high resolution manometry were used to characterize oesophageal 
motility pressure parameters. Thermal compensation was applied before any measurements were 
taken. Double swallows or swallows associated with belching or retching were excluded from 
analysis. The measurements of all the Chicago classification parameters as well as most of the 
generic parameters such as LOS and UOS pressure throughout this study required manual 
analysis. All measurements relating to LOS as well as intrabolus pressure were referenced to 
gastric baseline pressure. Oesophageal body contractility and UOS resting pressure were 
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referenced to atmospheric pressure.  If after a swallow, no distal oesophageal contraction 
occurred, the parameters representing distal function could not be produced and subsequently 
these swallows were excluded from the analysis. 
 
1 After manually positioning the required GOJ markers oesophageal contraction amplitudes at 
5 and 10cm as well as the UOS resting pressure, the length of LOS and gastric pressure were 
measured using the analysis software.  
2 All of the other parameters were measured manually including: LOS relaxation pressure and 
resting pressure, distal contractile integral (DCI), transition zone (TZ), contractile front velocity 
(CFV), Distal contractile latency (DL), Intrabolus pressure (IBP), Integrated relaxation pressures 
(IRP), contractile deceleration point (CDP). An isobaric contour of 20 mmHg was used 
throughout the analysis except for the measurement of transition zone for which isobaric contour 
of 40 mmHg was used.  
3 The analysis software measured the amplitude of contractions automatically at 5 and 10 cm 
above GOJ.  
4 GOJ upper and lower limits were marked at the highest and lowest borders recorded at end 
inspiration and end expiration respectively. LOS resting pressure was measured using a generic 
integrated tool in the analysis software at the end expiratory point referenced to intragastric 
pressure excluding the diaphragmatic crural effect. GOJ integrated relaxation pressures (IRP) 4-s 
was measured using a special tool integrated in the analysis software. GOJ relaxation was 
measured during a 10-s post deglutition time window in the electronically generated e-sleeve 
signal through the anatomic zone defined as the GOJ. GOJ nadir relaxation pressure was 
measured as the minimum pressure reached during 10 s post deglutition period. 
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5 The transition zone (TZ) was defined as the distance between the end of the proximal 
oesophageal segment and the beginning of the distal oesophageal segment in the 40-mmHg 
isobaric contour. The 20-mmHg isobaric contour used in other studies Smout (247) would mask 
this gap on most of the swallows. Brief peristaltic contractions shorter than 1 cm in length within 
the transition zone were ignored and were not considered as the beginning of the distal 
oesophageal segment. 
6 The contractile front velocity (CFV) was defined as the slope of the line connecting the 
points on the 20-mmHg isobaric contour at the proximal and the distal margin of the distal 
oesophageal segment. 
7 Distal contractile latency (DL) was defined as the interval between the start of UOS 
relaxation and the contractile deceleration point (CDP< the inflection point along the 20 mmHg 
isobaric contour where propagation velocity slows demarcating the tubular oesophagus from the 
phrenic ampulla). 
8 The distal contractile integral (DCI) was calculated using integrated Chicago calculation tool 
in the analysis software which multiplies the length of the smooth muscle segment of the 
oesophagus generating the peristaltic contraction, by the duration of propagation of the 
contractile wave front and the mean pressure in the entire box excluding pressures below 20 
mmHg. 
9 Intrabolus pressure (IBP) was measured between the peristaltic wave front and the GOJ . 
 
13.4 Statistical analysis and presentation of data 
 
Data were tested for normality of the distribution using the Kolmogorov–Smirnov. Data are 
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presented as the mean, median and 5th and 95th percentiles. Normal values were defined as the 
interval between the 5th and 95th percentile of values.  
 
14 RESULTS 
 
Sixty-nine healthy volunteers successfully completed oesophageal high-resolution manometry 
with single swallows of water. Only values of distal latency and LOS resting pressure passed the 
Kolmogorof-Smirnof normality test.  
 
14.1 Oesophageal  peristaltic wave pressure topography 
 
Table 1 provides manometric findings of  oesophageal  peristaltic parameters both from our 
study and in comparison with Chicago group (59) and the recent study from Smout et al (247). 
As shown in this table, the mean DCI was 1941 mmHg.s.cm, with a 5–95th percentile range of 
606.7-4998 (median 1533 SD: 1492). The mean CFV was 3.95 cm/s, 5–95th percentile range 2-
6.55. The mean DL was 6.94 s, 5–95th percentile range 5.19-8.81. The mean IBP was 9.93 
mmHg, with a 5–95th percentile range of 1.97-17.61. The mean amplitude of contraction 
measured at 5 and 10 cm above the GOJ were 121.00 and 78.52.00 mmHg, respectively. The 
mean TZ length was 2.34 cm, 5–95th percentile range 0.00–6.00. 
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Table 1 - Comparison of the parameters in our study, study by Smout et al and the Chicago group. 
 N Mean SD Median 5th 95th 95TH Smout 
et. al 
95th 
Chicago 
DCI 68 1941 1492 1533 606.7 4998 3407.60 <5000 
IRP4 69 10.86 5.76 9 2.5 23.5 28.28 <15 
CFV 68 3.95 1.28 4 2 6.55 6.50 <7.5 
DL 68 6.94 1.11 6.9 5.19 8.81 8.70 <4.5 
IBP 68 9.93 4.58 9.85 1.97 17.61 19 <15 
AMP 5 68 121 61.15 110.5 43.8 260 146 <146.1 
AMP 10 68 78.52 39.68 71 22.9 168.1 - - 
 
 
Figure 22 to Figure 28: Demonstrating the scatter plot for the Chicago parameters related to the 
oesophageal boy measurements. TZ= transition zone, dci= distal contractal integral, cfv= 
contractile front velocity, DL= distal latency, IBP= intrabolus pressure. 
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Figure 22 – (Figures 21-27: Demonstrating the scatter plot for the Chicago parameters related to the oesophageal body 
measurements.) 
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14.2 Sphincteric and gastric parameters 
 
Mean UOS  resting pressure was 78.84 mmHg with a 5–95th percentile range of 36.68-186.1 
mmHg (Table 1). Mean GOJ  length was 3.65 cm, with a 5–95th percentile range of 1.9-5.1 cm. 
Mean LOS resting pressure was 29.35 mmHg, with a 5–95th percentile range of 8.95–51.40 
mmHg. Mean LOS nadir relaxation pressure was 4.9 mmHg, with a 5–95th percentile range of 
0.10-10.45 mmHg. Mean IRP for 4 s was 10.86 mmHg, with a 5–95th percentile range of 2.5-
6.55. Mean gastric pressure was 4.52 mmHg, with a 5–95th percentile range of 0.15-12.10 
mmHg. 
 
 
Figure 29 to Figure 35: Demonstrating the scatter plot and whisker and box plot for the Chicago 
parameters related to the sphincteric and gastric measurements. Vertical (y) axis corresponds to 
amplitude of the pressure mmHg.
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Figure 29 – (Figures 28-34: Demonstrating the scatter plot and whisker and box plot for the Chicago parameters related 
to the sphincteric and gastric measurements.) 
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15 DISCUSSION 
 
The evaluation of oesophageal motor function made by oesophageal manometry devices 
may be influenced by the manometric system employed. Therefore, it is recommended 
that normal values are established for each system. In the present chapter of this PhD 
thesis, the normative metrics for high-resolution manometry data obtained with the 
Unisensor AG assembly during water swallows in recumbent position in healthy 
volunteers are reported. The normal values of the parameters investigated in this study 
had some differences from those of the previous studies that used the MonoScan system. 
While the normal values for DCI in our study were similar to the data previously 
established by Chicago Classification, the CFV and DL cutoffs were slightly different. 
This fact may be the result of  interobserver variability of measure of CFV and DL 
possibly due to the artifact produced by intra oesophageal pressurization (183). Even 
more important, the upper cutoff for IRP in the supine position utilized in the Chicago 
Classification of  oesophageal  motor disorders is 15 mmHg (248), whereas according to 
our results with the Unisensor AG HRM device it should be 23.5 mmHg. This is a 
particularly important issue because IRP is a key measurement in the HRM criteria to 
decide on the completeness of the LOS relaxation during  diagnosis of achalasia (249). 
Our findings share similarities with those of Smout et al (247) who used Unisensor AG 
catheter, 3.3mm in diameter coupled to a MMS system (247); it is noteworthy that their 
IRP upper cut off (28 mmHg). 
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Our IRP results are also similar to those reported for a Chinese population by Shi Y et al, 
who used a Unisensor AG catheter with 4.2mm in diameter and a Sandhill system 
identical to ours (246). Since our study was conducted on volunteers recruited among 
Caucasian populations in UK and Brazil, this similarity suggests that racial differences do 
not influence GOJ function. One significant difference between our study and both the 
Chicago and Smout groups is the peristaltic amplitude at 5cm above LOS. This measure 
in our study yielded an amplitude nearly twice as of in the other studies. This result is 
partly due to the 4 outlier healthy participants with very high amplitude peristaltic 
contractions. Otherwise we could not explain the exact cause for this difference.  
 
It is important to remember that this present study shows normative data for supine 
position. As it has been demonstrated by other studies, there are significant differences 
between HRM results in supine and upright positions, especially regarding the IRP and 
DCI (164, 250). Therefore, our normative results cannot be applied to the studies 
performed in sitting or upright positions. 
 
 
15.1 Conclusion 
 
Our results, taken together with those of Smout et al (247) and of Shi et al, indicate that 
HRM systems using the Unisensor AG catheter provides consistently higher IRP values  
in healthy volunteers than those of ManoScan system used to establish the Chicago 
classification. For the purpose of our work in this thesis, I used our normative values.  
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CHAPTER 3-2: Normal values and 
reproducibility of oesophageal stimulation tests 
 
16 Introduction 
 
In recent years, high-resolution manometry (HRM) has become the test of choice for the 
evaluation of oesophageal motor function and has been helpful in revealing previously 
unrecognized oesophageal physiologic mechanisms and pathophysiologic patterns. When 
oesophageal function is impaired due to ineffective oesophageal motility, due to the 
gradual loss of neuromuscular functionality, it is possible that there is still some 
functionality to be reserved. This reserved capacity of oesophageal contractility can be 
revealed in special challenging circumstances. Nevertheless, using single water swallows 
seems not to be sufficient to reveal the reserved oesophageal neuromuscular capacity. 
This is particularly important in making the distinction between reversible and 
irreversible oesophageal motor dysfunction which consequently can affect clinical 
decision making.  
Patients presenting with oesophageal symptoms (dysphagia, chest pain, etc.) unexplained 
by endoscopy or barium studies are frequently referred for oesophageal high resolution 
manometry (HRM) to investigate a motor basis for symptoms (251). However, in many 
instances, the standard HRM may be normal in the presence of clinical symptoms or 
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while asymptomatic patients may have abnormal oesophageal motility. Consequently, 
provocative testing can give additional insight. Examples of provocative tests include 
multiple rapid swallows (MRS), solid bolus swallows (252), and abdominal compression 
test.  Responses to provocative/stimulation tests may be useful in subtyping a spectrum of 
oesophageal disorders (253). Furthermore, these tests may predict oesophageal body 
contraction reserve and potentially assist in predicting the likelihood of postoperative 
dysphagia in patients undergoing antireflux surgery (254, 255). 
 
16.1 Multiple rapid swallowing 
 
MRS represents a simple provocative manoeuvre that can be easily incorporated into the 
oesophageal manometry protocol, and could demonstrate integrity of neural and motor 
processes in the smooth muscle oesophagus (256). Multiple swallows of water in rapid 
sequence induce central and peripheral neuronal inhibition of motor activity in the 
smooth muscle of the oesophagus and the lower oesophageal sphincter (LOS), and is 
dependent on intact inhibitory and excitatory neural function. A normal response during 
repetitive swallowing consists of inhibition of oesophageal body peristalsis and profound 
relaxation of the LOS (256, 257). After the last swallow of the series, there is a rebound 
excitatory response with an exaggerated oesophageal body peristaltic sequence and re-
establishment of LOS tone following a brief after-contraction .  
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An abnormal response consists of either incomplete inhibition during the MRS, with 
contraction of the oesophageal smooth muscle during the expected inhibition phase, 
and/or suboptimal or absent peristaltic response after multiple swallows (256, 257). 
Multiple rapid swallows responses can be visually assessed during the inhibition and 
contraction phases on HRM .  HRM quantitative parameters such as the distal contractile 
integral (DCI) can be used to quantitate the peristaltic response following MRS (255, 
258). There are two versions of multiple repetitive swallows of water described in the 
literature, one with large volume of water i.e. 200ml (173) and another one with 10-15ml 
(256). It is believed that multiple swallow of large volume of water is more useful in the 
study of the retention of water i.e. in OGJ obstruction or achalasia rather than the study of 
oesophageal body motility. This is because large volume of water can at times distend 
oesophageal lumen to the extent that can prevent from initiating any contraction in the 
body. Multiple swallows of small amount of water is therefore more useful in identifying 
the potential vigor of oesophageal body in producing stronger response to the increased 
workload. Thus for the purpose of this PhD studies I employed the multiple swallows 
with small volume of water. 
Figure 36. Example of a 
normal multiple rapid 
swallowing response. 
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16.2 Solid bolus swallow 
 
In healthy volunteers, compared to water swallows, viscous or solid swallows show 
improved peristaltic co-ordination, increased contractile pressure and duration (259). An 
impaired response to solid swallows may be more clinically relevant than water swallows 
when the patient is tested in upright position. In this testing position the effect of gravity 
on transporting liquid bolus is more significant whilst solid bolus still requires some 
propulsive force from oesophageal body for transportation. 
 
16.3 Abdominal compression 
 
Increased abdominal pressure results in corresponding increase of intragastric pressure 
which in turn affects oesophageal peristaltic contraction and duration of peristalsis (260-
264).  This effect might be used as an additional test to assess the reserved capacity of the 
oesophageal muscle function. In animal models, increased intragastric pressure causes: 1)  
slowing  of  the  peristaltic  wave  in  the  distal  oesophagus,  2)  increased  pressure  
wave  duration  in  the  distal  oesophagus,  3)  increased  oesophageal  diameter,  and  4)  
increased  duration  of  lower  oesophageal  sphincter  opening (263).   
 
16.4 Normal values of provocative tests 
 
Normal values for stimulation test are limited. Furthermore, similarly to normal values 
for standard liquid swallows HRM protocols, there ia a need to establish normal values 
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for stimulation tests in each motility laboratory using specific HRM systems.  With 
regards to the solid bolus swallows, Sweis et al, provided normal values using a HRM 
Given system (164).  
In this chapter I provide quantitative normal values for all stimulation tests using our 
Unisensor HRM cathteter and Sandhill system. I also assessed  the reproducibility of the 
three stimulation tests – multiple rapid swallows (MRS), abdominal compression test and 
bread swallows to address the interindividual variability of these manometric findings. 
 
17 METHODS 
 
17.1.1 Participants 
 
The study population consisted of 26 healthy subjects median age of 23.5 years, ranging 
from 19-52 years. Seventeen  were female (54%). 
recruited to undergo high-resolution manometry in the Upper GI Physiology Unit at the 
Royal London Hospital. All subjects were required to have no significant foregut 
symptoms and not taking any form of medication that might affect gastrointestinal 
motility in any way and/or gastric secretion. Those with previous surgical intervention of 
the upper gastrointestinal tract were also excluded. Each of the volunteers underwent 
oesophageal HRM by solid-state catheter, Unisensor AG assembly with 32 sensors, in 
two separate sessions at least one week apart.  
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Studies on healthy volunteers was approved by the NRES Committee: South East Coast – 
Kent Ethics committee reference number: 12/LO/0835 Queen Mary, University of 
London reference number: ReDA008188 
 
 
17.1.2 High resolution manometry 
HRM studies were conducted using an Unisensor AG assembly (Figure 36). The High 
resolution manometry probe consisted of 32 pressure, 12 Fr, each with 12 circumferential 
pressure sensors. All studies were analyzed using 
the most recent software version Bioview analysis 
software available from Sandhill Scientific  at the 
time of the analysis (version 5.6.3.0).  
 
 
 
 
 
 
 
 
Figure 37 - Unisensor AG high resolution assembly. 
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Prior to the test, subjects were fasted for at least 6 hours. Topical anesthetic was applied 
into the nostril, followed by transnasal intubation of the oesophagus. Catheter placement 
included initially at 60cm from nares in order to record the gastric baseline and then the 
catheter was repositioned in order to position one or two pressure channels above the 
upper oesophageal sphincter (UOS), and 2-3 cm below the crural diaphragm (CD). Deep 
inspiration helped to identify the CD(increased pressure amplitude of the CD, as well as 
increased intra-abdominal and decreased intra thoracic pressure). 
 
Subjects were studied in the semi-recumbent position. Subjects were allowed 5–10 
minutes to accommodate to the presence of the catheter without coughing or choking, 
This was followed by ten 5 mL water swallows, separated by 20 seconds of interval. The 
OGJ and oesophageal body were allowed to return to their resting state prior to each of 
the 10 swallows. 
 
17.1.3 Stimulation tests 
1) Multiple rapid swallowing (MRS): After baseline HRM recording of 10 single 
swallows of 5 ml water, three sets of MRS - 2ml water every 1-2 seconds, 5 times 
was performed.  
2) Abdominal compression test: Next after multiple swallows of water, an inflatable 
waist belt was fitted around the subject’s waist. The pressure cuff was inflated and 
the inflation of the cuff continued until a pressure of between 100-180 mmHg was 
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achieved on external pressure manometry gauge depending on the tolerance of the 
patient. The subject was offered 10 swallows of 5ml water at not less than 30 
seconds intervals (Error! Reference source not found.). 
 
 
3) Solid bolus swallows: After allowing 5-10 minutes rest to the subject, ten bread 
swallows (pieces 2-3 cm3)(164) of white bread without crust were conducted. The 
subject was allowed to chew the bread freely until ready to swallow in one single 
swallow.  
 
 
17.1.4 Assessment of the gastro-oesophageal junction and oesophageal body 
 
GOJ relaxation is studied using integrated relaxation pressure (IRP). IRP is taken relative 
to intragastric pressure.  To determine the IRP, using a computer tool first the upper and 
lower margins of the OGJ is determined, and then a 10-second time window is identified 
that begins at the start of LOS relaxation initiated by swallowing. This tool measures 
pressure simultaneously over the length of the rectangle drew over the 10 second 
distance. Then, it calculates maximum pressure along the height of the rectangle at each 
time point within the 10-second time window. The 4-second IRP algorithm takes these 
pressures and averages the lowest of them, the nadir pressure, over 4 continuous or 
discontinuous seconds. Using 4 discontinuous seconds to determining nadir pressure 
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eliminates cardiovascular artefacts, and pressures produced by contraction of the crural 
diaphragm during inspiration from calculation of the IRP. 
 
Assessment of oesophageal body characteristics is defined based on the current 
parameters introduced by Chicago classification including measures of (i) breaks in the 
isobaric contour of 20 mmHg, (ii) circular muscle strength using contraction amplitude 
and distal contractile integral (DCI); and (iii) wave propagation using contractile front 
velocity, distal latency (CFV and DL). Each parameter is measured in the distal (smooth 
muscle) oesophageal body rather than the proximal (striated muscle). Pressure 
measurements of the oesophageal body are taken relative to atmospheric pressure.  
 
Breaks in the integrity of peristalsis were assessed in the 20 mmHg isobaric contour 
(measured using the specific tool in the Bioview software). To determine peristaltic 
integrity, a 20 mmHg isobaric contour line is applied to the HRM.  A threshold value of 
20 mmHg above which intact oesophageal peristalsis is defined was chosen originally by 
the Chicago consensus group because this is the peristaltic pressure required for normal 
bolus transit when the OGJ is functioning normally. Peristaltic integrity is assessed by 
measuring gaps in the 20 mmHg contour along the length of the oesophagus, between the 
UOS and LOS.  
 
Circular muscle contraction amplitudes is measured at 5cm level of the distal segment of 
the oesophageal body and expressed as global measure of distal contractions – the distal 
contractile integral (DCI). The software allows automated measure contraction amplitude 
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at the distal 5cm along the length of the oesophageal body. The peak of the pressure 
upstroke reflects the contraction amplitude and is taken relative to the oesophageal 
baseline pressure of that particular channel. I measured the contraction amplitude at 5cm 
above the proximal border of the OGJ as an additional indicator of the oesophageal body 
strength. 
 
There are 2 measures to evaluate propagation of oesophageal pressure waves; the 
"contraction front velocity (CFV)" and the "distal latency (DL)". The CFV is a measure 
of peristaltic velocity in the smooth muscle oesophagus; that is, from the distal extent of 
the transition zone to a landmark called the "contractile deceleration point (CDP)" (265). 
The CDP is the time point during a peristaltic pressure wave at which peristalsis in the 
distal oesophagus appears to slow appreciably. Functionally the CDP is the time at which 
oesophageal peristalsis terminates, and the LOS begins to descend to its resting position. 
Descent of the LOS is seen radiographically as emptying of the phrenic ampulla. Wave 
propagation is defined as the CFV is expressed as cm/s. The CFV is obtained by 
calculating velocity from a best linear fit along the 20 mmHg isobaric contour line at the 
leading edge of the peristaltic pressure wave from transition zone to CDP. The CFV can 
appear rapid when the bolus is pressurized between an unyielding OGJ and a peristaltic 
contraction. This situation might be mistaken by automated analysis software as a 
simultaneous contraction. This circumstance can be remedied by choosing an isobaric 
contour pressure that exceeds pressure at the GOJ.  
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The distal latency is not a measure of peristaltic contraction velocity. Instead, it identifies 
the time from the start of swallow induced UOS opening to arrival of oesophageal 
contraction at the CDP (266). It is presumed to measure post deglutitive inhibition and 
adequacy of inhibitory neuromuscular function in the smooth muscle oesophagus (267, 
268). A short DL indicates early arrival of the oesophageal contraction in the distal 
oesophagus. It is now used instead of rapid CFV in the Chicago classification to diagnose 
distal oesophageal spasm because it more reliably identifies patients with this disorder 
(269). 
 
The DCI reflects the calculation of integrated pressures above 20 mmHg from the upper 
border of the LOS to the lower border of the transition zone and is used to measure the 
robustness of peristaltic contraction in the smooth muscle oesophagus. The DCI 
integrates pressure, distance and time along the oesophagus (269). The analysis is 
performed by making a box that encompasses all swallow induced motor activity 
produced by contractile segments S2 and S3. The DCI is calculated by summing 
pressures > 20 mmHg from all of the time/length foci within the box. It is basically an 
aggregate of the mean contraction amplitude of the smooth muscle oesophagus, the 
length over which that contraction propagates, and duration of contraction. All efforts are 
used to avoid including intrabolus pressure or pressure produced by vascular structures in 
the calculation of DCI. 
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17.1.5 Data analysis 
To assess the effectiveness of the stimulation tests in provoking stronger response in the 
oesophageal body, the DCI achieved by each stimulation test is compared against the 
DCI of the single swallows of 5ml water.  According to the Chicago Consensus, DCI is 
considered as the indicator of the oesophageal contractility (59). 
Normal values for all the major parameters used in the Chicago Classification were 
established in each of the stimulation tests. These include: integrated relaxation period 
(IRP), distal contractile integral (DCI), peristaltic break (PB), distal latency (DL) and 
contractile front velocity (CFV) (59). Variables are expressed as the mean plus or minus 
standard deviation or as median with range. Fifth and 95th percentile values were 
calculated and taken as lower and upper limits of the normal variations. 
 
Figure 38 - Area of peristaltic 
contraction used for calculation 
of DCI (in the square). Source of 
image, internal. 
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The main variable to quantify the peristaltic contractility in studying the reproducibility 
of the stimulation tests was Distal Contractile Integral (DCI). In statistical analysis of 
reproducibility, percentage coefficient of variation (100 · SD/mean: %COV) was derived 
as a measure of inter and intraindividual variation. Moreover, intra-class correlation 
coefficient (ICC) and concordance correlation coefficient (CCC) were measured as other 
means of assessment of reproducibility. Bland–Altman plots were used to express the 
concordance of variables graphically. 
 
18 RESULTS 
 
In evaluating the effectiveness of the oesophageal stimulation tests in provoking more 
vigorous contraction in oesophageal body, DCI was compared between stimulation tests 
and single swallows of 5ml water (Figure 39 and Figure 40). As demonstrated in Table 2, 
the P values of the change of DCI in stimulation tests versus baseline swallows of 5ml 
water were statistically significant. Table 3 demonstrates the comparative ranges for the 
stimulation tests versus routine single swallows of water. 
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Table 2 - Effectiveness of the stimulation tests: this table demonstrates that how different is DCI comparing water 
swallows and each of the stimutation tests. P values confirm that there is a significant change of DCI by implying 
each of the stimulation tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Effectiveness of the stimulation tests 
Comparative values 
(Paired t test) 
Effectiveness 
MRS DCI 
vs 
DCI WATER 
Effectiveness 
PRESS DCI 
vs 
DCI WATER 
Effectiveness 
BREAD DCI 
vs 
DCI WATER 
P value 0.0001 < 0.0001 0.0002 
Mean of differences 934 627.8 668.2 
Page 145 of 281 
 
 
 
 
Table 3 - Comparative ranges for the stimulation tests versus routine swallows of water 
 Effectiveness of the 
stimulation tests 
Descriptive values 
DCI 
WATER 
DCI  
PRESS 
DCI  
MRS  
DCI  
BREAD  
Number of values 26 26 26 26 
25% Percentile 716.8 1291 1349 1361 
Median 1208 2017 1800 1771 
75% Percentile 1904 2407 2769 2133 
5.000% Percentile 421.0 844.8 732.2 739.2 
95.00% Percentile 3861 4221 6741 4402 
Mean 1375 2003 2309 2043 
Std. Deviation 893.8 888.0 1566 1032 
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Figure 39 - Comparison of the stimulation tests versus routine swallows of water. 
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Figure 40 - Comparison of the stimulation tests versus routine swallows of water. 
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MRS measurements –The normal values are defined with 3 sets of MRS. 
Normal mean residual pressure (4 s-IRP) was 5.5 mmHg (95th percentile: 12.3 mmHg) . 
 
Contraction amplitude of oesophageal circular muscle. was 134.4 mmHg (95th percentile: 
216 mmHg, 5th percentile: 68 mmHg).  
 
The mean DCI was 2160 mmHg cm s, median DCI 1727 mmHg second cm (95th 
percentile: 6741 mmHg second cm, 5th percentile: 250 mmHg cm s) with a maximum of 
6977 mmHg cm s.  
 
 
Abdominal compression measurements -The normal values are defined with swallows of 
5ml water with average increase in intragastric pressure of 11.8 mmHg, with a range of 
3.6 – 26.4 mmHg, median = 11.6 mmHg. Gastric baseline pressure with abdominal 
compression was used as  the reference to calculate the IRP. 
Normal mean residual pressure (4 s-IRP) was 7.6 mmHg, range of 0-16 mmHg (95th 
percentile: 16 mmHg). 
 
Contraction amplitude of oesophageal circular muscle was measured at 5 cm above the 
OGJ. At five centimetres above the OGJ, the mean contraction amplitude was 129.6 
mmHg (95th percentile: 195mmHg, 5th percentile:72 mmHg). 
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The mean DCI was 2003 mmHg cm s, median DCI 2017 mmHg second cm (95th 
percentile: 4221 mmHg second cm, 5th percentile: 844.8 mmHg cm s) with a maximum 
of 4471 mmHg cm s. 
 
Bread swallow measurements – The normal values for bread swallows are defined using 
10 swallows of 3 cm3 of bread (Table 6). Normal mean residual pressure (4 s-IRP) was 
10.7 mmHg, range of 3-20 mmHg (95th percentile: 19.6 mmHg). 
 
Contraction amplitude of oesophageal circular muscle was measured at 5 cm above the 
OGJ. At five centimetres above the OGJ, the mean contraction amplitude was 137.3 
mmHg (95th percentile: 278.7 mmHg, 5th percentile:69.2mmHg).  
 
The mean DCI was 2043 mmHg cm s, median DCI 1771 mmHg second cm (95th 
percentile: 4402 mmHg second cm, 5th percentile: 739 mmHg cm s) with a maximum of 
4531 mmHg cm s. 
 
Tables 4-6 demonstrate manometric normal values for each stimulation test. Table 7 
provides normal values for single swallows of 5ml water in order to facilitate the 
comparison with stimulation tests. Tables 8-13 demonstrate comparison of different 
parameters between stimulation tests and water swallows.  
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Table 4 - Normal values for MRS  
 DCI CFV DL PB IRP Ampl 5cm 
Number of values 26 26 26 26 26 23  
Median 1800 4 6.55 0.15 5.5 129.0 
5.000% Percentile 732.2 3 4.84 0 -1.3 68.00 
95.00% Percentile 6741 6.3 11.31 3.13 12.3 216.0 
Mean 2309 3.962 6.885 0.7192 5.423 134.4 
Std. Deviation 1566 0.9992 1.605 1.017 3.744 46.16 
 
Table 5 - Normal values for abdominal compression test 
 DCI CFV DL PB IRP Ampl 
Number of values 26 26 26 26 26 25  
Median 2017 3 6.65 1 7.9 128.0 
5.000% Percentile 844.8 2.35 4.675 0 -0.95 72.00 
95.00% Percentile 4221 5.65 8.96 3 16 195.3 
Mean 2003 3.577 6.75 0.8654 7.608 129.6 
Std. Deviation 888.0 0.8566 1.203 0.9753 4.8 33.11 
 
Table 6 - Normal values for bread swallows 
 DCI CFV DL PB IRP Ampl 
Number of values 26 26 26 26 26 25  
Median 1771 3.5 7 0 10.5 127.0 
5.000% Percentile 739.2 2 5.535 0 3 69.20 
95.00% Percentile 4402 8.6 11.97 3.37 19.65 278.7 
Mean 2043 3.769 7.554 0.4808 10.77 137.3 
Std. Deviation 1032 1.608 1.643 0.9051 5.331 49.10 
 
Table 7 - Normal values for single swallows of water 
  DCI CFV DL IRP4 PB AMPL 
Number of values 26 26 26 26 26 25  
Median 1027 4.000 7.300 8.000 3.000 98.50 
5.000% Percentile 467.8 2.000 4.825 1.750 0.0 40.00 
95.00% Percentile 3096 5.000 8.750 14.25 10.00 236.5 
Mean 1330 3.647 7.194 7.559 3.326 102.0 
Std. Deviation 778.3 0.8121 0.9692 3.501 2.535 51.52 
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Comparative normal values for stimulation tests: 
 
Table 8 - Comparative normal values for stimulation tests DCI 
Normal values  DCI of 
MRS 
DCI of 
Pressure 
DCI of  
bread  
DCI of  
water 
Number of values 26 26 26 34 
Median 1800 2017 1771 1027 
5.000% Percentile 732.2 844.8 739.2 467.8 
95.00% Percentile 6741 4221 4402 3096 
Mean 2309 2003 2043 1330 
Std. Deviation 1566 888.0 1032 778.3 
 
Table 9 - Comparative normal values for stimulation tests PB 
Normal values  PB of 
MRS 
PB of 
Pressure 
PB of 
bread 
PB of 
water 
Number of values 26 26 26 34 
Median 0.15 1 0 3.000 
5.000% Percentile 0 0 0 0.0 
95.00% Percentile 3.13 3 3.37 10.00 
Mean 0.7192 0.8654 0.4808 3.326 
Std. Deviation 1.017 0.9753 0.9051 2.535 
 
Table 10 - Comparative normal values for stimulation tests CFV 
Normal values  CFV of 
MRS 
CFV of 
Pressure 
CFV of  
bread  
CFV of water 
Number of values 26 26 26 34 
Median 4 3 3.5 4.000 
5.000% Percentile 3 2.35 2 2.000 
95.00% Percentile 6.3 5.65 8.6 5.000 
Mean 3.962 3.577 3.769 3.647 
Std. Deviation 0.9992 0.8566 1.608 0.8121 
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Table 11 - Comparative normal values for stimulation tests DL 
  DL 
bread 
DL 
pressure 
DL 
MRS 
DL  
water 
Number of values 26 26 26 34 
Median 7 6.65 6.55 7.300 
5.000% Percentile 5.535 4.675 4.84 4.825 
95.00% Percentile 11.97 8.96 11.31 8.750 
Mean 7.554 6.75 6.885 7.194 
Std. Deviation 1.643 1.203 1.605 0.9692 
 
Table 12 - Comparative normal values for stimulation tests Amplitude at 5cm above LOS 
Normal values  Amplitude  
MRS 
Amplitude bread  Amplitude Pressure 
Amplitude  
water 
Number of values 23  25  25  34 
Median 129.0 127.0 128.0 98.50 
5.000% Percentile 68.00 69.20 72.00 40.00 
95.00% Percentile 216.0 278.7 195.3 236.5 
Mean 134.4 137.3 129.6 102.0 
Std. Deviation 46.16 49.10 33.11 51.52 
 
Table 13 - Comparative normal values for stimulation tests IRP 
Normal values  IRP of 
MRS 
IRP of 
Pressure 
IRP of 
bread  
IRP4 of 
water 
Number of values 26 26 26 34 
Median 5.5 7.9 10.5 8.000 
5.000% Percentile -1.3 -0.95 3 1.750 
95.00% Percentile 12.3 16 19.65 14.25 
Mean 5.423 7.608 10.77 7.559 
Std. Deviation 3.744 4.8 5.331 3.501 
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To assess the reproducibility of the stimulation tests, DCI is compared in visit one and 
visit two (Figure 41 to Figure 43). The choice of DCI is due to the fact that this 
multifactorial parameter is the key parameter in the evaluation of IOM used in this PhD 
thesis. HRM showed significant change of DCI during all stimulation tests compared to 
the single water swallows (P value < 0.05 in all stimulation tests).  There was no 
significant difference for DCI values between visit one compared to visit two in each 
stimulation test (MRS P value = 0.8380, pressure P value = 0.4112, bread swallows P 
value = 0.5637). This means that the DCI figures in visit one are reproduced in visit two. 
As additional tests of reproducibility, two more assessments were conducted. Coefficient 
of variation analysis which showed minimal differences between inter and intra-
individual %COV indicating reproducibility of the stimulation tests. Significant but not 
perfect concordance values were found for all stimulation tests (CCC bread = 0.77, CCC 
MRS = 0.74, CCC pressure belt = 0.64). ICC showed high values for intra-individual 
reproducibility for all stimulation tests, the highest being for bread swallows (ICC 
average measures = 0.87). Figure 44 to Figure 46 show the Bland–Altman plots for DCI 
in MRS, abdominal compression test and bread swallows. In these plots the data points 
are relatively closely scattered around the x-axis, indicative of a small difference between 
the two measurements as compared to the mean of the two measurements.(Table 14) 
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Table 14 - Bland–Altman parameters for reproducibility 
Bland–Altman parameters 
for reproducibility 
 
 
MRS 
ABDOMINAL 
COMPRESSION TEST 
BREAD 
SWALLOWS 
Bias -43.56 -122.8 -87.27 
SD of bias 1075 749.2 760.4 
95% Limits of Agreement    
From -2150 -1591 -1578 
To 2063 1346 1403 
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Figure 41  - Comparing DCI of visti 1 and 2 for abdominal compression test 
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Figure 42 - comparing DCI of visti 1 and 2 for MRS 
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Figure 43  - Comparing DCI of visit 1 and 2 for bread swallows 
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Figure 44 
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Figure 45 
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Figure 46 
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19 Discussion 
 
The most appropriate and clinically relevant measurement protocol for oesophageal 
stimulation tests has not been established. Current diagnostic classifications for 
conventional and HRM are based on repeated small volume water swallows in the supine 
position (55, 248). Some authors have recommended performing stimulation tests such as 
solid swallows (164), to increase sensitivity to symptomatic dysmotility and dysfunction; 
however the pressure record is more complex under these conditions and reference values 
have not been established. This study presents normative values for HRM parameters of 
peristaltic and OGJ function that predict effective liquid and solid bolus transport (159, 
171, 64, 272) in multiple rapid swallowing, bread swallows and swallows with abdominal 
compression. These data provide a systematic analysis of ‘normal’ high-resolution 
manometry thresholds in 26 healthy volunteers using Unisensor AG HRM assembly. The 
data include metrics of the recently published Chicago classification. 
 
19.1.1 Effect of stimulation test on oesophageal contractility in healthy subjects 
 
Assessment of the effect of the oesophageal stimulation tests on the oesophageal body 
contractility is defined based on the distal contractile integral (DCI)(255). The distal 
contractile integral (DCI) is an index of contractile vigor in high-resolution oesophageal 
pressure topography  calculated as the product of amplitude, duration, and span of the 
distal oesophageal contraction (59). The mean of the differences in DCI produced by 
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each of the stimulation tests were compared against single water swallows. All three 
stimulation tests were able to induce DCIs significantly higher than single swallows of 
water. The mean of the difference of DCI for bread swallows and abdominal compression 
were 668.2 mmHg and 627.8 mmHg respectively (P values = 0.0001). MRS achieved the 
highest mean of the DCI differences amongst the stimulation tests, mean of the difference 
= 934 mmHg, P value = 0.0001 
 
19.1.2 Effect of stimulation test on OGJ relaxation in healthy subjects 
 
 
GOJ relaxation is studied using integrated relaxation pressure (IRP). The summary of the 
mean IRP (mmHg) finding is as following (IRP during abdominal compression is not 
discussed here because due to the nature of this test, the results are technically 
inappropriate):  
 
MRS (5.4) < Water (7.5) < Bread (10.7)  
 
MRS yielded in the lowest IRP amongst all the swallowing tests. The reason for such a 
low IRP with MRS, which is even lower than single water swallows, is most likely due to 
the prolonged inhibition of LOS during multiple swallows of water. Multiple swallows 
provide enough time for the LOS to relax completely and there is no increased intrabolus 
pressure as in bread swallows. From previous studies (164, 256, 273) it was expected that 
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there would be an increase in IRP for solids compared to liquids because this parameter 
increases not only with LOS dysfunction (i.e. impaired relaxation and opening), but also 
with increased friction between the bolus and the luminal wall (61). Our study confirms 
this concept in which the difference of IRP mean is the highest in bread swallows.  
 
Assessment of oesophageal body characteristics is defined based on the current 
parameters introduced by Chicago classification including measures of (i) breaks in the 
isobaric contour of 20 mmHg, (ii) circular muscle strength; contraction amplitude and 
DCI; and (iii) wave propagation; CFV and DL.  
 
Effects of bolus consistency and load on oesophageal function were consistent with 
previous studies using conventional and high-resolution manometry (159, 274, 275). 
Overall, as expected from previous studies (164), as workload increased, oesophageal 
contractile response was slower [lower contraction front velocity (CFV)], better 
coordinated (shorter PTZ) and more vigorous [greater distal contractile integral (DCI)] 
This comparison is clear for solid versus single swallows of water but it is hard to decide 
which stimulation test bears higher workload compared to the other. In table 15 
comparison of the findings in regards to CFV, PB and DCI is demonstrated. 
 
Table 15 - comparison of the findings in regards to CFV, PB and DCI 
CFV mean cm/s Pressure(3.5) Water (3.6) Bread (3.7) MRS (3.9) 
PB mean cm Bread (0.4) MRS (0.7) Pressure (0.8) Water (3.3) 
DCI,mean,mmHg.cm.s Water (1330) Bread (2043) Pressure(2066) MRS (2309) 
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It is clear that peristaltic break i.e. transition zone during all three stimulation tests were 
significantly lower than in single swallows of water (mean of the PB in MRS, abdominal 
compression, bread and water swallows = 0.7, 0.8, 0.4 and 3.3 cm). PB in bread swallows 
was the lowest amongst all different types of swallows. This finding makes bread 
swallows the best stimulation test amongst others to test the continuity of the peristaltic 
wave as well as the coordination of striated-smooth muscle in transition zone. 
 
Mean DCI, a global measure of distal oesophageal circular muscle strength, ranged from 
2003 mmHg in swallows with abdominal compression to 2309 mmHg in MRS. Bread 
swallows stands in between these two stimulation tests with 2043 mmHg. Therefore, 
MRS seems to be the stimulation test with the highest provocative capacity to induce 
stronger contractility in oesophageal wall. 95 percentile of the DCI achieved by MRS is 
beyond the 5000 mmHg limit of the normal DCI defined by the Chicago group (95% DCI 
of MRS = 6741 mmHg). 
 
I calculated peak amplitude at 5cm above the proximal border of the OGJ as reference 
value. Our data clearly shows an increase in average peak contraction amplitude achieved 
by stimulation tests compared to single swallows of water in the distal oesophagus. Bread 
swallows induced the highest contraction amplitude at 5cm level followed by MRS and 
abdominal compression: 137.3 mmHg,  134.4 mmHg, 129.6 mmHg respectively. 
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The mean CFV from bread swallows and MRS were higher than  water swallows 
measuring in descending order: MRS (3.9 cm/s) > bread swallows (3.7 cm/s) > pressure 
3.5 (cm/s).  
 
As expected the DL of the bread swallows was higher than water swallows (mean = 7.5 
sec). Surprisingly the DL of the abdominal compression and MRS were both shorter than 
single swallows of water (mean DL of MRS and compression 6.8 sec and 6.7 sec 
respectively). This finding indicates that two of the stimulation tests (abdominal 
compression and MRS) induce faster peristaltic contraction.  Comparing the DL and CFV 
of the stimulation tests should yield in similar ranking however the finding is that 
although abdominal compression induces the shortest DL, it has the highest CFV.  
 
DL: bread > MRS > pressure 
CFV: MRS > bread > pressure 
 
19.1.3 Assessment of the reproducibility of the stimulation tests 
 
In this study, overall reproducibility of stimulation tests in oesophageal HRM data was 
good and this can be considered as an important validation of the reliability of these new 
techniques.  
 
Page 162 of 281 
 
As was shown, there was minimal difference between inter and intra-individual %COV 
(table 16). In addition, concordance testing showed that significant but not perfect 
concordance values were found for all stimulation tests. Although considerable absolute 
variations occurred between the first and the second measurement, the values stayed 
within the normal range in these healthy subjects, limiting the importance of these 
variations. Most importantly, in the first and the second measurements, no large 
differences were found for DCI. 
 
Table 16 - COEFFICIENT OF VARIATIONS 
COEFFICIENT OF VARIATIONS 
 VISIT 1 %COV 
Intra-individual 
variation of DCI 
VISIT 2 %COV 
Intra-individual 
variation of DCI 
TOTAL %COV 
Inter-individual 
variation of DCI 
BREAD SWALLOWS 50.5 57.6 54.0 
MRS 67.8 60.3 63.5 
ABDOMINAL 
COMPRESSION 
44.3 42.0 42.8 
 
It should be realized that even large variations in DCI between different days are only of 
importance when they change the overall conclusion of the measurement. Whether the 
observed day-to-day changes in the measured parameters will affect overall conclusion of 
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the measurement can only be answered in a study in which patients are measured twice 
(276). Our concordance data showed that at least in healthy volunteers, the day-to-day 
variability does not frequently change values in a way that they would alter the final 
conclusion of the test. This supports the use of stimulation tests as additional tools in the 
clinical evaluation of the patients with oesophageal motor disorders in order to assess the 
reserve oesophageal neuromuscular capacity.  
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CHAPTER 4: Oesophageal stimulation tests and 
symptoms in patients with IOM 
 
20 INTRODUCTION 
 
Ineffective oesophageal motility (IOM) is characterized by a weak oesophageal motility 
response to swallows associated with poor bolus transit in the distal oesophagus. 
Ineffective motility occurs when 30-50% (according to Spechler and Blonoki) (55) (277) 
or more of swallows are followed by contraction amplitudes of less than 30 mmHg at 3 or 
8 cm above the lower oesophageal sphincter (55) (277). Ineffective oesophageal motility 
is believed to be an important pathologic feature of both gastroesophageal reflux disease 
(GORD)(278) and non-obstructive dysphagia (68) (279).  
With the advent of high-resolution manometry (HRM) and oesophageal pressure 
topography, there are new metrics to define oesophageal motor function. Measures of 
peristaltic integrity and vigour involve both peristaltic amplitude and breaks in the 
peristaltic wave front. The new metric is called distal contractile integral (DCI). In the 
Chicago Classification of oesophageal motility, the definition of weak peristalsis is based 
on the length of breaks in the 20 mmHg isobaric contour (IBC), as these have been 
shown to be associated with impaired bolus transit with both fluoroscopy (280) and 
intraluminal impedance monitoring(60). Also important in the description of weak 
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peristalsis is the location of these breaks, as they may have distinct pathologic origins and 
consequences. Xiao et al utilized DCI to define ineffective swallows(236). Their data 
suggest that the manometric correlate of IOM in HRM is a mixture of failed swallows 
and IBC break in the middle/ distal troughs. A DCI value<450 mmHg-s-cm can be 
utilized to predict ineffective oesophageal swallow. IOM can be defined by >50% 
swallows with weak /failed peristalsis or with a DCI <450 mmHg-s-cm. 
In spite of new and better definitions of IOM, its clinical relevance is not completely 
clear. Furthermore, in some patients IOM is associated with dysphagia whereas in other 
IOM patients underlies poor oesophageal clearance of gastro-oesophageal reflux.  
The stimulation tests used in this study. – (multiple swallows of water, increasing outlet 
resistance at GOJ by applying abdominal compression, bread swallows ) - theoretically 
use different pathways to stimulate oesophageal contraction. Multiple rapid swallows 
particularly requires intact deglutitive inhibition and preserved excitatory mechanism to 
provoke after MRS contraction (281). Bread swallows requires preserved afferent 
pathway to detect the presence of the solid bolus in the oesophageal body and effective 
excitatory efferent pathway to enhance the strength and coordination of oesophageal 
contractions (282). Abdominal compression requires an intact mechanism that detects 
increased resistance at the GOJ level and increases excitatory pathways to augment the 
strength of contraction to overcome the resistance and assure oesophageal emptying (234, 
256, 263, 283). 
I hypothesised that 1) IOM is associated with a specific defective inhibitory or excitatory 
mechanisms that regulates oesophageal body motility. 2) This failure can be specific for 
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different symptoms and 3) Such specific mechanism failure  can be predicted by different 
oesophageal stimulation tests 
The aim of this study was to assess the relationship between response to oesophageal  
stimulation tests and  symptoms profile (dysphagia, heartburn/regurgitation, cough) in 
patients with IOM.  
 
21 Methods 
21.1 Subjects and study protocol 
Patients referred for oesophageal high resolution manometry who were diagnosed with 
IOM according to the modified Chicago Classification (236) were selected. Patients 
should: 1) present with either one or a combination of: reflux symptoms (heartburn 
and/or regurgitation) and dysphagia. Patients were excluded if: 1) motility disorders other 
than IOM such as spastic contractions or OGJ obstructions existed, 2) Barrett’s 
oesophagus larger than 3 cm (endoscopic evidence), 3) hiatus hernial larger than 3cm.  
 
21.2 High resolution manometry protocol 
Please see chapter 2 for the details of high resolution manometry protocol. 
21.3 Reflux monitoring protocol 
 
Please see chapter 2 for details of reflux monitoring protocol.  
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To assess the symptoms, all patients were provided with a symptom questionnaire to 
highlight their main symptom. 
21.4 HRM analysis 
The HRM plot of each swallow was analyzed for integrity of the 20 mmHg isobaric 
contour. Peristalsis was defined as intact if no break longer than 2 cm was observed in the 
IBC. Failed peristalsis was defined by minimal (<3cm) integrity of the 20mmHg isobaric 
contour distal to the proximal pressure trough. When the 20mm Hg isobaric contour was 
disrupted, the length of the break was measured using the dedicated tools in each of the 
analysis software. Weak contractions were categorized as weak contraction with large 
breaks (>5cm in length) or weak contraction with small breaks (2–5cm in length). The 
Distal Contractile Integral (DCI) was calculated as the mean amplitude (greater than 20 
mmHg) of the distal oesophageal contraction in mmHg-s-cm(59). The final diagnosis of 
the HRM for every patient was made according to the 2012 version of the Chicago 
Classification: ‘weak peristalsis with large peristaltic defects’ if greater than 20% of 
swallow exhibited large (>5 cm) breaks in the 20 mmHg IBC, ‘weak peristalsis with 
small peristaltic defects’ if greater than 30% of swallows exhibited small (2–5 cm) breaks 
in the 20 mmHg IBC, or ‘frequent failed peristalsis’ if >30% but <100% of swallows 
were associated with failed peristalsis(59).  For the purpose of this study I excluded the 
patients diagnosed with ‘weak peristalsis with small peristaltic defects’. I defined severe 
ineffective oesophageal motility (IOM) as being either: ‘weak peristalsis with large 
peristaltic defects’ or ‘frequent failed peristalsis’. Absent peristalsis was not included in 
this study. 
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Changes in DCI were used to evaluate the response to stimulation tests. A normal 
response to a stimulation test was defined when the DCI changed between 5 and 95 
percentiles observed in normal subjects. Using these criteria, normal response was 
defined as a DCI >732 mmHg.sec.cm for MRS, >844 mmHg.sec.cm for abdominal 
compression and >739 mmHg.sec.cm for bread swallows. (See following figure) 
 
 
 
 
 
 
21.5 Statistical analysis 
 
The results of DCIs were expressed as either normal or abnormal. For each patient I 
identify the predominant symptom a as being dysphagia or reflux 
(heartburn/regurgitation) Combinations of the responses to stimulation tests were 
considered to further identify the most significant defective pathways in the oesophageal 
body motility system. Comparisons among these variables were made using contingency 
tables, and Fisher's exact test. A P-value <0.05 was accepted as statistically significant in 
all analyses.  
Figure 47 - Different types of peristalsis defects: A) weak peristalsis with large peristaltic defect, B) failed 
peristalsis, C) weak peristalsis with small peristaltic defect. 
Gastroesophageal reflux 
detected by combined 
multichannel intraluminal 
impedance and pH (MII-pH) 
Combined 
multichannel 
intraluminal 
impedance and pH 
A B C 
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22 Results 
 
In total, 42 patients were included, 22 male and 20 female with the age range of 25-70 
years old, median age 56 years old. There were 9 patients with hiatus hernia (<3cm) 
detected in total, 6 from reflux group and 3 from dysphagia group. 
The symptoms included: 32 patients who predominantly presented with reflux symptoms 
either heartburn or regurgitation and 10 patients with dysphagia as their dominant 
symptom.  
22.1 High-resolution manometry 
 
7/42 patients had normal response to all stimulation tests (2/10 with dysphagia and 5/32 
with reflux). 
 
In the reflux group, the incidence of abnormal multiple rapid swallow was 16/29 (55%), 
abnormal abdominal compression 17/31(54.8%) and abnormal bread swallows 
22/32(68.7%) [the reason for different total number of each test is that some participants 
did not manage to complete one or the other test]. In the dysphagia group the incidence of 
abnormal multiple rapid swallow was 4/10 (40%), abnormal abdominal compression 7/10 
(70%) and abnormal bread swallows 5/10 (50%). The most common abnormal response 
to stimulation tests was seen for bread swallows with 28 out of 42 patients (5/10 in 
dysphagia group and 23/32 in reflux group).  
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All three stimulation tests were abnormal in 14 patients (33.3%). This was more common 
in the patients whose main symptom was reflux (13/32, 40.62%) compared to the patients 
with dysphagia (1/10, 10%) although the P value was not statistically significant (P value 
= 0.4229). 9/32 patients with reflux symptoms had hiatus hernia of which 4 (44.5%) 
patients had abnormal response to all stimulation tests and 2 had normal response to all. 
15/32 patients with reflux symptoms were found to have pathological gastro-oesophageal 
reflux of which 6 (40%) had all responses abnormal and 2 all normal.  
The IRP was normal in all patients. However, IRP was slightly higher in patients with 
dysphagia compared to patients to patients with reflux symptoms (median IRP 9.1 mmHg 
versus 6.7 mmHg, P value = 0.04).  
 
23 Discussion 
IOM is one of the most common oesophageal motility findings in GI physiology units 
(58% of all the diagnosis) (66). It is also the most prevalent oesophageal motor disorder 
in GORD, found in 21–38% of patients in large series (69, 71-73). Moreover, IOM was 
present in 27–32% of patients presenting with non-obstructive dysphagia without GORD 
(67-70). However, the role of IOM in pathophysiology of reflux symptoms and dysphagia 
is still a matter of debate. It is not clear why one motility pattern i.e. IOM can be 
associated with different symptoms profile (reflux dominant and dysphagia dominant). In 
this study I used three different stimulation tests to assess the neuromuscular integrity of 
the oesophageal body in patients with severe hypomotility. I hypothesized that a distinct 
response to stimulation test would predict the predominant symptom. However, our 
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findings did not support such hypothesis. There was no clear difference in response to 
stimulation tests between patients with predominant reflux symptoms compared to 
patients with predominant dysphagia.  
More than one third of patients with reflux symptoms and pathological acid GOR(37,5%)  
had all three stimulation tests abnormal whilst this finding was the least frequent in the 
dysphagia group (10%).  
Having hiatus hernia increased the likelihood of having abnormal response to all 
stimulation tests (45%) of the patients with hiatus hernia had all responses abnormal). 
Although the group differences between reflux and dysphagia patients was not 
significant, I observe a trend suggesting that reflux patients were more likely to fail 
response in all three stimulation tests.  Based on this trend, I can just speculate that the 
mechanism underlying OH in reflux disease is different from that in dysphagia. Tutuian 
et al reported that a higher proportion of oesophageal motility abnormalities during bread 
swallows was observed in patients with chest pain and GORD symptoms compared to 
patients with dysphagia (284).  
The IRP in patients with dysphagia was slightly higher than in the reflux group 
suggesting that increased intrabolus pressure associated with a higher distal resistance 
might be more relevant to dysphagia sensation than the severe hypomotility alone. In 
contrast, patients with lower IRP (reflux group) had more abnormal response to all three 
stimulation tests, suggesting that a better motility response to stimulation tests has less 
impact in dysphagia perception.  
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What are the potential mechanisms that trigger increased contractions during stimulation 
tests? Oesophageal mechano-receptors (stretch sensors) are probably initially implicated 
in the 3 stimulation tests, in the outlet obstruction induced by abdominal compression, the 
increased resistance against the passage of bolus and peristaltic propelling pressure 
provokes increased wall expansion and stretch. Such stimulus can trigger a peripheral 
reflex (in the oesophageal wall) resulting in increased circular and longitudinal  smooth 
muscle contraction in the segment above the bolus via a cholinergic, muscarinic 
mechanism (285, 286). Furthermore, changes either in the preload (muscle length or 
stretch) or afterload (the mass of the bolus) induces contraction with higher amplitude 
(287, 288). Finally, pressure sensors in the abdominal cavity or stomach might stimulate 
the afferent limb of a vagovagal reflex arch modulating oesophageal peristalsis (287, 
289).  
Similar mechanisms can explain the effect of bread swallows. However, the after 
contraction at the end of multiple rapid swallowing probably requires  an additional 
central input from CNS. During repetitive  swallows, there are central inhibitory signals 
transmitted to the oesophageal body causing hyperpolarisation of the smooth muscle cells 
leading to a strong after-contraction (290). 
In normal subjects, the different stimulation tests used in this study are able to trigger 
increased oesophageal contractility. They use peripheral and central pathways. The MRS 
uses more central and the abdominal compression and bread swallows more peripheral 
pathways. In my study I used the tests to assessed reserve capacity of patients with severe 
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hypomotility. I identified a group of patients with appropriate reserve capacity 
(hypomotility in basal condition and increased contractility during stimulation).  
 
23.1 Limitations  
The lack of differences between groups could be due to Type 2 error due to small number 
of dysphagia patients.  
I did not have simultaneous confirmation of the bolus retention during swallows that 
could be associated with dysphagia. However, for reflux symptoms, I could link these 
symptoms to pathological GOR objectively because it was possible to measure retention 
of refluxate corresponding to each symptom. 
 
23.2 Summary 
 
In conclusion, the present study used high-resolution manometry using multiple rapid 
swallowing, abdominal compression and bread swallows to identify differences between 
patients with IOM who present with dysphagia and GORD symptoms. I could not 
demonstrate significant differences in response to stimulation tests between reflux and 
dysphagia patients. However, I identified a trend towards a more severe failure (i.e. 
worse reserve capacity) in reflux patients compared to dysphagia.  
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CHAPTER 5: Proximal oesophageal 
hypomotility: definition, prevalence and clinical 
relevance in patients with severe distal 
hypomotility 
24 Introduction 
While the Chicago classification has extensively characterized contractions of the distal 
smooth muscle oesophagus and the length of transitional zone, pathology of proximal 
(striated muscles) oesophageal motility is not included in this classification (291). 
However, there are patients with weak or absent proximal oesophageal contractions with 
normal or abnormal distal oesophageal motility. The clinical relevance of this finding is 
unknown. Previous studies with standard manometry have described abnormalities 
affecting only the striated muscle portion  of the oesophagus such as myasthenia 
gravis(292) and polymyositis(293). So far, emphasis has been given to the lower 
oesophageal motility in the development of clinical symptoms and little attention has 
been paid to the role of proximal oesophageal motility in this regard.  
The normal values for the proximal oesophageal motility were defined using a high 
resolution manometry system(291) (Sierra Scientific Instruments). A 10 mmHg isobaric 
contour was used to define the boundaries of the proximal oesophageal contraction area. 
In our studies, I use a different HRM device (Sandhill Scientific Inc., Highlands Ranch, 
CO, USA) and I used a 20 mmHg isobaric contour, which provides more precise 
discrimination between proximal and distal motility areas Figure 48.  
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Figure 48 – The difference of applying 20 mmHg (black) versus 10 mmHg (grey) isobaric contour. When 10 mmHg 
isobaric contour is used, there is more chance that the noise surrounding the actual contraction area will be 
included in measurement of DCI. (Image from internal source) 
  
.This study aims to (1) establish normative values for proximal oesophageal motility (2) 
assess the prevalence of proximal OH in the population of patients with severe distal OH 
(3) identify the clinical relevance of the proximal OH to symptoms. 
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25 Material and Methods 
25.1 Subjects 
 
25.1.1 Healthy volunteers 
 
Manometric studies were performed on 30 asymptomatic volunteers (age range 21-51 
years old, median 23 years old, 14 male and 16 female) with no history of gastrointestinal 
symptoms, upper gastrointestinal tract surgery, or significant medical conditions. 
Informed consent was obtained from each subject. 
 
25.1.2 Patients 
 
35 patients with IOM based on the Chicago Classification were recruited (age range 18-
72 years old, median 40 years old, 15 male and 20 female). This consisted of patients 
with the following diagnoses: frequent failed peristalsis, weak peristalsis with large 
peristaltic defect and absent peristalsis. The patients included in this study clinically 
presented with reflux symptoms (heartburn and/or regurgitation) and/or dysphagia. They 
were grouped in to two groups according to their predominant symptom to reflux 
dominant and dysphagia dominant. All patients were requested to stop all medications 
affecting gastric acid level and oesophageal motility five days prior to their test day. They 
all completed high resolution manometry and 24 hour impedance-pH monitoring. 
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Informed consent was obtained prior to any procedure. Patients with history of previous 
upper GI tract surgeries were excluded from this study. 
 
25.2 High resolution manometry protocol 
 
Manometric studies were done with the patients in the semi-recumbent position after at 
least a 6-h fast. I used a HRM system with a 32- channel probe (Sandhill HRiM catheter 
InSight; Sandhill Scientific Inc., Highlands Ranch, CO, USA). Data acquisition, display 
and analysis were performed using dedicated software (Sandhill Bioview Analysis). 
Transducers were calibrated using externally applied pressure. The patients underwent 
transnasal placement of the manometric assembly and the catheter was positioned to 
record from the hypopharynx to the stomach. The manometric assembly was positioned 
with at least 3-5 intragastric sensors to optimize OGJ and intragastric recording. The 
catheter was then taped to the cheek of the patient. The manometric protocol included a 
5-min baseline recording followed by ten 5-ml water swallows. 
 
25.3 HRM analysis 
 
Assessment of the distal oesophageal motility - each swallow was analyzed for 
integrity of the 20 mmHg isobaric contour (IBC). The final HRM  diagnosis for every 
patient was made according to the 2012 version of the Chicago Classification: ‘weak 
peristalsis with large peristaltic defects’ if greater than 20% of swallow exhibited large 
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(>5 cm) breaks in the 20 mmHg IBC, ‘weak peristalsis with small peristaltic defects’ if 
greater than 30% of swallows exhibited small (2–5 cm) breaks in the 20 mmHg IBC, or 
‘frequent failed peristalsis’ if >30% but <100% of swallows were associated with failed 
peristalsis(59). For the purpose of this study I excluded the patients diagnosed with ‘weak 
peristalsis with small peristaltic defects’. I defined severe ineffective oesophageal 
motility (IOM) as ‘weak peristalsis with large peristaltic defects’ and ‘frequent failed 
peristalsis’. Absent peristalsis was also included in this study. 
Assessment of the proximal oesophageal motility - The following parameters were 
characterize in the proximal oesophagus: (Figure 49) 
  
Figure 49 – Quantifying proximal oesophageal parameters – PFV: proximal front velocity, PCI: proximal 
contractile integral. Isobaric contour is set for 20 mmHg. (image from internal source) 
 
 
 
 
B A C 
A 
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25.4 Length of proximal oesophageal contraction (striated segment of the 
oesophagus): 
 
Oesophageal peristalsis comprises two distinct contractile waves, corresponding to the 
distinct muscle types (294, 295). The transition zone represents the region of 
spatiotemporal merger between these two contractile waves. The length of proximal 
oesophageal contraction is defined by measuring the peristaltic contraction from the 
lower border of upper oesophageal sphincter to the beginning of transition zone. This 
vertical length parameter also corresponds to the length of the striated muscle. An 
isobaric contour of 20 mmHg is used to delineate the boundaries of the peristaltic wave. 
 
25.5 Proximal Contractile integral (PCI): 
 
Proximal contractile integral is defined as the product of length of peristalsis, duration of 
peristalsis, and amplitude of the proximal contraction. (mm Hg.cm s). The length of the 
proximal contraction was decided from the lower border of the UOS up to the beginning 
of the transition zone using 20 mmHg isobaric contour line.  
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25.6 Contractile Front Velocity (Proximal Velocity): 
 
The propagation rate of the contractile front through the proximal oesophageal segment is 
also derived from the isobaric contour plots and characterized as the slope of the line 
connecting the points on the isobaric contour level of 20 mm Hg calculated in cm/sec. 
The junction of the peristalsis slope with lower border of the UOS is considered to be at 
the beginning of the slope, whilst the end of the velocity measurement is considered the 
point where there is a rapid deceleration of velocity identifiable on the slope of the 
contractile front velocity.  
 
25.7 Statistical analysis 
Establishing the normal values for proximal oesophageal motility: The major parameters 
included: proximal contractile integral (PCI), proximal peristaltic length (PPL), and 
proximal contractile front velocity (PFV). Variables are expressed as the mean, standard 
deviation or as median with range. Fifth and 95th percentile values were calculated and 
taken as lower and upper limits of the normal variations. 
Evaluation of the prevalence and relevance of proximal oesophageal motility in patients 
with severe distal hypomotility: Proximal contractile integral (PCI), proximal peristaltic 
length (PPL), and proximal contractile front velocity (PFV) in each of the patients were 
measured and compared against the normal range from the healthy group. The relation of 
symptoms and reflux parameters with abnormal proximal motility was assessed. Student's 
t-test or chi-squared analysis was used as appropriate.  
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26 Results 
26.1 Normal values for proximal oesophageal motility 
 
The normal values for proximal oesophagus manometric parameters are shown in 
(Table17). On average around 300 swallows from 30 asymptomatic healthy volunteers 
were analysed (age range 21-51 years old, median 23 years old,  14 male and 16 female). 
Mean of proximal peristaltic front velocity was 7.5 cm/sec with a range of 2.1-16.7 
cm/sec. Mean of proximal contractile integral (PCI) was 236.5 mmHg.s.cm with a range 
of 74.5-420.7 mmHg.s.cm. Mean of proximal peristaltic length was 4.9 cm with a range 
of 2.6-6.8 cm. (Figure 50 to Figure 52) 
 
Table 17 - Normal values for proximal oesophagus manometric parameters 
 
 
 
PFV cm/sec 
(proximal front 
velocity) 
PCI mmHg.s.cm 
(proximal 
contractile integral) 
PPL cm 
(proximal peristaltic 
length i.e. Length of 
Number of swallows 296 301 303 
    
Minimum 1.6 18 1.7 
25% Percentile 3.9 154.6 4.4 
Median 5.25 240.1 5.2 
75% Percentile 7.675 312.2 5.8 
Maximum 82.6 637.4 7.6 
    
5.000% Percentile 2.1 74.51 2.6 
95.00% Percentile 16.7 420.7 6.8 
    
Mean 7.517 236.5 4.994 
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Figure 52 
 
26.2 Prevalence and symptomatology of abnormal proximal oesophageal motility 
in IOM 
 
In total 35 patients with distal oesophageal hypomotility completed high resolution 
manometry and reflux monitoring (age range 18-72 years old, median 40 years old, 15 
male and 20 female). There was no correlation between the prevalence of oesophageal 
hypomotility with age or gender in this group of patients.  
 
The criteria to measure the vigor of peristalsis to identify proximal oesophageal 
hypomotility was PCI. Eleven out of 35 (31%) patients had lower than normal PCI and 
were hence diagnosed with proximal oesophageal hypomotility 3 with dominantly 
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dysphagia and 8 with dominantly reflux symptom. Only 2 patients out of those with 
proximal hypomotility and reflux symptoms had pathological gastro-oesophageal reflux. 
(Figure 53 to Figure 56) The prevalence of abnormal PFV and abnormal length of striated 
muscle were 2/35 and 3/35. 
 
Dysphagia and reflux scores were available for 21 patients. The average reflux score was 
higher in patients with both proximal (based on PCI) and distal oesophageal hypomotility 
(reflux score 18 versus 13). The average score for dysphagia was lower in patients with 
both proximal (based on PCI) and distal oesophageal hypomotility (dysphagia score 9 
versus 13).  
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proximal hypomotility
Normal proximal motility
 
Figure 53 
 
Prevalence of abnormal proximal velocity in 
IOM
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Normal velocity
 
Figure 54 
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Figure 55 
 
Symptomatology of proximal oesophageal 
hypomotility in IOM patients
Dysphagia 
27%
Reflux symptoms
73%
 
Figure 56 
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27 Discussion 
 
While significant interest has appropriately been focused on the distal oesophagus and 
OGJ in the clinical presentation of oesophageal hypomotility, the functional role of the 
proximal oesophagus has received sparse attention. Historically, this was primarily due to 
the lack of an appropriate technology to facilitate a detailed segmental analysis of 
oesophageal peristalsis. The introduction of HRM offers us an opportunity to improve 
upon this by standardising the testing protocol and facilitating quantitative analysis of 
proximal oesophageal motility. Such was the first objective of this chapter. With the use 
of a state-of-the-art HRM probe, I sought to firstly define proximal oesophageal normal 
motility and secondly define proximal oesophageal hypomotility. Finally, I examined the 
prevalence of proximal hypomotility in patients with severe distal hypomotility and 
evaluated the clinical relevance of proximal hypomotility in this group of patients. 
Normal ranges for PCI representing proximal motility vigour in our study was 
significantly smaller than the figures presented by other group (64) (Table: mean PCI of 
236.5 mmHg.s.cm versus 779 mmHg.s.cm). This could be mainly due to the use of 
higher isobaric contour pressure in our study compared to other studies (20 mmHg in our 
study versus 10 mmHg ) which significantly reduces the area of the contractility (please 
see Figure 48 above). 
 
PFV was also different between our study and previous reseach study (2.1 – 16.7 cm/s in 
our study versus 1.9 – 3.8 cm/s). Although the same isobaric contour was detected in both 
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studies, this difference of proximal velocities particularly in the 95th value could be due to 
the difference in the selection area for velocity measurement. Similar to the distal 
peristalsis, there is a two-step contractility pattern in the proximal contractility 
representing two different velocity figures. Therefore, a proximal deceleration point is 
identifiable similar to the distal deceleration point. Depending on to which front of the 
contraction is taken in to account to measure the velocity of proximal peristalsis the PFV 
might significantly differ. This stepwise deceleration of contraction in the proximal 
peristalsis is not described in the literature. One explanation could be that structural 
dynamic of striated muscle is different from smooth muscle having initially very high 
velocity reaching to a peak and slowing down after the peak point (296). As seen in Figure 
57 which compares the force-velocity curve between two types of muscles in general, the 
velocity of striated muscle follows a different pattern compared to the smooth muscle and 
our finding of normal ranges for velocity of the striated muscle is compatible with this 
physiological characteristic of these two types of muscles. 
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Figure 57 - Skeletal and smooth muscle force–velocity curves. Although the peak forces may be similar, the 
maximum shortening velocity of smooth muscle is typically 100 times lower than that of skeletal muscle (296). 
 
Another major finding of the analysis was that proximal hypomotility occurred in  one 
third of the patients with severe distal hypomotility. Proximal oesophageal hypomotility 
can arise due to multiple factors such as weakening of the muscle e.g. myasthenia gravis, 
mechanisms affecting excitatory cholinergic pathways e.g. anticholinergic medications, 
or enhanced inhibitory mechanisms ie NO pathway. The majority of the patients with 
proximal oesophageal hypomotility presented with predominantly reflux symptoms rather 
than dysphagia. Moreover, the reflux score was higher in patients who presented with 
oesophageal hypomotility in both proximal and distal oesophagus. In the previous chapter 
I reported that the patients with severe distal oesophageal hypomotility whose main 
presentation is reflux symptoms have more widespread oesophageal motility pathways 
damaged. It is possible that for the same reason, the patients with reflux symptoms also 
have more defective motility in the proximal oesophagus. 
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27.1 Conclusion 
 
This is the first study attempting to establish clinical relations between symptoms and 
hypomotility of the proximal oesophagus.   
I characterised the prevalence and clinical relevance of the proximal oesophageal 
hypomotility in patients with distal oesophageal hypomotility. Weak proximal motility is 
strongly associated with presentation of the reflux symptoms. These values may prove 
clinically useful and could contribute to future studies with dysphagic and GORD 
patients. 
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CHAPTER 6: TREATMENT OF OESOPHAGEAL 
HYPOMOTILITY: Effect of Azithromycin on IOM  
 
28 Introduction 
Ineffective oesophageal motility (IOM) is defined as a swallow response associated with 
low amplitude contractions and poor bolus transit in the distal oesophagus. 
With the advent of high-resolution manometry (HRM) and oesophageal pressure 
topography IOM is defined as 50% or more swallows with failed or fragmented 
peristalsis or 2) 50% or more swallows associated with a DCI < 450 mmHg-s-cm238. 
IOM is found in 30% of patients with dysphagia and 20–50% of patients with 
GORD(69).  It is reported that 25% to 55% of patients with oesophagitis have peristaltic 
dysfunction (297). Therefore, correcting IOM might be beneficial in patients with GORD 
symptoms or dysphagia.  
There is no proven therapy for IOM, but some patients with IOM can improve with 
treatment of associated reflux disease and/or with prokinetic medications (298). Several 
pharmaceutical agents known as prokinetic drugs can stimulate GI motility. Prokinetics 
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like erythromycin, metoclopramide, domperidone and cisapride have been used in adults 
and paediatric patients (159, 205, 211, 212, 214, 225, 259, 299-304) with variable and 
somewhat disappointing results. A partial explanation for the disappointing results in 
clinical practice and clinical trials could be that patients were prescribed prokinetic 
therapy based on symptoms or reflux monitoring without considering their oesophageal 
motility status. Theoretically, only patients with significant oesophageal hypomotility 
would benefit from prokinetic drugs.  
Prokinetics may have significant side effects.  For example cisapride and tegaserod 
increase the risk of cardiac arrhythmias and death (305); Bethanechol can cause anxiety, 
depression, drowsiness, fatigue, involuntary movements and muscle spasms (306); 
Metoclopramide can cause tardive dyskinesia (306, 307).  Prokinetics may induce 
tachyphylaxis (308, 309). For instance reduced efficacy has been seen with erythromycin 
after 7-14 days of treatment. 
Macrolide antibiotics, such as erythromycin (ERY) have a significant prokinetic effect on 
proximal gastrointestinal motility via activation of the motilin receptor (206, 303, 310). 
However, the clinical effectiveness of macrolides for the treatment of chronic GORD - 
and oesophageal hypomotility - has been hampered by the rapid loss of prokinetic 
activity due to desensitization of the motilin receptor (311).  Azithromycin (AZI) is a 
macrolide antibiotic with similar in vitro prokinetic effects compared to that observed 
with erythromycin. Azithromycin stimulates gastric antral activity similar to 
erythromycin and moreover has a longer duration of effect (approximately 68 hours). 
However, unlike erythromycin, azithromycin does not have significant drug-drug 
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interactions(219). Azithromycin is distinguishable due to the long half life and lower 
drug-drug interactions from the other macrolides/ketolides, despite case reports of cardiac 
toxicity (312-314). Azithromycin minimally inhibits CYP3A4, which results in the lack 
of an appreciable interaction with CYP3A4 substrates; thus, azithromycin appears to be 
the safest macrolide derivative from a cardiac toxicity perspective (315). In a recent 
publication from the FDA it is recommended to the healthcare providers to be cautious 
about azithromycin-induced fatal cardiac arrhythmias for patients already at risk for 
cardiac death and other potentially arrhythmogenic cardiovascular conditions(316). 
Unlike the short-lasting prokinetic effect of ERY, the effect of AZI on reflux parameters 
was found several months after start of treatment(214). 
Azithromycin has been reported to have clinical efficacy in disorders associated with 
reduced gastrointestinal motility(219). In a single blinded, placebo-controlled 
manometric study of 11 healthy patients comparing oral AZI, midecamycin acetate to 
placebo, Sifrim et al. (317) found that oral AZI 500mg single dose or 250mg b.i.d 
statistically increased the postprandial antral motility index as compared with placebo. In 
addition, a recent study showed a statistically significant increased incidence of 
gastrointestinal side-effects (mainly nausea and diarrhoea) in a group of COPD patients 
in those on AZI suggesting an AZI-induced gastro-duodenal hypermotility as the cause 
(318). Finally, a case report using AZI in an elderly patient with diabetic gastroparesis 
showed symptom improvement after a 3-day treatment with intravenous AZI (319).  
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28.1 Aim  
 
The aim of this study was to assess the effect of AZI on oesophageal motility in patients 
with IOM. Secondary outcome measures include the impact of AZI on gastro-
oesophageal reflux parameters, gastric emptying, dysphagia and reflux symptoms.  
 
29 MATERIALS AND METHODS 
 
29.1 Subjects and study protocol 
Patients referred for oesophageal high resolution manometry who were diagnosed with 
IOM according to the modified Chicago Classification (236) were selected. 740 patients 
with IOM were identified from a pool of nearly 5000 patients referred for oesophageal 
manometry assessments within two centres, Royal London Hospital and Guy’s Hospital. 
Eventually, twenty-six patients fulfilled all the criteria and successfully completed all 
treatment phases and physiological testing. Patients selected for this study were those 
who present with one or a combination of dysphagia, heartburn and regurgitation. 
Excluded patients were those with: 1) motility disorders other than oesophageal 
hypomotility such as spastic contractions or OGJ obstructions, 2) Barrett’s oesophagus 
larger than 3 cm (endoscopic criteria), 3) hiatus hernia larger than 3cm 4) current cardiac 
diseases or abnormal ECG performed on each patient before entering the trial study. The 
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study protocol was approved by the NRES Committee South East Coast - Kent and 
informed consent was obtained from each subject.  
To evaluate the effect of AZI on gastro-oesophageal reflux and gastric motility all 
patients underwent reflux monitoring with MII-pH and gastric emptying measurements 
with octanoic acid breath tests before start of the treatment and on the day of taking the 
last dose of the medication (AZI or placebo).  
 
29.2 High resolution manometry protocol 
 
For details of high resolution manometry protocol see the chapter 2 “methodology”. The 
manometric protocol in the current study included a 5-min baseline recording, ten 5-ml 
water swallows, stimulation tests consisted of 3 sets of multiple rapid swallows each of 
which included 5 x 3ml of water in each set, ten swallows of 5-ml water with externally 
applied abdominal compression, and 10 swallows of 2 cm3 bread (164). 
 
29.3 HRM analysis 
The HRM plot of each swallow was analyzed for integrity of the 20 mmHg isobaric 
contour. Peristalsis was defined as intact if no break longer than 2 cm was observed in the 
isobaric contour. Failed peristalsis was defined by minimal (<3cm) integrity of the 
20mmHg isobaric contour distal to the proximal pressure trough. When the 20mm Hg 
isobaric contour was disrupted, the length of the break was measured using the dedicated 
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tools in each of the analysis software. Fragmented contractions were categorized as 
contractions with breaks larger than 5cm in the mid oesophagus. The Distal Contractile 
Integral (DCI in mmHg-s-cm) was calculated as amplitude of the oesophageal 
contraction (between the transition zone and the LOS) multiplied by the duration and 
length of peristalsis (59). IOM was defined if 1) 50% or more swallows were followed by 
failed or fragmented peristalsis or 2) 50% or more swallows triggered contractions with a 
DCI < 450 mmHg-s-cm (236). Normalising IOM was defined as either reducing the 
fragmentation to less than 50% of swallows showing >5cm gap in the peristalsis, or less 
than 50% of swallows show DCI < 450 mmHg-s-cm. 
 
Measurement of LOS baseline pressure was performed using dedicated tool in Bioview 
Analysis software. The average of end expiratory LOS pressure in at least 3 respiratory 
cycles in a quiescent area of the tracing (with no effect from swallows or artefacts) was 
measured. 
29.4 Reflux monitoring protocol 
 
For details of reflux monitoring see the chapter 2 “methodology”. The clearance time in 
this study was measured automatically by the Bioview Analysis software after manually 
editing the reflux events. 
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29.5 Gastric emptying 
 
For details of gastric emptying studies see the chapter 2 “methodology”. 
 
29.6 Symptom questionnaire 
 
To evaluate the effect of AZI on symptoms I used the following questionnaires: 
Dysphagia Odynophagia Questionnaire – This is a validated 10-item questionnaire that 
assesses the frequency of dysphagia, food impaction and odynophagia. Items are scored 
from 0-5, using a Likert scale where higher scores represent worse symptoms. A total 
score out of 50 is calculated – higher scores represent more severe dysphagia. A score of 
>5 has 86% sensitivity and 97% specificity for identifying the presence of dysphagia 
(Escobar, Pandolfino et al. 2011). 
 
Reflux symptoms were assessed using the Reflux Disease Questionnaire (RDQ)  (232) – 
This is a 12-item self-administered questionnaire, was designed to assess the frequency 
and severity of heartburn, regurgitation, and dyspeptic complaints and to facilitate the 
diagnosis of GORD in primary care (232). It scores 12 individual items relating to the 
frequency and severity of reflux, using Likert scale, where 0 represents the most negative 
option and 5 the most positive one. A raw score is calculated for domains of heartburn 
(score: 0-20), regurgitation (score: 0-20) and dyspepsia (score: 0-20), the scores of 
heartburn and regurgitation can be combined to give a total GORD score (0-40). 
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Psychological assessment was performed using Hospital Anxiety and Depression Scale 
(HADS) (233). This is a fourteen item scale that generates ordinal data. Seven of the 
items relate to anxiety and seven relate to depression. Each item on the questionnaire is 
scored from 0-3 and this means that a person can score between 0 and 21 for either 
anxiety or depression. 
 
29.7 Treatment with AZI/placebo  
 
Patients received AZI 250mg orally three times per week on alternate days (214) for four 
weeks. Identical placebo was administered in the same way. Both placebo and AZI were 
packed and blinded by the manufacturer (Newcastle Specials, Newcastle upon Tyne, 
England, UK). Randomization was done by automated software in ratio of 1:1. This study 
used a double-blind, placebo controlled, parallel design (Figure 58). 
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Figure 58 – AZI study protocol 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
 
 
 
Dysphagia and GORD Questionnaire 
Oesophageal stimulation tests:  
1. MRS 
2. Abdominal compression 
3. 10-15 minutes rest 
4. Solid bolus swallows 
 
Basal oesophageal HRM 
 
 
 
Patient Screening,                           
Obtaining Informed Consent 
Treatment with 
Azithromycin 4 weeks 
(13 patients) 
 
 
Randomisation of patients  
Treatment with placebo 
 4 weeks (13 patients) 
All assessments on the day of the last dose of treatment:  
1. MRS 
2. Abdominal compression 
3. 10-15 minutes rest 
4. Solid bolus swallows 
- Gastric emptying test 
- MII-pH reflux test 
 
 
  
- Gastric emptying test 
- MII-pH reflux test (24hr study) 
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29.8 Statistical analysis 
 
The primary outcome measure used in the analysis of the data was the drug-induced 
change in distal contractile integral (DCI). The cut off level of DCI to diagnose IOM  is 
450 mmHg.cm.s (236). I expected that the increase of DCI post azithromycin therapy to 
be at least 50% above the baseline. For the calculation of sample size I considered the 
level of significance of the test to be 0.05 and the power of the test to be 80%. Using 
these criteria, the required number of participants in each arm (azithromycin and placebo) 
was 13 subjects. 
Comparisons among the variables from Azithromycin and placebo group were made 
using contingency tables and non-parametric analysis appropriately (Mann-Whitney 
analysis when the data is paired and Wilcoxon Signed Rank Test when the data is 
unpaired). A P-value <0.05 was accepted as statistically significant. The data are 
presented as mean (±SD.) or median (±interquartile range) as appropriate. 
 
30 RESULTS 
30.1 Subjects 
Review of our HRM database identified 740 patients with IOM. These patients were 
contacted and invited to participate in the study. A total of 44 patients were recruite based 
on their original HRM findings reporting IOM but after entering the study and 
performing HRM, 19 patients were excluded because they did not have significant 
Page 204 of 281 
 
hypomotility. Twenty-six patients [twelve female, median age 54 (25–75 years)] fulfilled 
the criteria and successfully completed all treatment phases and physiological testing (13 
patients in each arm of the study). (Figure 58) 
Figure 59 - Number of patients recruited 
 
 
 
 
 
The HADS (psychological scoring) was used to compare the psychological profile before 
the treatment between the two groups in order to exclude psychological differences that 
can influence the effect of drugs on symptoms. HADS score pre-treatment was 5.2 ± 4.7 
in AZI group and 9 ± 5.1 in placebo group (NS).  
Azithromycin was not associated with any severe side-effects and no patient discontinued 
the treatment due to side effects. In AZI group loose stool was reported by 1 subject, 
abdominal cramps by 3 and nausea by 1. In placebo group one patient reported 
experiencing abdominal cramps and one patient nausea.  
Double blindedness of the study should not be affected due to the symptoms as in both 
arms of the study the participants were guessing to be either on AZI or placebo almost 
equally.  
740 patients with IOM identified 
 
44 patients recruited 
26 patients successfully completed 
(13 patients in each arm of the study) 
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30.2 Effect of Azithromycin on oesophageal motility (primary outcome) 
Azithromycin increased the DCI from 337.7 ± 286.2 mmHg.cm.s to 617.8 ± 384 
mmHg.cm.s (P< 0.01). Placebo increased the DCI from 374.9 ± 235.9 mmHg.cm.s to 
484.4 ± 260 mmHg.cm.s (P< 0.01). Comparing the change of DCI against pre treatment 
session there was no significant difference between AZI and placebo groups (P< 0.1). 
The % increase of DCI after AZI was 162.9±361.2 whereas  the % increase of DCI after 
placebo was 64.5±92.8.  
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Figure 60 – Comparison of DCI pre and post treatment with AZI and placebo. *Change of DCI against baseline was 
significant in both group. 
 
30.3 Effect of Azithromycin on IOM 
In the AZI group 9 patients had IOM, with DCI <450 mmHg.cm.s.  All 13 had 
fragmented peristalsis. In the placebo group 8 patients had IOM with DCI <450 
mmHg.cm.s and 5 with fragmented peristalsis.  
In total, AZI significantly changed IOM, either due to normalising the DCI or 
normalising the fragmented peristalsis. Normalising both DCI and fragmentation together 
occurred in 4/13 patients in AZI group and none in placebo group. 
AZI normalised IOM in 5/9 patients with abnormal DCI whilst placebo did not show 
such effect in any of the patients with abnormal DCI (P = 0.039). 
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AZI normalised IOM in 7/13 patients with fragmented peristalsis whilst placebo 
normalized only 1patient (P< 0.03).   
AZI induced >50% increase in DCI in 7/9 patients whilst placebo induced >50% increase 
in DCI in 4/8 patients (P = 0.4).  
 
Calculation of Odds Ratio and Confidence Interval for the effect of AZI and placebo on 
normalising IOM: this data confirms the significance of the above findings 
 Rate Risk Ratio Odds Odds 
Ratio 
95% Confidence Interval 
of Odds Ratio 
AZI  0.44 0.8 
Placebo  0.92 
0.48 
12 
0.066 Observed = 0.6 
Lower limit = 0.005 
Upper limit = 0.75 
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30.4 Effect of AZI on LOS baseline pressure 
 
LOS baseline pressure was increased by AZI from 6.8 (2.3-14.6) mmHg to 11.1 (8.5-
16.1) mmHg  (P= 0.054). Placebo did not increase LOS pressure [7 (4.7-10.7) mm Hg to 
5.2 (2.8-13.3) mm Hg, (P= 0.9)].  
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Figure 61 – Comparison of LOS baseline pre and post treatment with AZI and placebo. 
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30.5 Effect of Azithromycin on gastric emptying 
11/26 patients had delayed gastric emptying (5 in the AZI group and 6 in the placebo 
group. Azithromycin did not affect gastric emptying significantly. During AZI, t ½ 
decreased from 134.8 ± 35.4 min to 124 ± 34.7 min (means, P< 0.4) whilst with placebo 
the change was from 135.5± 22.4 to 144.2±53.3 (means, P< 0.5). The number of patients 
who changed to normal gastric emptying was similar in both groups (AZI: 4 and placebo: 
3 patients). 
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Figure 62 – Comparison of gastric emptying half time pre and post treatments. 
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30.6 Effect of Azithromycin on gastro-oesophageal reflux  
 
From the 26 patients with IOM that completed the study, only 4 patients had pathological 
gastro-oesophageal reflux (3 in the AZI group and 1 in the placebo group). 
 
AZI trended to reduce the total number of reflux events (acid and non-acid) from 30.9 ± 
20.7 to 20.3±7.1 (P< 0.09). AZI trended to reduce the number of acid reflux from 22.4 ± 
18.9 to 12.6 ± 7.4 (P< 0.07).  Placebo did not affect number of reflux episodes [total 
(34.8 ± 30.5 to 30.4 ± 25.6, P< 0.4) or acid (21.3 ± 22.6 to 21.6 ± 20.1, P< 0.9) reflux]. 
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Figure 63 – Comparison of total number of reflux events pre and post treatments. 
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Figure 64 – Comparison of number of acid reflux events pre and post treatments. 
Azithromycin  trended to reduced reflux volume clearance time from 1.14% ± 0.9 to 
0.7% ± 0.4 (P< 0.1). Placebo increased clearance time from 1.04 ±1.1 to 1.2± 1.1 (P< 
0.2).  
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CLEARANCE TIME AZI vs placebo
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Figure 65 – Comparison of oesophageal clearance time pre and post treatments. 
 
In spite of reducing the number of acid reflux episodes and the clearance time, AZI had 
no significant impact on acid exposure time (AET) [AET changed from 3.2 (1.4-4.1) to 2 
(1.3-3.8); P< 0.6)].  
AET was pathological (pH >4.2) in 3 patients in the AZI group. In these patients, AZI 
reduced the number of acid reflux episodes from 57 (41-61) to 22 (16-30) (P< 0.2), 
clearance time from 2.4 (1-3.2) to 0.4 (0.2-1.9) (P< 0.2) and acid exposure time from 6.7 
(4.2-9.4) to 3.3 (2.1-8.4) (P< 0.5). AZI normalised acid exposure in 2/3 patients who had 
pathological reflux pre-treatment whilst the only patient with pathological acid exposure 
in the placebo group remained abnormal.  
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30.7 Effect of Azithromycin on symptoms 
 
Both AZI but not placebo showed significant improvement in the perception of 
dysphagia. In the AZI group the dysphagia score dropped from 12.45±9 to 9.1±7.4 (P< 
0.01, 95% confidence interval: 0.8630 to 4.228) whereas in the placebo group the drop 
was from 10.3±7 to 7±4.1  (4.5-9.5) (P< 0.06, 95% confidence interval: 0.1539 to 6.446). 
The change in dysphagia perception was not significantly different between patients on 
AZI and patients on placebo (P= 0.7). 
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Figure 66 – Comparison of dysphagia score pre and post treatments. (* significant change due to treatment 
compared to baseline). 
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Both AZI and placebo showed slight improvement (AZI showed borderline significant 
effect) in reflux symptoms. In the AZI group the reflux score went from 18.6 ± 13.5 to 
14.8 ± 12.6 (P< 0.049, 95% confidence interval: -0.02181 to 7.295) whereas in the 
placebo group the drop was from 21.7 ± 15.3 to 15.8 ± 11.1 (P< 0.08, 95% confidence 
interval: -1.031 to 10.36). There were no statistically differences between treatments.  
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Figure 67 – Comparison of reflux score pre and post treatments. 
 
30.8 Effect of correction of IOM on symptoms  
 
Patients that changed from IOM to non-IOM (either by change in DCI or fragmentation) 
in the AZI group showed reduction in their reflux scores from 13 ± 11.4 to 9.3 ± 8 
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(means, P< 0.07) and the dysphagia scores from 13.2 ± 9 to 10.7 ± 7.8 (means, P< 0.01). 
Patients who did not change from IOM to non-IOM showed no significant reduction in 
their reflux scores from 9.3 ± 10.6 to 7.3 ± 8.3 (means, P< 0.8) and the dysphagia scores 
from 14 ± 14.4 to 11 ± 12.9 (means, P< 0.06). 
 
31 Discussion 
 
This study assessed the effects of azithromycin on oesophageal body motility in a group 
of symptomatic patients with IOM.   
The main results were: 1. Change of DCI post-treatment with AZI was not significantly 
different from placebo (although both AZI and placebo changed DCI against baseline 
DCI in each group). 2. AZI converted IOM status to normal motility in half of the 
patients whilst placebo did not show such effect. 3. Azithromycin trended to increase 
LOS pressure 4. AZI did not accelerate gastric emptying. 5. AZI trended to reduce the 
number of acid reflux events and clearance times. 6. Both AZI and placebo improved the 
dysphagia and reflux symptoms scores similarly.  
To the best our knowledge there is no previous study describing the effect of 
azithromycin on oesophageal body motility in human. Most previous studies using 
prokinetics showed marginal increase in oesophageal body contractions. However, these 
studies were performed either in healthy subjects or in patients with GORD without 
severe hypomotility. Our results showed that AZI can improve motility diagnosis in a 
group of patients with IOM (severe hypomotility) to a normal motility status. This effect 
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was observed after four weeks of oral treatment whilst most previous studies on the 
prokinetic effect of this drug were performed after short treatment periods ( < 24 hours) 
(218, 219, 320). The effect of AZI on mean DCI, was larger than that observed with 
placebo suggesting a potential therapeutic gain which will require further clinical 
investigation to confirm due to not reaching significant P value. Furthermore, only AZI 
was able to normalize IOM by increasing DCI or changing the peristaltic pattern.  
 
A significant inter-individual variability in the effect of AZI was observed. The drug-
induced increased oesophageal motility was observed in a subgroup of patients with 
IOM. The reasons for such variability are unclear. Factors involved could be 1. severity 
or aetiology of the neuromuscular dysfunction, 2. doses of AZI administered or 3. 
Individual impaired efficacy after 4 weeks of treatment. A test to predict response to AZI 
would be desirable. I attempted to use provocative tests (pre-treatment) to predict 
response to AZI. (The results discussed in chapter 7).  
 
It is known that macrolides such as erythromycin have significant prokinetic effect in the 
oesophagus(67, 321, 322). However, there is lack of clinical efficacy for GORD in longer 
term use of macrolides (219, 323). In our study AZI showed significant effect on 
oesophageal motility diagnosis after 4 weeks of treatment. These results are encouraging 
for the clinical use of AZI in patients with demonstrated oesophageal hypomotility.  
AZI trended to increase LOS pressure more than placebo. This effect has been previously 
shown with other macrolide prokinetics (324). 
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The pressure increase was not significant (probably due to a type 2 error). In contrast, 
unlike previous studies (218, 219, 317, 320), I could not observe an effect of AZI on 
gastric emptying. The reasons for this are unclear.  It could be due to the fact that all our 
patients had normal gastric emptying at baseline making difficult to further accelerate 
normal emptying rate. Alternatively, the prolonged effect observed in the oesophageal 
body might have disappeared after 4 weeks of treatment from the stomach.   
 
AZI trended to reduce the number of reflux events and oesophageal clearance time. This 
effect of azithromycin on reflux parameters has previously been reported by other 
investigators (214, 325). Our study did not show statistically significant changes  in 
reflux parameters compared to placebo as demonstrated in other studies. This could be 
due to a type 2 error (the study was powered for the primary outcome i.e. change in DCI). 
Another explanation could be that very few of our patients had pathological reflux. 
Nevertheless, acid exposure of 2/3 patients was normalised by AZI whilst the only 
abnormal patient in placebo group remained abnormal. Alternatively, the effect of AZI on 
reflux parameters might be due to its effect on proximal gastric motility and position of a 
postprandial acid pocket (326, 327) (325, 328) rather than an effect on oesophageal 
motility.  
 
Both AZI and placebo improved the dysphagia and reflux symptoms scores similarly, 
The sensation of dysphagia was significantly improved in both groups. This is most likely 
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due to the placebo effect of the whole intervention and the care of patients during the 
course of this study. Furthermore, a previous study of our group showed a poor 
correlation between oesophageal motility and bolus transit (measured with impedance) 
and perception of dysphagia (329). 
 
31.1 Limitations 
 
In the current study I observed a trend or borderline significant results in several 
parameters which could theoretically become significant by higher number of the 
participants in this study. Moreover, recruiting more patients with IOM and pathological 
gastro-oesophageal reflux might help defining the effect of AZI on both reflux 
parameters and gastric emptying more precisely. 
 
31.2 Conclusion 
 
Our investigation shows that AZI has subtle effects on DCI that did not appear to be as 
dramatic as it was hoped for. Nevertheless this medication can convert IOM to normal 
motility to a significantly higher extent compared to placebo. This finding might suggest 
that, if future studies based on this pilot study can confirm the positive effect of AZI, it 
can potentially play a role in treatment of conditions associated with IOM such as 
dysphagia and GORD. 
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CHAPTER 7: Predictive factors of response to 
Azithromycin in patients with IOM 
 
32 Introduction 
Oesophageal peristaltic function is compromised in patients with peptic oesophagitis 
and/or those presenting with dysphagia (147), with a high incidence of failed peristalsis 
and hypotensive peristaltic contractions. Oesophageal clearance is compromised 
significantly when the amplitude of peristaltic contractions in the distal oesophagus falls 
to values below 25-30 mm Hg (58, 56). With the advent of high-resolution manometry 
(HRM) and oesophageal pressure topography IOM is defined 238 as 50% or more 
swallows with failed or fragmented peristalsis or 2) 50% or more swallows associated 
with a DCI < 450 mmHg-s-cm. Absent or incomplete peristaltic contractions invariably 
result in little or no volume clearance. It was demonstrated that a minimal regional 
peristaltic amplitude is required to prevent retrograde escape of gastric content (56, 330). 
Correcting this dysfunction might improve symptoms in these patients. Unfortunately, 
there are no proven treatments for improving oesophageal dysmotility(331). 
Several prokinetic agents can stimulate gastrointestinal motility such as erythromycin, 
metoclopramide, domperidone and cisapride which have been used in adults and 
paediatric patients with IOM (211) with variable and somewhat disappointing results 
(331). It is possible that such disappointing results were due to combining patients from 
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across the GORD or dysphagia spectrum instead of targeting those patients with 
reversible oesophageal hypomotility. IOM can be due to impaired neuromuscular control 
of oesophageal motility and/or a structural muscle dysfunction i.e. fibrosis in 
scleroderma. The pathogenesis and degree of reversibility of IOM in an individual patient 
would determine response to prokinetic therapy.   
 
I performed a placebo controlled trial on the effect of the macrolide AZI on IOM in 
patients with dysphagia and GORD (see chapter 6). AZI had a positive effect (compared 
to baseline and placebo) in a subgroup of patients in whom AZI improved DCI and 
normalised IOM.   
 
It is not known which factors are able to predict response to prokinetic therapy in patients 
with IOM. It has been hypothesised that oesophageal stimulation tests could assess the 
reserve capacity in oesophageal neuromuscular system and hence predict the response to 
prokinetic therapy. The stimulation tests used in this study. – (multiple swallows of 
water, increasing outlet resistance at GOJ by applying abdominal compression, bread 
swallows ) - use different pathways to stimulate oesophageal contraction. Multiple rapid 
swallows particularly requires intact deglutitive inhibition and preserved excitatory 
mechanism to provoke after MRS contraction (281). Bread swallows requires preserved 
afferent pathway to detect the presence of the solid bolus in the oesophageal body and 
effective excitatory efferent pathway to enhance the strength and coordination of 
oesophageal contractions (282). Abdominal compression requires an intact mechanism 
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that detects increased resistance at the GOJ level and increases excitatory pathways to 
augment the strength of contraction to overcome the resistance and assure oesophageal 
emptying (234, 256, 263, 283). 
In this chapter, I assessed the predictive value of the stimulation tests for positive 
response to Azithromycin in patients with ineffective oesophageal motility 
 
33 Materials and methods  
 
33.1 Patients 
In the AZI group 9 patients had IOM with DCI <450 mmHg.cm.s.  The other 4 patients 
were included based on presence of fragmented peristalsis. 
AZI normalised IOM in 5/9 patients with abnormal DCI and corrected fragmented 
peristalsis in 8/13 patients. When both DCI and fragmentation criteria was combined, 
AZI normalised 8/13 patients. 
For the purpose of assessment of predictive factors of positive response to AZI, I 
performed 2 analyses. First, I considered as responders only those 5 patients that had 
significant increase in DCI. Second, I considered responders all patients that normalized 
IOM i.e. increased DCI and/or improved fragmented peristalsis.  
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33.2 Predictive value of the stimulation tests  
 
I determined the average baseline DCI before provocative tests (during single water 
swallows) and the DCI at the after-contraction following multiple rapid swallows; during 
bread swallows and during water swallows under abdominal compression. Thereafter, I 
calculated a  provocative test/wet swallow DCI ratio.  
A ROC analysis was used to determine the threshold for each parameter that best 
discriminated patients with good response to AZI. Thereafter, I calculated the sensitivity, 
specificity, predictive values and likelihood ratios.  
 
34 Results  
 
The first analysis considered as responders all patients that improved their motility with 
AZI to a non-IOM condition i.e. 8/13 patients had significant increase in DCI and/or 
normalised the peristaltic fragmentation.   
ROC analysis showed the following results: 
The best threshold value for DCI after MRS was ≥248 mmHg.cm.s. This cut off value 
could segregate responders to AZI from non-responders with a sensitivity of 78%, 
specificity of 75%, PPV of 87.5%,  NPV of 60% and the LR of 3.11. 
The ability of DCI to identify patients responders to AZI during bread swallows and 
abdominal compression was lower than DCI after MRS and are shown in table 18.  
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Combining the criteria for DCI after MRS and DCI during abdominal compression 
yielded in a sensitivity of 67% and negative predictive value of 80%. 
 
In a second analysis, the ratio of the DCI of each stimulation test/baseline DCI was 
calculated. The optimum cut off value for the ratio of DCI after MRS was >1.2. This cut 
off value could segregate responders to AZI from non-responders with a sensitivity of 
78% , specificity 75%, PPV 87.5%, NPV 60% and the LR of 3.11. 
The ability of DCI ratios to identify patients responders to AZI during bread swallows 
and abdominal compression was lower than DCI ratios after MRS and are shown in 
table18.  
 
In a third analysis I considered as responders only those 5 patients who had significant 
increase in DCI with AZI to a non-IOM condition. 
The best threshold value for DCI after MRS was ≥395 mmHg.cm.s. This cut off value 
could segregate responders to AZI from non-responders with a sensitivity of 80%, 
specificity 75%, PPV was 80%, NPV 75% and LR 3.2. 
The best cut-off value for DCI during bread swallows was >296mmHg.cm.s. Using this cut 
off, the sensitivity was 60 the specificity was 50, the PPV was 60 the NPV was 50 and 
the LR was 1.2. 
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The best cut-off value for DCI during abdominal compression was >587 mmHg.cm.s. 
Using this cut off, the sensitivity was 80% the specificity was 75%, the PPV was 80% the 
NPV was 75% and the LR was 3.2. 
 
Combining the criteria for DCI after MRS and DCI during abdominal compression 
increased sensitivity and negative predictive value to 100%. 
 
 
 
 
Table 18 – Predictive value of the stimulation tests 
Predictive value of the stimulation tests based on DCI and peristaltic fragmentation of 
oesophageal response to tests (Pure DCI values) 
 
Pure DCI of 
stimulation tests 
Sensitivity 
% 
Specificity 
% 
Likelihood 
ratio 
Positive 
predictive 
value % 
Negative 
predictive 
value % 
Area 
under 
ROC 
curve 
Multiple rapid 
swallow DCI (≥248 
mmHg.cm.s) 
78 75 3.11 87.5 60 0.6 
Bread swallow DCI 
(<565mmHg.cm.s) 
60 33.3 0.9 75 20 0.7 
Swallow with 
abdominal 
compression DCI 
(>769 mmHg.cm.s) 
80 50 1.6 50 80 0.65 
Combining MRS and 
abdominal 
compression  
67 40 1.11 25 80 na 
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Predictive value of the stimulation tests based on DCI and peristaltic fragmentation of 
oesophageal response to tests (Ratios) 
 
Ratio of stimulation 
test/baseline swallow 
DCI 
Sensitivity 
% 
Specificity 
% 
Likelihood 
ratio 
Positive 
predictive 
value % 
Negative 
predictive 
value % 
Area 
under 
ROC 
curve 
Multiple rapid 
swallow/ baseline 
(>1.2) 
78 75 3.11 87.5 60 0.67 
Bread swallow / 
baseline (<2.1) 
56 25 0.7 62.5 20 0.72 
Swallow with 
abdominal 
compression / baseline 
(>3.9) 
80 50 1.6 50 80 0.57 
Combining MRS and 
abdominal 
compression  
100 50 2.25 50 100 na 
Predictive value of the stimulation tests based on DCI of oesophageal response to tests  
 Sensitivity 
% 
Specificity 
% 
Likelihood 
ratio 
Positive 
predictive 
value % 
Negative 
predictive 
value % 
Area 
under 
ROC 
curve 
Multiple rapid 
swallow DCI (≥395 
mmHg.cm.s) 
80 75 3.2 80 75 0.85 
Bread swallow DCI 
(>296mmHg.cm.s) 
50 20 0.6 50 20 0.5 
Swallow with 
abdominal 
compression DCI 
(>587 mmHg.cm.s) 
67 50 1.33 75 40 0.75 
Combining MRS and 
abdominal 
compression  
100 67 3 60 100 na 
 
 
 
 
Page 227 of 281 
 
35 Discussion 
 
In the current chapter, I assessed the oesophageal body response to stimulation tests to 
identify patients with clear oesophageal hypomotility who are more likely to respond to 
AZI therapy. I hypothesized that such stimulation tests could reveal the degree of 
preserved contractile capacity in patients with ineffective oesophageal motility (255-258, 
332). Theoretically, those patients with preserved contractile capacity would be the 
responders to prokinetic therapy with AZI. 
 
I analysed the contractile response to AZI in 3 different ways. First I considered 
responders all patients that normalized the IOM (increasing their DCI and/or improving 
peristaltic fragmentation). Second, I calculated a ratio between DCI after the tests and 
DCI at baseline and I used such ratio to segregate patients. Finally, I only consider as 
responders those patients that normalized the DCI (without considering fragmentation).  
 
The general results of these analysis showed that the predictive value of stimulation tests 
is moderately good (the areas under ROC curves were between 0.5 and 0.85 and the 
likelihood ratios were between 0.7 and 3.2). The best predictors were the absolute value 
of DCI after MRS and during abdominal compression. Furthermore, combining these two 
stimulation tests increased the negative predictive value of the tests. Interestingly, the 
worst predictor was the DCI during bread swallows.  
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Previous studies have shown that multiple rapid swallowing is a reliable maneuver to test 
the reserved neuromuscular oesophageal capacity (255, 256).  Studies by Gyawali et.al, 
using a similar analysis of DCI before and after fundoplication, concluded that multiple 
rapid swallowing has a predictive value to identify patients that will develop late 
dysphagia after anti reflux surgery (255, 258). In the current study, I found that patients 
that responded to AZI had higher contractile response to provocative tests such as MRS.  
Previous studies have reported the effect of increased oesophageal outlet resistance on 
generating an immediate increase of DCI (333). Our study suggests that presenting a 
more vigorous response to abdominal compression can also be interpreted as having 
sufficient reserved capacity to respond to AZI.  
 
Interestingly, analysis of combined MRS and abdominal compression provided a very 
high negative predictive value, suggesting that a patient with oesophageal hypomotility 
that is unable to increase contractility after MRS and abdominal compression is unlikely 
to respond to prokinetic therapy such as AZI or other similar drugs.   
 
A significant limitation of this study is the small number of patients analysed. It is 
possible that the results are influenced by such small number. Therefore, I still consider 
these results as preliminary and will need to increase the number of patients to provide 
more definite conclusions. 
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The low likelihood ratios that I observed with our tests suggest that other parameters such 
us duration and severity of IOM, age, BMI etc. might be involved and could have an 
impact on response to AZI. 
 
In conclusion, our preliminary results suggest that provocative tests such as multiple 
rapid swallowing and/or swallows with abdominal compression can assess oesophageal 
peristaltic reserve in the oesophageal body. Assessment of such reserve capacity might 
have clinical value during evaluation of patients with IOM and,may help predicting the 
response of these patients to prokinetic therapy.  
. 
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Chapter 8 
General discussion  
and future prospects 
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Chapter 8: General discussion 
 
IOM is a common diagnosis in upper GI physiology units in general. Smout et al reported 
OH with or without hypotensive LOS in 58% of 2610 patients referred for oesophageal 
manometry(66) (they used the term OH which is a more generic term than IOM). Others 
reported IOM in 27–32% of patients presenting with non-obstructive dysphagia without 
GORD(67-70). It is also the most prevalent oesophageal motor disorder in GORD, found 
in 21–38% of patients in large series(69, 71-73). 
 
Pathogenesis of IOM is not completely understood. IOM can be secondary to other 
diseases or a primary entity.  Impaired cholinergic stimulation is considered to be the 
main defect underlying IOM (90). Few myopathic pathologies such as Progressive 
Systemic Sclerosis can produce oesophageal hypomotility(91).  IOM can be observed in 
patients without evidence of GORD or connective tissue disorders. It is suggested that 
patients with IOM may have an imbalance between excitatory and inhibitory neural 
activity in the oesophageal body, due to an abnormal ratio between choline 
acetyltransferase (ChAT) and nitric oxide synthase (nNOS) by neurons in the myenteric 
plexus(91).  
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In GORD, inflammatory mediators, such as interleukin-6 and platelet-activating factor, 
produced during acute oesophagitis, can reduce acetylcholine release from excitatory 
myenteric neurons to circular smooth muscle(89, 106, 107).  
 
Symptoms associated with IOM include dysphagia, odynophagia, heartburn and 
regurgitation. Also, extra-oesophageal symptoms such as cough(146), globus and 
hoarseness are attributed to oesophageal hypomotility. However, there is no clear 
agreement between objective measurements of oesophageal function and subjective 
perception of bolus passage i.e. dysphagia. Increased bolus passage perception in patients 
without mechanical obstruction might be due to oesophageal hypersensitivity (329). 
Therefore, symptom based diagnosis is not reliable in patients with swallowing problems, 
heartburn and other dyspeptic complaints (154, 155).  
 
Oesophageal manometry is considered  the gold standard for diagnosis of IOM. Using 
high-resolution manometry IOM is defined238 as 50% or more swallows with failed or 
fragmented peristalsis or 2) 50% or more swallows associated with a DCI < 450 
mmHg.cm.s. HRM cannot distinguish the underlying cause of the oesophageal 
hypomotility i.e. structural i.e. scleroderma versus neural imbalance i.e. GORD.  
In the process of developing treatment strategies in oesophageal hypomotility, testing the 
potential reversibility of IOM in patients could be useful to predict the response of these 
patients to new treatments and prokinetic drugs. Provocative tests during HRM include 
multiple rapid swallows (MRS), solid bolus swallows (252), and abdominal compression 
test. Responses to provocative/stimulation tests may be useful to assess the reserve 
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capacity of oesophageal motility (253). For example, multiple rapid swallows test may 
predict the likelihood of postoperative dysphagia in patients undergoing antireflux 
surgery(254, 255). 
 
IOM can improve with treatment of associated reflux disease and/or with prokinetic 
medications (Fornari et al 2007). Prokinetics like erythromycin, metoclopramide, 
domperidone and cisapride have been used in adults and paediatric patients (159, 205, 
211, 212, 214, 225, 259, 299-304) with variable and somewhat disappointing results. A 
partial explanation for the disappointing results in clinical practice and clinical trials 
could be that patients were prescribed prokinetic therapy based on symptoms or reflux 
monitoring without considering their oesophageal motility status. Theoretically, only 
patients with significant oesophageal hypomotility would benefit from prokinetic drugs.  
 
The research studies that conform this PhD thesis aimed to establish a methodology for 
identification of patients with sufficient reserved oesophageal neuromuscular 
functionality to respond to prokinetic therapy. Therefore, I aimed to: 1. assess IOM in 
patients with non-obstructive dysphagia and GORD, using HRM; 2. develop and 
standardize a set of “stimulation tests” to assess degree of IOM reversibility, 3. treat IOM 
with a prokinetic agent and assess the outcome on oesophageal  motility, dysphagia and 
GORD; 4. evaluate the role of stimulation tests in predicting manometric and clinical to 
prokinetic therapy in patients with  IOM. 
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36 High resolution manometry 
 
 
The evaluation of oesophageal motor function may be influenced by the manometric 
system employed. HRM can be performed with devices manufactured by different 
companies. I first established the normal range for high resolution manometry values 
using a Sandhill-Unisensor AG assembly and compared our data with the values 
published by the consensus Chicago group using the Sierra Scientific Instruments system 
(59).  
 
Our findings from this comparison revealed that the normal values of the parameters 
investigated with Unisensor AG assembly had some differences from those of the 
previous studies that used the MonoScan system. While the normal values for DCI in our 
study were similar to the data previously established by Chicago Classification, the CFV 
and DL cut offs were slightly different. Even more importantly, the upper cut off for IRP 
in the supine position utilized in the Chicago Classification is 15 mmHg (248), whereas 
according to our results with the Unisensor AG HRM device it should be 23.5 mmHg. 
This is a particularly important issue because IRP is a key measurement in the HRM 
criteria to decide on the completeness of the LOS relaxation during  diagnosis of 
achalasia (249).  
 
Our results, taken together with those of Smout et al (247) and of Shi et al, indicated that 
HRM systems using the Unisensor AG catheter provides consistently higher IRP values  
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in healthy volunteers than those of ManoScan system used to establish the Chicago 
classification.  
37 Oesophageal stimulation tests 
 
 
Current diagnostic classifications for conventional and HRM are based on repeated small 
volume water swallows in the supine position (55, 248). Some authors have 
recommended performing stimulation tests such as solid swallows (164), to increase 
sensitivity to symptomatic dysmotility and dysfunction; In our studies I established  
normal values for HRM parameters of peristaltic and OGJ function during stimulation 
tests. 
 
The mean of the differences in DCI produced by each of the stimulation tests were 
compared against single water swallows. All three stimulation tests were able to induce 
DCIs significantly higher than single swallows of water.  
 
MRS yielded the lowest IRP amongst all the swallowing tests. Multiple swallows provide 
enough time for the LOS to relax completely and there is no increased intrabolus pressure 
as in bread swallows. From previous studies (164, 256, 273) it was expected an increase 
in IRP during bread swallows (61). Our study confirmed this concept.  
 
Effects of bolus consistency and load on oesophageal function were consistent with 
previous studies using conventional and high-resolution manometry (159, 274, 275). As 
expected from previous studies (164), as workload increased, oesophageal contractile 
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response was slower [lower contraction front velocity (CFV)], better coordinated (shorter 
transition zone) and more vigorous [greater distal contractile integral (DCI)].  
The peristaltic break i.e. transition zone during stimulation tests was shorter than during 
single water swallows. This was more pronounced during. bread swallows.   
MRS was found to be the stimulation test with the highest provocative capacity to induce 
stronger contractility in the oesophageal body.  
 
Overall reproducibility of stimulation tests in oesophageal HRM data was good. There 
was minimal difference between inter and intra-individual %COV. In addition, 
concordance testing showed that significant but not perfect concordance values were 
found for all stimulation tests. This supports the use of stimulation tests as additional 
tools in the clinical evaluation of the patients with oesophageal motor disorders in order 
to assess the reserved oesophageal neuromuscular capacity.  
 
 
What are the potential mechanisms that trigger increased contractions during stimulation 
tests? Oesophageal mechano-receptors (stretch sensors) are probably initially implicated 
in the 3 stimulation tests.  In the outlet obstruction induced by abdominal compression, 
the increased resistance against the passage of bolus and peristaltic propelling pressure 
provokes increased wall expansion and stretch. Such stimulus can trigger a peripheral 
reflex (in the oesophageal wall) resulting in increased circular and longitudinal  smooth 
muscle contraction in the segment above the bolus via a cholinergic, muscarinic 
mechanism (285, 286). Furthermore, changes either in the preload (muscle length or 
stretch) or afterload (the mass of the bolus) induces contraction with higher amplitude 
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(287, 288). Finally, pressure sensors in the abdominal cavity or stomach might stimulate 
the afferent limb of a vago-vagal reflex arch modulating oesophageal peristalsis(287, 
289).  
 
Similar mechanisms can explain the effect of bread swallows. However, the after 
contraction at the end of multiple rapid swallowing probably requires an additional 
central input from central nervous system. During repetitive  swallows, there are central 
inhibitory signals transmitted to the oesophageal body causing hyperpolarisation of the 
smooth muscle cells leading to a strong after-contraction (290). 
 
In normal subjects, the different stimulation tests used in this study were able to trigger 
increased oesophageal contractility. Peripheral and central pathways are involved. The 
MRS uses more central and the abdominal compression and bread swallows more 
peripheral pathways. In our study I used the tests to assessed reserve capacity of patients 
with severe hypomotility. I identified a group of patients with appropriate reserve 
capacity (hypomotility in basal condition and increased contractility during stimulation).  
 
I could not demonstrate significant differences in response to stimulation tests between 
IOM patients with reflux or presenting with dysphagia. However, I identified a trend 
towards a more severe failure i.e. worse reserve capacity in reflux patients compared to 
patients with dysphagia.  
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I hypothesized that a distinct response to stimulation test would predict the predominant 
symptom. However, our findings did not support such a hypothesis. There was no clear 
difference in response to stimulation tests between patients with predominant reflux 
symptoms compared to patients with predominant dysphagia.  
More than one third of patients with reflux symptoms and pathological acid gastro-
oesophageal reflux (37,5%) had all three stimulation tests abnormal whilst this finding 
was the least frequent in the dysphagia group (10%) (it should be noted that I had only 34 
patients studied in this section).  
Based on this trend, I could speculate that the mechanism underlying oesophageal 
hypomotility in reflux disease is different from that in dysphagia. Tutuian et al reported 
that a higher proportion of oesophageal motility abnormalities during bread swallows was 
observed in patients with chest pain and GERD symptoms compared to patients with 
dysphagia (284).  
 
The IRP in patients with dysphagia was slightly higher than in the reflux group 
suggesting that increased intrabolus pressure associated with a higher distal resistance 
might be more relevant to dysphagia sensation than the severe hypomotility alone. In 
contrast, patients with lower IRP (reflux group) had more abnormal response to all three 
stimulation tests, suggesting that a better motility response to stimulation tests has less 
impact in dysphagia perception.  
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38 Proximal hypomotility and clinical presentation of IOM patients  
 
 
While significant interest has appropriately been focused on the distal oesophagus and 
OGJ in the clinical presentation of oesophageal hypomotility, the functional role of the 
proximal oesophagus has received sparse attention. Historically, this was primarily due to 
the lack of an appropriate technology to facilitate a detailed segmental analysis of 
oesophageal peristalsis. The introduction of HRM offers us an opportunity to improve 
upon this by standardising the testing protocol and facilitating quantitative analysis of 
proximal oesophageal motility. With the use of a state-of-the-art HRM probe, I sought to 
firstly define proximal oesophageal normal motility and secondly define proximal 
oesophageal hypomotility. Finally, I examined the prevalence of proximal hypomotility 
in patients with severe distal hypomotility and evaluated the clinical relevance of 
proximal hypomotility in this group of patients. 
 
Normal range for proximal contractile integral (PCI) representing proximal motility 
vigour in our study was significantly smaller than the figures presented by other groups 
(64). This could be mainly due to the use of higher isobaric contour pressure in our study 
compared to other studies (20mmHg vs 10mmHg) which significantly reduce the area of 
the contractility. When higher threshold is selected, the area under isobaric contour will 
be reduced. 
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Proximal hypomotility occurred in one third of patients with severe distal hypomotility. 
Proximal oesophageal hypomotility can arise due to multiple factors such as weakening 
of the muscle e.g. myasthenia gravis, mechanisms affecting excitatory cholinergic 
pathways e.g. anticholinergic medications, or enhanced inhibitory mechanisms ie NO 
pathway. The majority of the patients with proximal oesophageal hypomotility presented 
with dominantly reflux symptoms rather than dysphagia. The reflux score was higher in 
patients who presented with oesophageal hypomotility in both proximal and distal 
oesophagus.  
 
39 Treatment of IOM with Azithromycin 
 
 
I investigated the effects of azithromycin on oesophageal body motility in a group of 
symptomatic patients with IOM.   
The main results were: 1. there is an indication that Azithromycin may significantly 
increase oesophageal body motility (DCI). 2. AZI converted IOM status to normal 
motility in half of the patients whilst placebo did not show such effect. 3. Azithromycin 
trended to increase LOS pressure 4. AZI did not accelerate gastric emptying. 5. AZI 
trended to reduce number of acid reflux events and clearance times. 6.AZI improved the 
dysphagia and reflux symptoms scores similar to placebo.  
 
To the best our knowledge there is no previous study describing the effect of 
azithromycin on oesophageal body motility in humans. Most previous studies using 
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prokinetics showed marginal increase in oesophageal body contractions. However, these 
studies were performed either in healthy subjects or in patients with GORD without 
severe hypomotility. Our results showed that AZI can improve motility in a group of 
patients with IOM to a normal motility status. This effect was observed after four weeks 
of oral treatment whilst most previous studies on the prokinetic effect of this drug were 
performed after short treatment periods ( < 24 hours) (218, 219, 320). The effect of AZI 
on DCI, was larger than that observed with placebo suggesting a potential therapeutic 
gain. Furthermore, only AZI was able to normalize IOM by increasing DCI.  
 
I observed a significant inter-individual variability in the effect of AZI. The drug-induced 
increased oesophageal motility was observed in a subgroup of patients with IOM. The 
reasons for such variability are unclear. Factors involved could be 1. severity or aetiology 
of the neuromuscular dysfunction, 2. doses of AZI administered or 3. individual impaired 
efficacy in longer term treatment.  
 
It is known that macrolides such as erythromycin have significant prokinetic effect in the 
oesophagus (67, 321, 322). However, there is lack of clinical efficacy for GORD in 
longer term use of macrolides (219, 323). In our study AZI showed indication of possible 
significant effect on oesophageal motility after 4 weeks of treatment. These results are 
encouraging for the clinical use of AZI in patients with demonstrated oesophageal 
hypomotility.  
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AZI trended to increase LOS pressure more than placebo. This effect has been previously 
shown with other macrolide prokinetics (324). The pressure increase was not significant 
(probably due to a type 2 error). In contrast, unlike previous studies(218, 219, 317, 320), 
I could not observe an effect of AZI on gastric emptying. The reasons for this are unclear.  
It could be due to the fact that all our patients had normal gastric emptying at baseline 
making difficult to further accelerate normal emptying rate. 
 
AZI trended to reduce the number of reflux events and oesophageal clearance time. The 
significant effect of Azithromycin on reflux parameters has previously been reported by 
other investigators(214, 325). Our investigation did not show statistically significant 
changes in reflux parameters compared to placebo as was demonstrated in other studies. 
This could also be due to type 2 error (the study was powered for the primary outcomes 
i.e. change in DCI). Another explanation could be that very few of our patients had 
pathological reflux. Nevertheless, acid exposure of 2/3 patients was normalised by AZI 
whilst the only patient with abnormal acid exposure in the placebo group did not benefit 
from AZI. Alternatively, the effect of AZI on reflux parameters might be due to its effect 
on proximal gastric motility and position of a postprandial acid pocket (326, 327) (325, 
328) rather than an effect on oesophageal motility.  
 
Our investigation which is a pilot study shows that AZI may convert IOM to normal 
motility to a significantly higher extent compared to placebo. This finding might suggest 
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that AZI can potentially play a role in treatment of conditions associated with IOM such 
as dysphagia and GORD. 
 
 
 
40 Predictive value of stimulation tests for treatment of IOM with 
AZI 
 
 
I assessed the oesophageal body response to stimulation tests to identify patients with OH 
who are more likely to respond to AZI therapy. Our hypothesis was that such stimulation 
tests could reveal the degree of preserved contractile capacity in patients with ineffective 
oesophageal motility (255-258, 332). Theoretically, those patients with preserved 
contractile capacity would be more likely to respond to prokinetic therapy with AZI. 
 
The predictive value of stimulation tests was moderately good. The best predictors were 
the absolute value of DCI after MRS and during abdominal compression. Furthermore, 
combining these two stimulation tests increased the negative predictive value of the tests. 
Interestingly, the worst predictor was the DCI during bread swallows.  
 
Previous studies have shown that multiple rapid swallowing is a reliable manoeuvre to 
test the reserve neuromuscular oesophageal capacity (255, 256).  Studies by Gyawali et 
al, using a similar analysis of DCI before and after MRS, concluded that multiple rapid 
swallowing is able to identify patients who will develop late dysphagia after anti reflux 
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surgery (255, 258). I found that patients that responded to AZI had higher contractile 
response to provocative tests such as MRS. Previous studies have reported the effect of 
increased oesophageal outlet resistance on generating an immediate increase of DCI 
(333). Our study suggests that presenting a more vigorous response to abdominal 
compression can also be interpreted as having sufficient reserved capacity to respond to 
AZI.  
 
Interestingly, analysis of combined MRS and abdominal compression provided a very 
high negative predictive value, suggesting that a patient with OH that is unable to 
increase contractility after MRS and abdominal compression is unlikely to respond to 
prokinetic therapy such as AZI or other similar drugs.   
 
The low likelihood ratios that I observed with our tests suggest that other parameters such 
us duration and severity of IOM, age, BMI etc. might be involved and could have an 
impact on response to AZI. 
 
Our preliminary results suggest that provocative tests such as multiple rapid swallowing 
and/or swallows with abdominal compression may have clinical value during evaluation 
of patients with IOM and may potentially predict the response to prokinetic therapy.  
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41 Future prospects 
 
 
 
The research projects presented in this thesis aimed to study different aspects 
(pathophysiology, diagnosis and  treatment) of ineffective oesophageal motility (IOM). 
IOM is known to be prevalent in patients with GORD and/or dysphagia. However its role 
in pathophysiology of these conditions is not well established neither is there effective 
treatment available.  
The first studies characterized stimulation tests (multiple rapid swallowing, bread 
swallow and swallow with abdominal compression) in healthy volunteers. Subsequent 
studies assessed the therapeutic effect of Azithromycin in patients with IOM and the 
possible predictive factors for prokinetic therapy.  
 
I performed HRM in the semi-recumbent position in order to eliminate the effect of 
gravity on oesophageal motility. However, most dysphagia or reflux symptoms are 
perceived in the upright position. It may be useful to perform HRM in an upright position 
to establish normal values in more physiological conditions.  
 
Weak proximal motility is associated with presentation of the reflux symptoms. Patients 
with respiratory symptoms suspected of being secondary to oesophageal origin may 
benefit from the study of proximal oesophageal motility.  
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Azithromycin as a pilot study demonstrated indication of significant prokinetic effects on 
normalising IOM in a subgroup of patients with IOM. The treatment effects of AZI on 
oesophageal motility in the longer-term, the effect on symptoms and reflux parameters 
require further studies.  
 
Our preliminary results suggested that provocative tests such as multiple rapid 
swallowing and/or swallows with abdominal compression may assess oesophageal 
peristaltic reserve in the oesophageal body. This might have clinical value in the 
evaluation of patients with IOM to predict the response to prokinetic therapy. Further 
research is warranted to reproduce our results, and to determine if prokinetic therapy 
needs to be tailored to the response to MRS and swallow with abdominal compression.  
 
It would be worthwhile investigating the effect of newer prokinetic medications such as 
Prucalopride (a serotonin 5-HT4 agonist)(334), Mirtazapine (a noradrenergic and specific 
serotonergic antidepressant) (335) and Relamorelin (a ghrelin agonist) (336) on 
oesophageal motility in order to provide further treatment options for patients with IOM. 
 
Moreover, other stimulation tests such as edrophonium and bethanechol challenge tests 
may also play important role in further phenotyping the IOM patients and help with 
identifying and targeting the patients who have the potential to respond to prokinetic 
therapy. 
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The neuromuscular reserve in Parkinson’s disease and the elderly associated with IOM 
has not been studied and further investigations in this area could be invaluable to 
overcome dysphagia in these groups of patients. 
 
The role of hypomotility in refractory GORD has long been a matter for debate as to 
whether it is the consequence or the cause of GORD. It could be extremely valuable to 
study the effect of prokinetic therapy with the new targeting approach discussed in this 
PhD thesis on this group of patients.  Similarly, Barrett’s oesophagus is associated with 
hypomotility (337) and it is not known whether it is reversible after endoscopic ablation 
of the affected area of oesophagus and whether this can be predicted by stimulation tests.  
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